id	sid	tid	token	lemma	pos
iajs-3302	1	1	260	260	NUM
iajs-3302	1	2	this	this	DET
iajs-3302	1	3	work	work	NOUN
iajs-3302	1	4	is	be	AUX
iajs-3302	1	5	licensed	license	VERB
iajs-3302	1	6	under	under	ADP
iajs-3302	1	7	a	a	DET
iajs-3302	1	8	creative	creative	ADJ
iajs-3302	1	9	commons	common	NOUN
iajs-3302	1	10	attribution	attribution	NOUN
iajs-3302	1	11	4.0	4.0	NUM
iajs-3302	1	12	international	international	ADJ
iajs-3302	1	13	license	license	NOUN
iajs-3302	1	14	ihjpas	ihjpa	NOUN
iajs-3302	1	15	.	.	PUNCT
iajs-3302	2	1	37	37	NUM
iajs-3302	2	2	(	(	PUNCT
iajs-3302	2	3	2	2	NUM
iajs-3302	2	4	)	)	PUNCT
iajs-3302	2	5	2024	2024	NUM
iajs-3302	2	6	ibn	ibn	PROPN
iajs-3302	2	7	al	al	PROPN
iajs-3302	2	8	-	-	PUNCT
iajs-3302	2	9	haitham	haitham	PROPN
iajs-3302	2	10	journal	journal	PROPN
iajs-3302	2	11	for	for	ADP
iajs-3302	2	12	pure	pure	ADJ
iajs-3302	2	13	and	and	CCONJ
iajs-3302	2	14	applied	applied	ADJ
iajs-3302	2	15	sciences	sciences	PROPN
iajs-3302	2	16	journal	journal	PROPN
iajs-3302	2	17	homepage	homepage	NOUN
iajs-3302	2	18	:	:	PUNCT
iajs-3302	2	19	jih.uobaghdad.edu.iq	jih.uobaghdad.edu.iq	NOUN
iajs-3302	2	20	pissn	pissn	ADJ
iajs-3302	2	21	:	:	PUNCT
iajs-3302	2	22	1609	1609	NUM
iajs-3302	2	23	-	-	SYM
iajs-3302	2	24	4042	4042	NUM
iajs-3302	2	25	,	,	PUNCT
iajs-3302	2	26	eissn	eissn	NOUN
iajs-3302	2	27	:	:	PUNCT
iajs-3302	2	28	2521	2521	NUM
iajs-3302	2	29	-	-	SYM
iajs-3302	2	30	3407	3407	NUM
iajs-3302	2	31	reham	reham	NOUN
iajs-3302	2	32	khuldon	khuldon	NOUN
iajs-3302	2	33	ibrahim	ibrahim	PROPN
iajs-3302	2	34	1	1	NUM
iajs-3302	2	35	*	*	PUNCT
iajs-3302	2	36	,	,	PUNCT
iajs-3302	2	37	kadhim	kadhim	PROPN
iajs-3302	2	38	k.	k.	PROPN
iajs-3302	2	39	ghudhaib	ghudhaib	PROPN
iajs-3302	2	40	2	2	NUM
iajs-3302	2	41	and	and	CCONJ
iajs-3302	2	42	ali	ali	PROPN
iajs-3302	2	43	abdulmajid	abdulmajid	PROPN
iajs-3302	2	44	dyab	dyab	PROPN
iajs-3302	2	45	allawi	allawi	VERB
iajs-3302	2	46	3	3	NUM
iajs-3302	2	47	1,2	1,2	NUM
iajs-3302	2	48	department	department	NOUN
iajs-3302	2	49	of	of	ADP
iajs-3302	2	50	chemistry	chemistry	NOUN
iajs-3302	2	51	,	,	PUNCT
iajs-3302	2	52	college	college	NOUN
iajs-3302	2	53	of	of	ADP
iajs-3302	2	54	sciences	science	NOUN
iajs-3302	2	55	for	for	ADP
iajs-3302	2	56	women	woman	NOUN
iajs-3302	2	57	,	,	PUNCT
iajs-3302	2	58	university	university	NOUN
iajs-3302	2	59	of	of	ADP
iajs-3302	2	60	baghdad	baghdad	PROPN
iajs-3302	2	61	,	,	PUNCT
iajs-3302	2	62	baghdad	baghdad	PROPN
iajs-3302	2	63	,	,	PUNCT
iajs-3302	2	64	iraq	iraq	PROPN
iajs-3302	2	65	.	.	PUNCT
iajs-3302	3	1	3	3	NUM
iajs-3302	3	2	department	department	NOUN
iajs-3302	3	3	of	of	ADP
iajs-3302	3	4	medicine	medicine	NOUN
iajs-3302	3	5	,	,	PUNCT
iajs-3302	3	6	college	college	NOUN
iajs-3302	3	7	of	of	ADP
iajs-3302	3	8	medicine	medicine	NOUN
iajs-3302	3	9	,	,	PUNCT
iajs-3302	3	10	university	university	NOUN
iajs-3302	3	11	of	of	ADP
iajs-3302	3	12	baghdad	baghdad	PROPN
iajs-3302	3	13	,	,	PUNCT
iajs-3302	3	14	baghdad	baghdad	PROPN
iajs-3302	3	15	,	,	PUNCT
iajs-3302	3	16	iraq	iraq	PROPN
iajs-3302	3	17	.	.	PUNCT
iajs-3302	4	1	*	*	PUNCT
iajs-3302	4	2	corresbonding	corresbonde	VERB
iajs-3302	4	3	author	author	NOUN
iajs-3302	4	4	.	.	PUNCT
iajs-3302	5	1	doi.org/10.30526/37.2.3302	doi.org/10.30526/37.2.3302	PROPN
iajs-3302	5	2	abstract	abstract	ADJ
iajs-3302	5	3	due	due	ADP
iajs-3302	5	4	to	to	ADP
iajs-3302	5	5	high	high	ADJ
iajs-3302	5	6	blood	blood	NOUN
iajs-3302	5	7	sugar	sugar	NOUN
iajs-3302	5	8	over	over	ADP
iajs-3302	5	9	long	long	ADJ
iajs-3302	5	10	periods	period	NOUN
iajs-3302	5	11	,	,	PUNCT
iajs-3302	5	12	the	the	DET
iajs-3302	5	13	incidence	incidence	NOUN
iajs-3302	5	14	and	and	CCONJ
iajs-3302	5	15	prevalence	prevalence	NOUN
iajs-3302	5	16	of	of	ADP
iajs-3302	5	17	type	type	NOUN
iajs-3302	5	18	2	2	NUM
iajs-3302	5	19	diabetes	diabetes	NOUN
iajs-3302	5	20	are	be	AUX
iajs-3302	5	21	increasing	increase	VERB
iajs-3302	5	22	throughout	throughout	ADP
iajs-3302	5	23	the	the	DET
iajs-3302	5	24	world	world	NOUN
iajs-3302	5	25	.	.	PUNCT
iajs-3302	6	1	diabetic	diabetic	ADJ
iajs-3302	6	2	complications	complication	NOUN
iajs-3302	6	3	include	include	VERB
iajs-3302	6	4	microvascular	microvascular	NOUN
iajs-3302	6	5	and	and	CCONJ
iajs-3302	6	6	macrovascular	macrovascular	NOUN
iajs-3302	6	7	that	that	PRON
iajs-3302	6	8	target	target	VERB
iajs-3302	6	9	the	the	DET
iajs-3302	6	10	kidneys	kidney	NOUN
iajs-3302	6	11	,	,	PUNCT
iajs-3302	6	12	nerves	nerve	NOUN
iajs-3302	6	13	,	,	PUNCT
iajs-3302	6	14	eyes	eye	NOUN
iajs-3302	6	15	,	,	PUNCT
iajs-3302	6	16	and	and	CCONJ
iajs-3302	6	17	heart	heart	NOUN
iajs-3302	6	18	.	.	PUNCT
iajs-3302	7	1	hence	hence	ADV
iajs-3302	7	2	,	,	PUNCT
iajs-3302	7	3	the	the	DET
iajs-3302	7	4	current	current	ADJ
iajs-3302	7	5	study	study	NOUN
iajs-3302	7	6	aimed	aim	VERB
iajs-3302	7	7	to	to	PART
iajs-3302	7	8	investigate	investigate	VERB
iajs-3302	7	9	the	the	DET
iajs-3302	7	10	levels	level	NOUN
iajs-3302	7	11	of	of	ADP
iajs-3302	7	12	connective	connective	ADJ
iajs-3302	7	13	tissue	tissue	NOUN
iajs-3302	7	14	growth	growth	NOUN
iajs-3302	7	15	factor	factor	NOUN
iajs-3302	7	16	(	(	PUNCT
iajs-3302	7	17	ctgf	ctgf	NOUN
iajs-3302	7	18	)	)	PUNCT
iajs-3302	7	19	and	and	CCONJ
iajs-3302	7	20	transforming	transform	VERB
iajs-3302	7	21	growth	growth	NOUN
iajs-3302	7	22	factorβ1	factorβ1	NOUN
iajs-3302	7	23	(	(	PUNCT
iajs-3302	7	24	tgf	tgf	PROPN
iajs-3302	7	25	-	-	PUNCT
iajs-3302	7	26	β1	β1	PROPN
iajs-3302	7	27	)	)	PUNCT
iajs-3302	7	28	for	for	ADP
iajs-3302	7	29	both	both	PRON
iajs-3302	7	30	men	man	NOUN
iajs-3302	7	31	and	and	CCONJ
iajs-3302	7	32	women	woman	NOUN
iajs-3302	7	33	and	and	CCONJ
iajs-3302	7	34	to	to	PART
iajs-3302	7	35	demonstrate	demonstrate	VERB
iajs-3302	7	36	the	the	DET
iajs-3302	7	37	effect	effect	NOUN
iajs-3302	7	38	of	of	ADP
iajs-3302	7	39	sex	sex	NOUN
iajs-3302	7	40	on	on	ADP
iajs-3302	7	41	it	it	PRON
iajs-3302	7	42	.	.	PUNCT
iajs-3302	8	1	in	in	ADP
iajs-3302	8	2	addition	addition	NOUN
iajs-3302	8	3	,	,	PUNCT
iajs-3302	8	4	some	some	DET
iajs-3302	8	5	related	relate	VERB
iajs-3302	8	6	biochemical	biochemical	ADJ
iajs-3302	8	7	factors	factor	NOUN
iajs-3302	8	8	in	in	ADP
iajs-3302	8	9	patients	patient	NOUN
iajs-3302	8	10	with	with	ADP
iajs-3302	8	11	diabetes	diabetes	NOUN
iajs-3302	8	12	and	and	CCONJ
iajs-3302	8	13	diabetic	diabetic	ADJ
iajs-3302	8	14	nephropathy	nephropathy	NOUN
iajs-3302	8	15	are	be	AUX
iajs-3302	8	16	compared	compare	VERB
iajs-3302	8	17	with	with	ADP
iajs-3302	8	18	those	those	PRON
iajs-3302	8	19	in	in	ADP
iajs-3302	8	20	healthy	healthy	ADJ
iajs-3302	8	21	controls	control	NOUN
iajs-3302	8	22	.	.	PUNCT
iajs-3302	9	1	the	the	DET
iajs-3302	9	2	study	study	NOUN
iajs-3302	9	3	included	include	VERB
iajs-3302	9	4	120	120	NUM
iajs-3302	9	5	males	male	NOUN
iajs-3302	9	6	and	and	CCONJ
iajs-3302	9	7	females	female	NOUN
iajs-3302	9	8	with	with	ADP
iajs-3302	9	9	an	an	DET
iajs-3302	9	10	age	age	NOUN
iajs-3302	9	11	range	range	NOUN
iajs-3302	9	12	of	of	ADP
iajs-3302	9	13	(	(	PUNCT
iajs-3302	9	14	30	30	NUM
iajs-3302	9	15	-	-	SYM
iajs-3302	9	16	65	65	NUM
iajs-3302	9	17	)	)	PUNCT
iajs-3302	9	18	years	year	NOUN
iajs-3302	9	19	old	old	ADJ
iajs-3302	9	20	.	.	PUNCT
iajs-3302	10	1	ninety	ninety	NUM
iajs-3302	10	2	patients	patient	NOUN
iajs-3302	10	3	with	with	ADP
iajs-3302	10	4	type	type	NOUN
iajs-3302	10	5	2	2	NUM
iajs-3302	10	6	diabetes	diabetes	NOUN
iajs-3302	10	7	were	be	AUX
iajs-3302	10	8	subdivided	subdivide	VERB
iajs-3302	10	9	into	into	ADP
iajs-3302	10	10	three	three	NUM
iajs-3302	10	11	groups	group	NOUN
iajs-3302	10	12	on	on	ADP
iajs-3302	10	13	the	the	DET
iajs-3302	10	14	basis	basis	NOUN
iajs-3302	10	15	of	of	ADP
iajs-3302	10	16	acr	acr	PROPN
iajs-3302	10	17	criteria	criterion	NOUN
iajs-3302	10	18	.	.	PUNCT
iajs-3302	11	1	all	all	DET
iajs-3302	11	2	the	the	DET
iajs-3302	11	3	individuals	individual	NOUN
iajs-3302	11	4	in	in	ADP
iajs-3302	11	5	the	the	DET
iajs-3302	11	6	groups	group	NOUN
iajs-3302	11	7	visited	visit	VERB
iajs-3302	11	8	baghdad	baghdad	PROPN
iajs-3302	11	9	teaching	teaching	NOUN
iajs-3302	11	10	hospital	hospital	NOUN
iajs-3302	11	11	,	,	PUNCT
iajs-3302	11	12	medical	medical	ADJ
iajs-3302	11	13	city	city	NOUN
iajs-3302	11	14	,	,	PUNCT
iajs-3302	11	15	and	and	CCONJ
iajs-3302	11	16	al	al	PROPN
iajs-3302	11	17	-	-	PUNCT
iajs-3302	11	18	yarmouk	yarmouk	ADV
iajs-3302	11	19	teaching	teaching	NOUN
iajs-3302	11	20	hospital	hospital	NOUN
iajs-3302	11	21	during	during	ADP
iajs-3302	11	22	the	the	DET
iajs-3302	11	23	period	period	NOUN
iajs-3302	11	24	between	between	ADP
iajs-3302	11	25	december	december	PROPN
iajs-3302	11	26	2021	2021	NUM
iajs-3302	11	27	and	and	CCONJ
iajs-3302	11	28	may	may	PROPN
iajs-3302	11	29	2022	2022	NUM
iajs-3302	11	30	.	.	PUNCT
iajs-3302	12	1	the	the	DET
iajs-3302	12	2	ctgf	ctgf	NOUN
iajs-3302	12	3	and	and	CCONJ
iajs-3302	12	4	tfg	tfg	NOUN
iajs-3302	12	5	-	-	PUNCT
iajs-3302	12	6	β1	β1	NOUN
iajs-3302	12	7	levels	level	NOUN
iajs-3302	12	8	were	be	AUX
iajs-3302	12	9	determined	determine	VERB
iajs-3302	12	10	using	use	VERB
iajs-3302	12	11	the	the	DET
iajs-3302	12	12	elisa	elisa	NOUN
iajs-3302	12	13	technique	technique	NOUN
iajs-3302	12	14	.	.	PUNCT
iajs-3302	13	1	urea	urea	PROPN
iajs-3302	13	2	results	result	NOUN
iajs-3302	13	3	showed	show	VERB
iajs-3302	13	4	statistically	statistically	ADV
iajs-3302	13	5	significant	significant	ADJ
iajs-3302	13	6	differences	difference	NOUN
iajs-3302	13	7	between	between	ADP
iajs-3302	13	8	diabetic	diabetic	ADJ
iajs-3302	13	9	nephropathy	nephropathy	NOUN
iajs-3302	13	10	in	in	ADP
iajs-3302	13	11	the	the	DET
iajs-3302	13	12	patient	patient	NOUN
iajs-3302	13	13	group	group	NOUN
iajs-3302	13	14	and	and	CCONJ
iajs-3302	13	15	the	the	DET
iajs-3302	13	16	control	control	NOUN
iajs-3302	13	17	group	group	NOUN
iajs-3302	13	18	in	in	ADP
iajs-3302	13	19	female	female	ADJ
iajs-3302	13	20	cases	case	NOUN
iajs-3302	13	21	.	.	PUNCT
iajs-3302	14	1	still	still	ADV
iajs-3302	14	2	,	,	PUNCT
iajs-3302	14	3	there	there	PRON
iajs-3302	14	4	were	be	VERB
iajs-3302	14	5	no	no	DET
iajs-3302	14	6	statistically	statistically	ADV
iajs-3302	14	7	significant	significant	ADJ
iajs-3302	14	8	differences	difference	NOUN
iajs-3302	14	9	between	between	ADP
iajs-3302	14	10	male	male	ADJ
iajs-3302	14	11	patients	patient	NOUN
iajs-3302	14	12	with	with	ADP
iajs-3302	14	13	diabetic	diabetic	ADJ
iajs-3302	14	14	nephropathy	nephropathy	NOUN
iajs-3302	14	15	and	and	CCONJ
iajs-3302	14	16	the	the	DET
iajs-3302	14	17	control	control	NOUN
iajs-3302	14	18	group	group	NOUN
iajs-3302	14	19	.	.	PUNCT
iajs-3302	15	1	the	the	DET
iajs-3302	15	2	results	result	NOUN
iajs-3302	15	3	also	also	ADV
iajs-3302	15	4	revealed	reveal	VERB
iajs-3302	15	5	that	that	SCONJ
iajs-3302	15	6	there	there	PRON
iajs-3302	15	7	were	be	VERB
iajs-3302	15	8	statistically	statistically	ADV
iajs-3302	15	9	significant	significant	ADJ
iajs-3302	15	10	differences	difference	NOUN
iajs-3302	15	11	in	in	ADP
iajs-3302	15	12	albumin	albumin	NOUN
iajs-3302	15	13	/	/	SYM
iajs-3302	15	14	creatinine	creatinine	NOUN
iajs-3302	15	15	ratio	ratio	NOUN
iajs-3302	15	16	,	,	PUNCT
iajs-3302	15	17	estimated	estimate	VERB
iajs-3302	15	18	glomerular	glomerular	ADJ
iajs-3302	15	19	filtration	filtration	NOUN
iajs-3302	15	20	rate	rate	NOUN
iajs-3302	15	21	,	,	PUNCT
iajs-3302	15	22	urea	urea	NOUN
iajs-3302	15	23	,	,	PUNCT
iajs-3302	15	24	fasting	fast	VERB
iajs-3302	15	25	blood	blood	NOUN
iajs-3302	15	26	sugar	sugar	NOUN
iajs-3302	15	27	,	,	PUNCT
iajs-3302	15	28	and	and	CCONJ
iajs-3302	15	29	creatinine	creatinine	NOUN
iajs-3302	15	30	between	between	ADP
iajs-3302	15	31	the	the	DET
iajs-3302	15	32	diabetic	diabetic	ADJ
iajs-3302	15	33	nephropathy	nephropathy	ADJ
iajs-3302	15	34	group	group	NOUN
iajs-3302	15	35	and	and	CCONJ
iajs-3302	15	36	the	the	DET
iajs-3302	15	37	healthy	healthy	ADJ
iajs-3302	15	38	group	group	NOUN
iajs-3302	15	39	for	for	ADP
iajs-3302	15	40	both	both	DET
iajs-3302	15	41	men	man	NOUN
iajs-3302	15	42	and	and	CCONJ
iajs-3302	15	43	women	woman	NOUN
iajs-3302	15	44	.	.	PUNCT
iajs-3302	16	1	from	from	ADP
iajs-3302	16	2	these	these	DET
iajs-3302	16	3	results	result	NOUN
iajs-3302	16	4	,	,	PUNCT
iajs-3302	16	5	ctgf	ctgf	NOUN
iajs-3302	16	6	and	and	CCONJ
iajs-3302	16	7	tgf	tgf	PROPN
iajs-3302	16	8	-	-	PUNCT
iajs-3302	16	9	β1	β1	PROPN
iajs-3302	16	10	represent	represent	VERB
iajs-3302	16	11	good	good	ADJ
iajs-3302	16	12	early	early	ADJ
iajs-3302	16	13	prognostic	prognostic	ADJ
iajs-3302	16	14	markers	marker	NOUN
iajs-3302	16	15	in	in	ADP
iajs-3302	16	16	diabetic	diabetic	ADJ
iajs-3302	16	17	nephropathy	nephropathy	NOUN
iajs-3302	16	18	.	.	PUNCT
iajs-3302	17	1	keywords	keyword	NOUN
iajs-3302	17	2	:	:	PUNCT
iajs-3302	17	3	diabetes	diabetes	NOUN
iajs-3302	17	4	mellitus	mellitus	NOUN
iajs-3302	17	5	,	,	PUNCT
iajs-3302	17	6	diabetic	diabetic	ADJ
iajs-3302	17	7	nephropathy	nephropathy	NOUN
iajs-3302	17	8	,	,	PUNCT
iajs-3302	17	9	connective	connective	ADJ
iajs-3302	17	10	tissue	tissue	NOUN
iajs-3302	17	11	growth	growth	NOUN
iajs-3302	17	12	factor	factor	NOUN
iajs-3302	17	13	,	,	PUNCT
iajs-3302	17	14	transforming	transform	VERB
iajs-3302	17	15	growth	growth	NOUN
iajs-3302	17	16	factor	factor	NOUN
iajs-3302	17	17	-	-	PUNCT
iajs-3302	17	18	β1	β1	NOUN
iajs-3302	17	19	,	,	PUNCT
iajs-3302	17	20	albumin	albumin	NOUN
iajs-3302	17	21	to	to	ADP
iajs-3302	17	22	creatinine	creatinine	NOUN
iajs-3302	17	23	ratio	ratio	NOUN
iajs-3302	17	24	.	.	PUNCT
iajs-3302	18	1	1	1	X
iajs-3302	18	2	.	.	X
iajs-3302	18	3	introduction	introduction	NOUN
iajs-3302	18	4	diabetes	diabetes	NOUN
iajs-3302	18	5	mellitus	mellitus	NOUN
iajs-3302	18	6	(	(	PUNCT
iajs-3302	18	7	dm	dm	PROPN
iajs-3302	18	8	)	)	PUNCT
iajs-3302	18	9	is	be	AUX
iajs-3302	18	10	a	a	DET
iajs-3302	18	11	type	type	NOUN
iajs-3302	18	12	of	of	ADP
iajs-3302	18	13	metabolic	metabolic	NOUN
iajs-3302	18	14	disease	disease	NOUN
iajs-3302	18	15	that	that	PRON
iajs-3302	18	16	occurs	occur	VERB
iajs-3302	18	17	when	when	SCONJ
iajs-3302	18	18	patients	patient	NOUN
iajs-3302	18	19	suffer	suffer	VERB
iajs-3302	18	20	from	from	ADP
iajs-3302	18	21	elevated	elevated	ADJ
iajs-3302	18	22	blood	blood	NOUN
iajs-3302	18	23	glucose	glucose	NOUN
iajs-3302	18	24	levels	level	NOUN
iajs-3302	18	25	,	,	PUNCT
iajs-3302	18	26	and	and	CCONJ
iajs-3302	18	27	their	their	PRON
iajs-3302	18	28	bodies	body	NOUN
iajs-3302	18	29	do	do	AUX
iajs-3302	18	30	not	not	PART
iajs-3302	18	31	respond	respond	VERB
iajs-3302	18	32	to	to	ADP
iajs-3302	18	33	or	or	CCONJ
iajs-3302	18	34	develop	develop	VERB
iajs-3302	18	35	insulin	insulin	NOUN
iajs-3302	18	36	.	.	PUNCT
iajs-3302	19	1	typically	typically	ADV
iajs-3302	19	2	,	,	PUNCT
iajs-3302	19	3	diabetes	diabetes	NOUN
iajs-3302	19	4	presents	present	NOUN
iajs-3302	19	5	in	in	ADP
iajs-3302	19	6	three	three	NUM
iajs-3302	19	7	forms	form	NOUN
iajs-3302	19	8	:	:	PUNCT
iajs-3302	19	9	type	type	NOUN
iajs-3302	19	10	1	1	NUM
iajs-3302	19	11	dm	dm	NOUN
iajs-3302	19	12	,	,	PUNCT
iajs-3302	19	13	type	type	NOUN
iajs-3302	19	14	2	2	NUM
iajs-3302	19	15	dm	dm	PROPN
iajs-3302	19	16	(	(	PUNCT
iajs-3302	19	17	t2	t2	NOUN
iajs-3302	19	18	dm	dm	PROPN
iajs-3302	19	19	)	)	PUNCT
iajs-3302	19	20	,	,	PUNCT
iajs-3302	19	21	and	and	CCONJ
iajs-3302	19	22	gestational	gestational	ADJ
iajs-3302	19	23	dm	dm	PROPN
iajs-3302	19	24	,	,	PUNCT
iajs-3302	19	25	with	with	ADP
iajs-3302	19	26	greater	great	ADJ
iajs-3302	19	27	emphasis	emphasis	NOUN
iajs-3302	19	28	placed	place	VERB
iajs-3302	19	29	on	on	ADP
iajs-3302	19	30	the	the	DET
iajs-3302	19	31	first	first	ADJ
iajs-3302	19	32	two	two	NUM
iajs-3302	19	33	forms	form	NOUN
iajs-3302	19	34	[	[	X
iajs-3302	19	35	1	1	NUM
iajs-3302	19	36	]	]	PUNCT
iajs-3302	19	37	.	.	PUNCT
iajs-3302	20	1	type	type	NOUN
iajs-3302	20	2	2	2	NUM
iajs-3302	20	3	dm	dm	NOUN
iajs-3302	20	4	arises	arise	VERB
iajs-3302	20	5	when	when	SCONJ
iajs-3302	20	6	the	the	DET
iajs-3302	20	7	body	body	NOUN
iajs-3302	20	8	does	do	AUX
iajs-3302	20	9	not	not	PART
iajs-3302	20	10	respond	respond	VERB
iajs-3302	20	11	to	to	ADP
iajs-3302	20	12	the	the	DET
iajs-3302	20	13	production	production	NOUN
iajs-3302	20	14	of	of	ADP
iajs-3302	20	15	insulin	insulin	NOUN
iajs-3302	20	16	.	.	PUNCT
iajs-3302	21	1	studying	study	VERB
iajs-3302	21	2	sex	sex	NOUN
iajs-3302	21	3	effect	effect	NOUN
iajs-3302	21	4	on	on	ADP
iajs-3302	21	5	ctgf	ctgf	NOUN
iajs-3302	21	6	,	,	PUNCT
iajs-3302	21	7	tgf	tgf	PROPN
iajs-3302	21	8	-	-	PUNCT
iajs-3302	21	9	b1	b1	NOUN
iajs-3302	21	10	levels	level	NOUN
iajs-3302	21	11	and	and	CCONJ
iajs-3302	21	12	some	some	DET
iajs-3302	21	13	relevant	relevant	ADJ
iajs-3302	21	14	parameters	parameter	NOUN
iajs-3302	21	15	in	in	ADP
iajs-3302	21	16	iraqi	iraqi	ADJ
iajs-3302	21	17	diabetic	diabetic	ADJ
iajs-3302	21	18	patients	patient	NOUN
iajs-3302	21	19	with	with	ADP
iajs-3302	21	20	glomeruli	glomeruli	NOUN
iajs-3302	21	21	and	and	CCONJ
iajs-3302	21	22	renal	renal	ADJ
iajs-3302	21	23	tubules	tubule	NOUN
iajs-3302	21	24	fibrosis	fibrosis	NOUN
iajs-3302	21	25	received:28	received:28	PROPN
iajs-3302	21	26	february	february	PROPN
iajs-3302	21	27	2023	2023	NUM
iajs-3302	21	28	accepted:30	accepted:30	X
iajs-3302	21	29	april	april	PROPN
iajs-3302	21	30	2023	2023	NUM
iajs-3302	21	31	published:20	published:20	NOUN
iajs-3302	21	32	april	april	PROPN
iajs-3302	21	33	2024	2024	NUM
iajs-3302	21	34	https://creativecommons.org/licenses/by/4.0/	https://creativecommons.org/licenses/by/4.0/	PROPN
iajs-3302	21	35	https://orcid.org/0000-0001-8472-3502	https://orcid.org/0000-0001-8472-3502	PROPN
iajs-3302	21	36	mailto:raham.khaldoun1105a@csw.uobaghdad.edu.iq	mailto:raham.khaldoun1105a@csw.uobaghdad.edu.iq	ADJ
iajs-3302	21	37	https://orcid.org/0000-0003-4966-4070	https://orcid.org/0000-0003-4966-4070	NOUN
iajs-3302	21	38	mailto:kadhemkg_chem@csw.uobaghdad.edu.iq	mailto:kadhemkg_chem@csw.uobaghdad.edu.iq	VERB
iajs-3302	21	39	https://orcid.org/0000-0002-1282-1813	https://orcid.org/0000-0002-1282-1813	NOUN
iajs-3302	21	40	mailto:aliallawi@comed.uobaghdad.edu.iq	mailto:aliallawi@comed.uobaghdad.edu.iq	NOUN
iajs-3302	21	41	,	,	PUNCT
iajs-3302	21	42	https://orcid.org/0000-0001-8472-3502	https://orcid.org/0000-0001-8472-3502	VERB
iajs-3302	21	43	mailto:raham.khaldoun1105a@csw.uobaghdad.edu.iq	mailto:raham.khaldoun1105a@csw.uobaghdad.edu.iq	ADJ
iajs-3302	21	44	https://orcid.org/0000-0003-4966-4070	https://orcid.org/0000-0003-4966-4070	NOUN
iajs-3302	21	45	mailto:kadhemkg_chem@csw.uobaghdad.edu.iq	mailto:kadhemkg_chem@csw.uobaghdad.edu.iq	VERB
iajs-3302	21	46	https://orcid.org/0000-0002-1282-1813	https://orcid.org/0000-0002-1282-1813	NOUN
iajs-3302	21	47	mailto:aliallawi@comed.uobaghdad.edu.iq	mailto:aliallawi@comed.uobaghdad.edu.iq	NOUN
iajs-3302	21	48	,	,	PUNCT
iajs-3302	21	49	https://orcid.org/0000-0001-8472-3502	https://orcid.org/0000-0001-8472-3502	VERB
iajs-3302	21	50	mailto:raham.khaldoun1105a@csw.uobaghdad.edu.iq	mailto:raham.khaldoun1105a@csw.uobaghdad.edu.iq	ADJ
iajs-3302	21	51	https://orcid.org/0000-0003-4966-4070	https://orcid.org/0000-0003-4966-4070	NOUN
iajs-3302	21	52	mailto:kadhemkg_chem@csw.uobaghdad.edu.iq	mailto:kadhemkg_chem@csw.uobaghdad.edu.iq	VERB
iajs-3302	21	53	https://orcid.org/0000-0002-1282-1813	https://orcid.org/0000-0002-1282-1813	NOUN
iajs-3302	21	54	mailto:aliallawi@comed.uobaghdad.edu.iq	mailto:aliallawi@comed.uobaghdad.edu.iq	NOUN
iajs-3302	21	55	,	,	PUNCT
iajs-3302	21	56	https://jih.uobaghdad.edu.iq/index.php/j/index#1609-4042	https://jih.uobaghdad.edu.iq/index.php/j/index#1609-4042	NOUN
iajs-3302	21	57	https://jih.uobaghdad.edu.iq/index.php/j/index#2521-3407	https://jih.uobaghdad.edu.iq/index.php/j/index#2521-3407	NOUN
iajs-3302	21	58	https://orcid.org/0000-0001-8472-3502	https://orcid.org/0000-0001-8472-3502	VERB
iajs-3302	21	59	mailto:raham.khaldoun1105a@csw.uobaghdad.edu.iq	mailto:raham.khaldoun1105a@csw.uobaghdad.edu.iq	ADJ
iajs-3302	21	60	https://orcid.org/0000-0003-4966-4070	https://orcid.org/0000-0003-4966-4070	NOUN
iajs-3302	21	61	mailto:kadhemkg_chem@csw.uobaghdad.edu.iq	mailto:kadhemkg_chem@csw.uobaghdad.edu.iq	VERB
iajs-3302	21	62	https://orcid.org/0000-0002-1282-1813	https://orcid.org/0000-0002-1282-1813	NOUN
iajs-3302	21	63	mailto:aliallawi@comed.uobaghdad.edu.iq	mailto:aliallawi@comed.uobaghdad.edu.iq	NOUN
iajs-3302	21	64	,	,	PUNCT
iajs-3302	21	65	https://orcid.org/0000-0001-8472-3502	https://orcid.org/0000-0001-8472-3502	VERB
iajs-3302	21	66	mailto:raham.khaldoun1105a@csw.uobaghdad.edu.iq	mailto:raham.khaldoun1105a@csw.uobaghdad.edu.iq	ADJ
iajs-3302	21	67	https://orcid.org/0000-0003-4966-4070	https://orcid.org/0000-0003-4966-4070	NOUN
iajs-3302	21	68	mailto:kadhemkg_chem@csw.uobaghdad.edu.iq	mailto:kadhemkg_chem@csw.uobaghdad.edu.iq	VERB
iajs-3302	21	69	https://orcid.org/0000-0002-1282-1813	https://orcid.org/0000-0002-1282-1813	NOUN
iajs-3302	21	70	mailto:aliallawi@comed.uobaghdad.edu.iq	mailto:aliallawi@comed.uobaghdad.edu.iq	NOUN
iajs-3302	21	71	,	,	PUNCT
iajs-3302	21	72	https://orcid.org/0000-0001-8472-3502	https://orcid.org/0000-0001-8472-3502	VERB
iajs-3302	21	73	mailto:raham.khaldoun1105a@csw.uobaghdad.edu.iq	mailto:raham.khaldoun1105a@csw.uobaghdad.edu.iq	ADJ
iajs-3302	21	74	https://orcid.org/0000-0003-4966-4070	https://orcid.org/0000-0003-4966-4070	NOUN
iajs-3302	21	75	mailto:kadhemkg_chem@csw.uobaghdad.edu.iq	mailto:kadhemkg_chem@csw.uobaghdad.edu.iq	VERB
iajs-3302	21	76	https://orcid.org/0000-0002-1282-1813	https://orcid.org/0000-0002-1282-1813	NOUN
iajs-3302	21	77	mailto:aliallawi@comed.uobaghdad.edu.iq	mailto:aliallawi@comed.uobaghdad.edu.iq	NOUN
iajs-3302	21	78	,	,	PUNCT
iajs-3302	21	79	https://orcid.org/0000-0001-8472-3502	https://orcid.org/0000-0001-8472-3502	VERB
iajs-3302	21	80	mailto:raham.khaldoun1105a@csw.uobaghdad.edu.iq	mailto:raham.khaldoun1105a@csw.uobaghdad.edu.iq	ADJ
iajs-3302	21	81	https://orcid.org/0000-0003-4966-4070	https://orcid.org/0000-0003-4966-4070	NOUN
iajs-3302	21	82	mailto:kadhemkg_chem@csw.uobaghdad.edu.iq	mailto:kadhemkg_chem@csw.uobaghdad.edu.iq	VERB
iajs-3302	21	83	https://orcid.org/0000-0002-1282-1813	https://orcid.org/0000-0002-1282-1813	NOUN
iajs-3302	21	84	mailto:aliallawi@comed.uobaghdad.edu.iq	mailto:aliallawi@comed.uobaghdad.edu.iq	NOUN
iajs-3302	21	85	,	,	PUNCT
iajs-3302	21	86	https://orcid.org/0000-0001-8472-3502	https://orcid.org/0000-0001-8472-3502	VERB
iajs-3302	21	87	mailto:raham.khaldoun1105a@csw.uobaghdad.edu.iq	mailto:raham.khaldoun1105a@csw.uobaghdad.edu.iq	ADJ
iajs-3302	21	88	https://orcid.org/0000-0003-4966-4070	https://orcid.org/0000-0003-4966-4070	NOUN
iajs-3302	21	89	mailto:kadhemkg_chem@csw.uobaghdad.edu.iq	mailto:kadhemkg_chem@csw.uobaghdad.edu.iq	VERB
iajs-3302	21	90	https://orcid.org/0000-0002-1282-1813	https://orcid.org/0000-0002-1282-1813	NOUN
iajs-3302	21	91	mailto:aliallawi@comed.uobaghdad.edu.iq	mailto:aliallawi@comed.uobaghdad.edu.iq	NOUN
iajs-3302	21	92	,	,	PUNCT
iajs-3302	21	93	https://orcid.org/0000-0001-8472-3502	https://orcid.org/0000-0001-8472-3502	VERB
iajs-3302	21	94	mailto:raham.khaldoun1105a@csw.uobaghdad.edu.iq	mailto:raham.khaldoun1105a@csw.uobaghdad.edu.iq	ADJ
iajs-3302	21	95	https://orcid.org/0000-0003-4966-4070	https://orcid.org/0000-0003-4966-4070	NOUN
iajs-3302	21	96	mailto:kadhemkg_chem@csw.uobaghdad.edu.iq	mailto:kadhemkg_chem@csw.uobaghdad.edu.iq	VERB
iajs-3302	21	97	https://orcid.org/0000-0002-1282-1813	https://orcid.org/0000-0002-1282-1813	NOUN
iajs-3302	21	98	mailto:aliallawi@comed.uobaghdad.edu.iq	mailto:aliallawi@comed.uobaghdad.edu.iq	NOUN
iajs-3302	21	99	,	,	PUNCT
iajs-3302	21	100	https://orcid.org/0000-0001-8472-3502	https://orcid.org/0000-0001-8472-3502	VERB
iajs-3302	21	101	mailto:raham.khaldoun1105a@csw.uobaghdad.edu.iq	mailto:raham.khaldoun1105a@csw.uobaghdad.edu.iq	ADJ
iajs-3302	21	102	https://orcid.org/0000-0003-4966-4070	https://orcid.org/0000-0003-4966-4070	NOUN
iajs-3302	21	103	mailto:kadhemkg_chem@csw.uobaghdad.edu.iq	mailto:kadhemkg_chem@csw.uobaghdad.edu.iq	VERB
iajs-3302	21	104	https://orcid.org/0000-0002-1282-1813	https://orcid.org/0000-0002-1282-1813	NOUN
iajs-3302	21	105	mailto:aliallawi@comed.uobaghdad.edu.iq	mailto:aliallawi@comed.uobaghdad.edu.iq	NOUN
iajs-3302	21	106	,	,	PUNCT
iajs-3302	21	107	https://orcid.org/0000-0001-8472-3502	https://orcid.org/0000-0001-8472-3502	VERB
iajs-3302	21	108	mailto:raham.khaldoun1105a@csw.uobaghdad.edu.iq	mailto:raham.khaldoun1105a@csw.uobaghdad.edu.iq	ADJ
iajs-3302	21	109	https://orcid.org/0000-0003-4966-4070	https://orcid.org/0000-0003-4966-4070	NOUN
iajs-3302	21	110	mailto:kadhemkg_chem@csw.uobaghdad.edu.iq	mailto:kadhemkg_chem@csw.uobaghdad.edu.iq	VERB
iajs-3302	21	111	https://orcid.org/0000-0002-1282-1813	https://orcid.org/0000-0002-1282-1813	NOUN
iajs-3302	21	112	mailto:aliallawi@comed.uobaghdad.edu.iq	mailto:aliallawi@comed.uobaghdad.edu.iq	NOUN
iajs-3302	21	113	,	,	PUNCT
iajs-3302	21	114	https://orcid.org/0000-0001-8472-3502	https://orcid.org/0000-0001-8472-3502	VERB
iajs-3302	21	115	mailto:raham.khaldoun1105a@csw.uobaghdad.edu.iq	mailto:raham.khaldoun1105a@csw.uobaghdad.edu.iq	ADJ
iajs-3302	21	116	https://orcid.org/0000-0003-4966-4070	https://orcid.org/0000-0003-4966-4070	NOUN
iajs-3302	21	117	mailto:kadhemkg_chem@csw.uobaghdad.edu.iq	mailto:kadhemkg_chem@csw.uobaghdad.edu.iq	VERB
iajs-3302	21	118	https://orcid.org/0000-0002-1282-1813	https://orcid.org/0000-0002-1282-1813	NOUN
iajs-3302	21	119	mailto:aliallawi@comed.uobaghdad.edu.iq	mailto:aliallawi@comed.uobaghdad.edu.iq	NOUN
iajs-3302	21	120	,	,	PUNCT
iajs-3302	21	121	https://orcid.org/0000-0001-8472-3502	https://orcid.org/0000-0001-8472-3502	VERB
iajs-3302	21	122	mailto:raham.khaldoun1105a@csw.uobaghdad.edu.iq	mailto:raham.khaldoun1105a@csw.uobaghdad.edu.iq	ADJ
iajs-3302	21	123	https://orcid.org/0000-0003-4966-4070	https://orcid.org/0000-0003-4966-4070	NOUN
iajs-3302	21	124	mailto:kadhemkg_chem@csw.uobaghdad.edu.iq	mailto:kadhemkg_chem@csw.uobaghdad.edu.iq	VERB
iajs-3302	21	125	https://orcid.org/0000-0002-1282-1813	https://orcid.org/0000-0002-1282-1813	NOUN
iajs-3302	21	126	mailto:aliallawi@comed.uobaghdad.edu.iq	mailto:aliallawi@comed.uobaghdad.edu.iq	NOUN
iajs-3302	21	127	,	,	PUNCT
iajs-3302	21	128	https://orcid.org/0000-0001-8472-3502	https://orcid.org/0000-0001-8472-3502	VERB
iajs-3302	21	129	mailto:raham.khaldoun1105a@csw.uobaghdad.edu.iq	mailto:raham.khaldoun1105a@csw.uobaghdad.edu.iq	ADJ
iajs-3302	21	130	https://orcid.org/0000-0003-4966-4070	https://orcid.org/0000-0003-4966-4070	NOUN
iajs-3302	21	131	mailto:kadhemkg_chem@csw.uobaghdad.edu.iq	mailto:kadhemkg_chem@csw.uobaghdad.edu.iq	VERB
iajs-3302	21	132	https://orcid.org/0000-0002-1282-1813	https://orcid.org/0000-0002-1282-1813	NOUN
iajs-3302	21	133	mailto:aliallawi@comed.uobaghdad.edu.iq	mailto:aliallawi@comed.uobaghdad.edu.iq	NOUN
iajs-3302	21	134	,	,	PUNCT
iajs-3302	21	135	ihjpas	ihjpa	VERB
iajs-3302	21	136	.	.	PUNCT
iajs-3302	22	1	37	37	NUM
iajs-3302	22	2	(	(	PUNCT
iajs-3302	22	3	2	2	NUM
iajs-3302	22	4	)	)	PUNCT
iajs-3302	22	5	2024	2024	NUM
iajs-3302	22	6	261	261	NUM
iajs-3302	22	7	diabetes	diabetes	NOUN
iajs-3302	22	8	may	may	AUX
iajs-3302	22	9	cause	cause	VERB
iajs-3302	22	10	long	long	ADJ
iajs-3302	22	11	-	-	PUNCT
iajs-3302	22	12	term	term	NOUN
iajs-3302	22	13	injury	injury	NOUN
iajs-3302	22	14	and	and	CCONJ
iajs-3302	22	15	damage	damage	NOUN
iajs-3302	22	16	to	to	ADP
iajs-3302	22	17	various	various	ADJ
iajs-3302	22	18	organs	organ	NOUN
iajs-3302	22	19	in	in	ADP
iajs-3302	22	20	chronic	chronic	ADJ
iajs-3302	22	21	conditions	condition	NOUN
iajs-3302	22	22	,	,	PUNCT
iajs-3302	22	23	particularly	particularly	ADV
iajs-3302	22	24	the	the	DET
iajs-3302	22	25	eyes	eye	NOUN
iajs-3302	22	26	,	,	PUNCT
iajs-3302	22	27	kidneys	kidney	NOUN
iajs-3302	22	28	,	,	PUNCT
iajs-3302	22	29	nerves	nerve	NOUN
iajs-3302	22	30	,	,	PUNCT
iajs-3302	22	31	heart	heart	NOUN
iajs-3302	22	32	,	,	PUNCT
iajs-3302	22	33	and	and	CCONJ
iajs-3302	22	34	blood	blood	NOUN
iajs-3302	22	35	vessels	vessel	NOUN
iajs-3302	22	36	.	.	PUNCT
iajs-3302	23	1	diabetes	diabetes	NOUN
iajs-3302	23	2	has	have	AUX
iajs-3302	23	3	entered	enter	VERB
iajs-3302	23	4	pandemic	pandemic	ADJ
iajs-3302	23	5	proportions	proportion	NOUN
iajs-3302	23	6	,	,	PUNCT
iajs-3302	23	7	impacting	impact	VERB
iajs-3302	23	8	more	more	ADJ
iajs-3302	23	9	than	than	ADP
iajs-3302	23	10	400	400	NUM
iajs-3302	23	11	million	million	NUM
iajs-3302	23	12	citizens	citizen	NOUN
iajs-3302	23	13	worldwide	worldwide	ADV
iajs-3302	23	14	,	,	PUNCT
iajs-3302	23	15	and	and	CCONJ
iajs-3302	23	16	has	have	AUX
iajs-3302	23	17	become	become	VERB
iajs-3302	23	18	of	of	ADP
iajs-3302	23	19	great	great	ADJ
iajs-3302	23	20	significance	significance	NOUN
iajs-3302	23	21	in	in	ADP
iajs-3302	23	22	developed	develop	VERB
iajs-3302	23	23	countries	country	NOUN
iajs-3302	23	24	,	,	PUNCT
iajs-3302	23	25	too	too	ADV
iajs-3302	24	1	[	[	X
iajs-3302	24	2	2	2	NUM
iajs-3302	24	3	]	]	PUNCT
iajs-3302	24	4	.	.	PUNCT
iajs-3302	25	1	type	type	NOUN
iajs-3302	25	2	2	2	NUM
iajs-3302	25	3	dm	dm	NOUN
iajs-3302	25	4	,	,	PUNCT
iajs-3302	25	5	also	also	ADV
iajs-3302	25	6	known	know	VERB
iajs-3302	25	7	as	as	ADP
iajs-3302	25	8	t2	t2	PROPN
iajs-3302	25	9	dm	dm	PROPN
iajs-3302	25	10	,	,	PUNCT
iajs-3302	25	11	is	be	AUX
iajs-3302	25	12	the	the	DET
iajs-3302	25	13	most	most	ADV
iajs-3302	25	14	prevalent	prevalent	ADJ
iajs-3302	25	15	form	form	NOUN
iajs-3302	25	16	among	among	ADP
iajs-3302	25	17	the	the	DET
iajs-3302	25	18	large	large	ADJ
iajs-3302	25	19	and	and	CCONJ
iajs-3302	25	20	heterogeneous	heterogeneous	ADJ
iajs-3302	25	21	number	number	NOUN
iajs-3302	25	22	of	of	ADP
iajs-3302	25	23	diabetes	diabetes	NOUN
iajs-3302	25	24	patients	patient	NOUN
iajs-3302	25	25	.	.	PUNCT
iajs-3302	26	1	t2	t2	NOUN
iajs-3302	26	2	dm	dm	PROPN
iajs-3302	26	3	is	be	AUX
iajs-3302	26	4	the	the	DET
iajs-3302	26	5	most	most	ADV
iajs-3302	26	6	pervasive	pervasive	ADJ
iajs-3302	26	7	form	form	NOUN
iajs-3302	26	8	among	among	ADP
iajs-3302	26	9	the	the	DET
iajs-3302	26	10	large	large	ADJ
iajs-3302	26	11	and	and	CCONJ
iajs-3302	26	12	heterogeneous	heterogeneous	ADJ
iajs-3302	26	13	number	number	NOUN
iajs-3302	26	14	of	of	ADP
iajs-3302	26	15	diabetes	diabetes	NOUN
iajs-3302	26	16	patients	patient	NOUN
iajs-3302	26	17	.	.	PUNCT
iajs-3302	27	1	it	it	PRON
iajs-3302	27	2	emerged	emerge	VERB
iajs-3302	27	3	from	from	ADP
iajs-3302	27	4	the	the	DET
iajs-3302	27	5	global	global	ADJ
iajs-3302	27	6	burden	burden	NOUN
iajs-3302	27	7	of	of	ADP
iajs-3302	27	8	diseases	disease	NOUN
iajs-3302	27	9	report	report	VERB
iajs-3302	27	10	in	in	ADP
iajs-3302	27	11	2016	2016	NUM
iajs-3302	27	12	that	that	PRON
iajs-3302	27	13	t2	t2	NOUN
iajs-3302	27	14	dm	dm	PROPN
iajs-3302	27	15	and	and	CCONJ
iajs-3302	27	16	its	its	PRON
iajs-3302	27	17	complications	complication	NOUN
iajs-3302	27	18	have	have	AUX
iajs-3302	27	19	been	be	AUX
iajs-3302	27	20	responsible	responsible	ADJ
iajs-3302	27	21	for	for	ADP
iajs-3302	27	22	the	the	DET
iajs-3302	27	23	22	22	NUM
iajs-3302	27	24	%	%	NOUN
iajs-3302	27	25	rise	rise	NOUN
iajs-3302	27	26	in	in	ADP
iajs-3302	27	27	damage	damage	NOUN
iajs-3302	27	28	over	over	ADP
iajs-3302	27	29	the	the	DET
iajs-3302	27	30	last	last	ADJ
iajs-3302	27	31	ten	ten	NUM
iajs-3302	27	32	years	year	NOUN
iajs-3302	27	33	,	,	PUNCT
iajs-3302	27	34	which	which	PRON
iajs-3302	27	35	has	have	AUX
iajs-3302	27	36	had	have	VERB
iajs-3302	27	37	a	a	DET
iajs-3302	27	38	significant	significant	ADJ
iajs-3302	27	39	consequence	consequence	NOUN
iajs-3302	27	40	on	on	ADP
iajs-3302	27	41	public	public	ADJ
iajs-3302	27	42	health	health	NOUN
iajs-3302	27	43	.	.	PUNCT
iajs-3302	28	1	diabetes	diabetes	NOUN
iajs-3302	28	2	mellitus	mellitus	NOUN
iajs-3302	28	3	has	have	VERB
iajs-3302	28	4	several	several	ADJ
iajs-3302	28	5	long	long	ADJ
iajs-3302	28	6	-	-	PUNCT
iajs-3302	28	7	term	term	NOUN
iajs-3302	28	8	problems	problem	NOUN
iajs-3302	28	9	connected	connect	VERB
iajs-3302	28	10	with	with	ADP
iajs-3302	28	11	it	it	PRON
iajs-3302	28	12	,	,	PUNCT
iajs-3302	28	13	such	such	ADJ
iajs-3302	28	14	as	as	ADP
iajs-3302	28	15	chronic	chronic	ADJ
iajs-3302	28	16	kidney	kidney	NOUN
iajs-3302	28	17	disease	disease	NOUN
iajs-3302	28	18	(	(	PUNCT
iajs-3302	28	19	ckd	ckd	NOUN
iajs-3302	28	20	)	)	PUNCT
iajs-3302	29	1	[	[	X
iajs-3302	29	2	3	3	NUM
iajs-3302	29	3	]	]	PUNCT
iajs-3302	29	4	.	.	PUNCT
iajs-3302	30	1	a	a	DET
iajs-3302	30	2	phenomenon	phenomenon	NOUN
iajs-3302	30	3	known	know	VERB
iajs-3302	30	4	as	as	ADP
iajs-3302	30	5	diabetes	diabetes	NOUN
iajs-3302	30	6	kidney	kidney	NOUN
iajs-3302	30	7	disease	disease	NOUN
iajs-3302	30	8	(	(	PUNCT
iajs-3302	30	9	dkd	dkd	ADJ
iajs-3302	30	10	)	)	PUNCT
iajs-3302	30	11	is	be	AUX
iajs-3302	30	12	characterized	characterize	VERB
iajs-3302	30	13	by	by	ADP
iajs-3302	30	14	alterations	alteration	NOUN
iajs-3302	30	15	in	in	ADP
iajs-3302	30	16	the	the	DET
iajs-3302	30	17	glomerular	glomerular	ADJ
iajs-3302	30	18	filtration	filtration	NOUN
iajs-3302	30	19	rate	rate	NOUN
iajs-3302	30	20	,	,	PUNCT
iajs-3302	30	21	leakage	leakage	NOUN
iajs-3302	30	22	of	of	ADP
iajs-3302	30	23	proteins	protein	NOUN
iajs-3302	30	24	(	(	PUNCT
iajs-3302	30	25	mainly	mainly	ADV
iajs-3302	30	26	albumin	albumin	ADJ
iajs-3302	30	27	)	)	PUNCT
iajs-3302	30	28	,	,	PUNCT
iajs-3302	30	29	metabolites	metabolite	NOUN
iajs-3302	30	30	,	,	PUNCT
iajs-3302	30	31	and	and	CCONJ
iajs-3302	30	32	ions	ion	NOUN
iajs-3302	30	33	into	into	ADP
iajs-3302	30	34	the	the	DET
iajs-3302	30	35	urine	urine	NOUN
iajs-3302	30	36	,	,	PUNCT
iajs-3302	30	37	and	and	CCONJ
iajs-3302	30	38	the	the	DET
iajs-3302	30	39	estimation	estimation	NOUN
iajs-3302	30	40	of	of	ADP
iajs-3302	30	41	the	the	DET
iajs-3302	30	42	glomerular	glomerular	ADJ
iajs-3302	30	43	filtration	filtration	NOUN
iajs-3302	30	44	rate	rate	NOUN
iajs-3302	30	45	(	(	PUNCT
iajs-3302	30	46	gfr	gfr	NOUN
iajs-3302	30	47	)	)	PUNCT
iajs-3302	30	48	.	.	PUNCT
iajs-3302	31	1	it	it	PRON
iajs-3302	31	2	is	be	AUX
iajs-3302	31	3	a	a	DET
iajs-3302	31	4	microvascular	microvascular	ADJ
iajs-3302	31	5	complication	complication	NOUN
iajs-3302	31	6	of	of	ADP
iajs-3302	31	7	diabetes	diabetes	NOUN
iajs-3302	31	8	characterized	characterize	VERB
iajs-3302	31	9	by	by	ADP
iajs-3302	31	10	injury	injury	NOUN
iajs-3302	31	11	to	to	ADP
iajs-3302	31	12	the	the	DET
iajs-3302	31	13	capillaries	capillary	NOUN
iajs-3302	31	14	,	,	PUNCT
iajs-3302	31	15	mesangial	mesangial	ADJ
iajs-3302	31	16	cell	cell	NOUN
iajs-3302	31	17	expansion	expansion	NOUN
iajs-3302	31	18	,	,	PUNCT
iajs-3302	31	19	extracellular	extracellular	ADJ
iajs-3302	31	20	matrix	matrix	NOUN
iajs-3302	31	21	accumulation	accumulation	NOUN
iajs-3302	31	22	,	,	PUNCT
iajs-3302	31	23	thickening	thickening	NOUN
iajs-3302	31	24	of	of	ADP
iajs-3302	31	25	glomerular	glomerular	ADJ
iajs-3302	31	26	basement	basement	NOUN
iajs-3302	31	27	membrane	membrane	NOUN
iajs-3302	31	28	gbm	gbm	NOUN
iajs-3302	31	29	,	,	PUNCT
iajs-3302	31	30	and	and	CCONJ
iajs-3302	31	31	podocyte	podocyte	NOUN
iajs-3302	31	32	and	and	CCONJ
iajs-3302	31	33	glomerular	glomerular	ADJ
iajs-3302	31	34	injury	injury	NOUN
iajs-3302	31	35	,	,	PUNCT
iajs-3302	31	36	leading	lead	VERB
iajs-3302	31	37	to	to	ADP
iajs-3302	31	38	glomerular	glomerular	ADJ
iajs-3302	31	39	sclerosis	sclerosis	NOUN
iajs-3302	31	40	and	and	CCONJ
iajs-3302	31	41	tubulointerstitial	tubulointerstitial	ADJ
iajs-3302	31	42	fibrosis	fibrosis	NOUN
iajs-3302	31	43	[	[	X
iajs-3302	31	44	4,5	4,5	NUM
iajs-3302	31	45	]	]	PUNCT
iajs-3302	31	46	.	.	PUNCT
iajs-3302	32	1	connective	connective	ADJ
iajs-3302	32	2	tissue	tissue	NOUN
iajs-3302	32	3	growth	growth	NOUN
iajs-3302	32	4	factor	factor	NOUN
iajs-3302	32	5	(	(	PUNCT
iajs-3302	32	6	ctgf	ctgf	NOUN
iajs-3302	32	7	)	)	PUNCT
iajs-3302	32	8	is	be	AUX
iajs-3302	32	9	engaged	engage	VERB
iajs-3302	32	10	in	in	ADP
iajs-3302	32	11	numerous	numerous	ADJ
iajs-3302	32	12	diseases	disease	NOUN
iajs-3302	32	13	,	,	PUNCT
iajs-3302	32	14	including	include	VERB
iajs-3302	32	15	the	the	DET
iajs-3302	32	16	growth	growth	NOUN
iajs-3302	32	17	of	of	ADP
iajs-3302	32	18	tumors	tumor	NOUN
iajs-3302	32	19	and	and	CCONJ
iajs-3302	32	20	tissue	tissue	NOUN
iajs-3302	32	21	fibrosis	fibrosis	NOUN
iajs-3302	32	22	,	,	PUNCT
iajs-3302	32	23	as	as	ADV
iajs-3302	32	24	well	well	ADV
iajs-3302	32	25	as	as	ADP
iajs-3302	32	26	multiple	multiple	ADJ
iajs-3302	32	27	biological	biological	ADJ
iajs-3302	32	28	processes	process	NOUN
iajs-3302	32	29	,	,	PUNCT
iajs-3302	32	30	including	include	VERB
iajs-3302	32	31	cell	cell	NOUN
iajs-3302	32	32	proliferation	proliferation	NOUN
iajs-3302	32	33	,	,	PUNCT
iajs-3302	32	34	angiogenesis	angiogenesis	NOUN
iajs-3302	32	35	,	,	PUNCT
iajs-3302	32	36	and	and	CCONJ
iajs-3302	32	37	wound	wound	NOUN
iajs-3302	32	38	healing	healing	NOUN
iajs-3302	32	39	.	.	PUNCT
iajs-3302	33	1	it	it	PRON
iajs-3302	33	2	is	be	AUX
iajs-3302	33	3	38	38	NUM
iajs-3302	33	4	kda	kda	NOUN
iajs-3302	33	5	and	and	CCONJ
iajs-3302	33	6	cysteine	cysteine	NOUN
iajs-3302	33	7	-	-	PUNCT
iajs-3302	33	8	rich	rich	ADJ
iajs-3302	33	9	(	(	PUNCT
iajs-3302	33	10	22	22	NUM
iajs-3302	33	11	cytosines	cytosine	NOUN
iajs-3302	33	12	in	in	ADP
iajs-3302	33	13	the	the	DET
iajs-3302	33	14	n	n	CCONJ
iajs-3302	33	15	-	-	PUNCT
iajs-3302	33	16	terminal	terminal	ADJ
iajs-3302	33	17	and	and	CCONJ
iajs-3302	33	18	16	16	NUM
iajs-3302	33	19	cytosines	cytosine	NOUN
iajs-3302	33	20	in	in	ADP
iajs-3302	33	21	the	the	DET
iajs-3302	33	22	c	c	NOUN
iajs-3302	33	23	-	-	PUNCT
iajs-3302	33	24	terminal	terminal	ADJ
iajs-3302	33	25	region	region	NOUN
iajs-3302	33	26	)	)	PUNCT
iajs-3302	33	27	.	.	PUNCT
iajs-3302	34	1	10	10	NUM
iajs-3302	34	2	.	.	X
iajs-3302	34	3	extracellular	extracellular	ADJ
iajs-3302	34	4	matrix	matrix	NOUN
iajs-3302	34	5	protein	protein	NOUN
iajs-3302	34	6	.	.	PUNCT
iajs-3302	35	1	the	the	DET
iajs-3302	35	2	mechanism	mechanism	NOUN
iajs-3302	35	3	causing	cause	VERB
iajs-3302	35	4	excessive	excessive	ADJ
iajs-3302	35	5	extracellular	extracellular	ADJ
iajs-3302	35	6	matrix	matrix	NOUN
iajs-3302	35	7	accumulation	accumulation	NOUN
iajs-3302	35	8	and	and	CCONJ
iajs-3302	35	9	transforming	transform	VERB
iajs-3302	35	10	growth	growth	NOUN
iajs-3302	35	11	factor	factor	NOUN
iajs-3302	35	12	-	-	PUNCT
iajs-3302	35	13	β	β	X
iajs-3302	35	14	(	(	PUNCT
iajs-3302	35	15	tgf	tgf	PROPN
iajs-3302	35	16	-	-	PUNCT
iajs-3302	35	17	β1	β1	PROPN
iajs-3302	35	18	)	)	PUNCT
iajs-3302	35	19	has	have	AUX
iajs-3302	35	20	been	be	AUX
iajs-3302	35	21	suggested	suggest	VERB
iajs-3302	35	22	as	as	ADP
iajs-3302	35	23	the	the	DET
iajs-3302	35	24	main	main	ADJ
iajs-3302	35	25	trigger	trigger	NOUN
iajs-3302	35	26	for	for	ADP
iajs-3302	35	27	both	both	CCONJ
iajs-3302	35	28	the	the	DET
iajs-3302	35	29	increased	increase	VERB
iajs-3302	35	30	collagen	collagen	NOUN
iajs-3302	35	31	production	production	NOUN
iajs-3302	35	32	and	and	CCONJ
iajs-3302	35	33	decreased	decrease	VERB
iajs-3302	35	34	matrix	matrix	NOUN
iajs-3302	35	35	degradation	degradation	NOUN
iajs-3302	35	36	pathways	pathway	NOUN
iajs-3302	35	37	in	in	ADP
iajs-3302	35	38	fibrosis	fibrosis	NOUN
iajs-3302	35	39	,	,	PUNCT
iajs-3302	35	40	being	be	AUX
iajs-3302	35	41	recognized	recognize	VERB
iajs-3302	35	42	as	as	ADP
iajs-3302	35	43	a	a	DET
iajs-3302	35	44	central	central	ADJ
iajs-3302	35	45	mediator	mediator	NOUN
iajs-3302	35	46	in	in	ADP
iajs-3302	35	47	the	the	DET
iajs-3302	35	48	development	development	NOUN
iajs-3302	35	49	of	of	ADP
iajs-3302	35	50	fibrosis	fibrosis	NOUN
iajs-3302	35	51	.	.	PUNCT
iajs-3302	36	1	renal	renal	ADJ
iajs-3302	36	2	fibrosis	fibrosis	NOUN
iajs-3302	36	3	is	be	AUX
iajs-3302	36	4	a	a	DET
iajs-3302	36	5	common	common	ADJ
iajs-3302	36	6	pathological	pathological	ADJ
iajs-3302	36	7	manifestation	manifestation	NOUN
iajs-3302	36	8	of	of	ADP
iajs-3302	36	9	ckd	ckd	PROPN
iajs-3302	37	1	[	[	X
iajs-3302	37	2	6	6	NUM
iajs-3302	37	3	]	]	PUNCT
iajs-3302	37	4	.	.	PUNCT
iajs-3302	38	1	numerous	numerous	ADJ
iajs-3302	38	2	diseases	disease	NOUN
iajs-3302	38	3	and	and	CCONJ
iajs-3302	38	4	ailments	ailment	NOUN
iajs-3302	38	5	can	can	AUX
iajs-3302	38	6	cause	cause	VERB
iajs-3302	38	7	ckd	ckd	PROPN
iajs-3302	38	8	.	.	PUNCT
iajs-3302	39	1	the	the	DET
iajs-3302	39	2	two	two	NUM
iajs-3302	39	3	most	most	ADV
iajs-3302	39	4	frequent	frequent	ADJ
iajs-3302	39	5	causes	cause	NOUN
iajs-3302	39	6	that	that	PRON
iajs-3302	39	7	affect	affect	VERB
iajs-3302	39	8	the	the	DET
iajs-3302	39	9	nephrons	nephron	NOUN
iajs-3302	39	10	include	include	VERB
iajs-3302	39	11	congenital	congenital	ADJ
iajs-3302	39	12	illnesses	illness	NOUN
iajs-3302	39	13	,	,	PUNCT
iajs-3302	39	14	urinary	urinary	ADJ
iajs-3302	39	15	tract	tract	NOUN
iajs-3302	39	16	infections	infection	NOUN
iajs-3302	39	17	,	,	PUNCT
iajs-3302	39	18	polycystic	polycystic	ADJ
iajs-3302	39	19	kidney	kidney	NOUN
iajs-3302	39	20	disease	disease	NOUN
iajs-3302	39	21	,	,	PUNCT
iajs-3302	39	22	blockages	blockage	NOUN
iajs-3302	39	23	,	,	PUNCT
iajs-3302	39	24	glomerulonephritis	glomerulonephritis	NOUN
iajs-3302	39	25	,	,	PUNCT
iajs-3302	39	26	medicines	medicine	NOUN
iajs-3302	39	27	,	,	PUNCT
iajs-3302	39	28	toxins	toxin	NOUN
iajs-3302	39	29	,	,	PUNCT
iajs-3302	39	30	and	and	CCONJ
iajs-3302	39	31	diabetes	diabetes	NOUN
iajs-3302	39	32	.	.	PUNCT
iajs-3302	40	1	this	this	DET
iajs-3302	40	2	damage	damage	NOUN
iajs-3302	40	3	may	may	AUX
iajs-3302	40	4	render	render	VERB
iajs-3302	40	5	the	the	DET
iajs-3302	40	6	kidneys	kidney	NOUN
iajs-3302	40	7	incapable	incapable	ADJ
iajs-3302	40	8	of	of	ADP
iajs-3302	40	9	removing	remove	VERB
iajs-3302	40	10	squanders	squander	NOUN
iajs-3302	40	11	.	.	PUNCT
iajs-3302	41	1	other	other	ADJ
iajs-3302	41	2	kidney	kidney	NOUN
iajs-3302	41	3	issues	issue	NOUN
iajs-3302	41	4	include	include	VERB
iajs-3302	41	5	tumors	tumor	NOUN
iajs-3302	41	6	,	,	PUNCT
iajs-3302	41	7	cysts	cyst	NOUN
iajs-3302	41	8	,	,	PUNCT
iajs-3302	41	9	and	and	CCONJ
iajs-3302	41	10	stones	stone	NOUN
iajs-3302	41	11	,	,	PUNCT
iajs-3302	41	12	hypertension	hypertension	NOUN
iajs-3302	41	13	and	and	CCONJ
iajs-3302	41	14	dm	dm	NOUN
iajs-3302	41	15	,	,	PUNCT
iajs-3302	41	16	and	and	CCONJ
iajs-3302	41	17	obesity	obesity	NOUN
iajs-3302	41	18	may	may	AUX
iajs-3302	41	19	be	be	AUX
iajs-3302	41	20	non	non	ADJ
iajs-3302	41	21	-	-	ADJ
iajs-3302	41	22	conventional	conventional	ADJ
iajs-3302	41	23	hazard	hazard	NOUN
iajs-3302	41	24	factors	factor	NOUN
iajs-3302	41	25	[	[	X
iajs-3302	41	26	7,8	7,8	NUM
iajs-3302	41	27	]	]	PUNCT
iajs-3302	41	28	.	.	PUNCT
iajs-3302	42	1	this	this	DET
iajs-3302	42	2	study	study	NOUN
iajs-3302	42	3	aims	aim	VERB
iajs-3302	42	4	to	to	PART
iajs-3302	42	5	investigate	investigate	VERB
iajs-3302	42	6	the	the	DET
iajs-3302	42	7	effect	effect	NOUN
iajs-3302	42	8	of	of	ADP
iajs-3302	42	9	sex	sex	NOUN
iajs-3302	42	10	on	on	ADP
iajs-3302	42	11	levels	level	NOUN
iajs-3302	42	12	of	of	ADP
iajs-3302	42	13	ctgf	ctgf	NOUN
iajs-3302	42	14	and	and	CCONJ
iajs-3302	42	15	tgf	tgf	PROPN
iajs-3302	42	16	-	-	PUNCT
iajs-3302	42	17	β1	β1	PROPN
iajs-3302	42	18	in	in	ADP
iajs-3302	42	19	diabetic	diabetic	ADJ
iajs-3302	42	20	patients	patient	NOUN
iajs-3302	42	21	with	with	ADP
iajs-3302	42	22	or	or	CCONJ
iajs-3302	42	23	without	without	ADP
iajs-3302	42	24	diabetic	diabetic	ADJ
iajs-3302	42	25	nephropathy	nephropathy	NOUN
iajs-3302	42	26	in	in	ADP
iajs-3302	42	27	comparison	comparison	NOUN
iajs-3302	42	28	with	with	ADP
iajs-3302	42	29	healthy	healthy	ADJ
iajs-3302	42	30	subjects	subject	NOUN
iajs-3302	42	31	.	.	PUNCT
iajs-3302	43	1	2	2	X
iajs-3302	43	2	.	.	X
iajs-3302	43	3	materials	material	NOUN
iajs-3302	43	4	and	and	CCONJ
iajs-3302	43	5	methods	method	NOUN
iajs-3302	43	6	2.1	2.1	NUM
iajs-3302	43	7	study	study	NOUN
iajs-3302	43	8	design	design	NOUN
iajs-3302	43	9	and	and	CCONJ
iajs-3302	43	10	patients	patient	NOUN
iajs-3302	43	11	a	a	DET
iajs-3302	43	12	total	total	NOUN
iajs-3302	43	13	of	of	ADP
iajs-3302	43	14	120	120	NUM
iajs-3302	43	15	subjects	subject	NOUN
iajs-3302	43	16	;	;	PUNCT
iajs-3302	43	17	aged	aged	ADJ
iajs-3302	43	18	30	30	NUM
iajs-3302	43	19	-	-	SYM
iajs-3302	43	20	65	65	NUM
iajs-3302	43	21	,	,	PUNCT
iajs-3302	43	22	participated	participate	VERB
iajs-3302	43	23	in	in	ADP
iajs-3302	43	24	the	the	DET
iajs-3302	43	25	study	study	NOUN
iajs-3302	43	26	;	;	PUNCT
iajs-3302	43	27	90	90	NUM
iajs-3302	43	28	of	of	ADP
iajs-3302	43	29	them	they	PRON
iajs-3302	43	30	were	be	AUX
iajs-3302	43	31	patients	patient	NOUN
iajs-3302	43	32	with	with	ADP
iajs-3302	43	33	dm	dm	PROPN
iajs-3302	43	34	who	who	PRON
iajs-3302	43	35	visited	visit	VERB
iajs-3302	43	36	baghdad	baghdad	PROPN
iajs-3302	43	37	teaching	teaching	NOUN
iajs-3302	43	38	hospital	hospital	NOUN
iajs-3302	43	39	,	,	PUNCT
iajs-3302	43	40	medical	medical	ADJ
iajs-3302	43	41	city	city	NOUN
iajs-3302	43	42	,	,	PUNCT
iajs-3302	43	43	and	and	CCONJ
iajs-3302	43	44	al	al	PROPN
iajs-3302	43	45	-	-	PUNCT
iajs-3302	43	46	yarmouk	yarmouk	ADV
iajs-3302	43	47	teaching	teaching	NOUN
iajs-3302	43	48	hospital	hospital	NOUN
iajs-3302	43	49	between	between	ADP
iajs-3302	43	50	december	december	PROPN
iajs-3302	43	51	2021	2021	NUM
iajs-3302	43	52	and	and	CCONJ
iajs-3302	43	53	may	may	AUX
iajs-3302	43	54	2022	2022	NUM
iajs-3302	43	55	,	,	PUNCT
iajs-3302	43	56	and	and	CCONJ
iajs-3302	43	57	40	40	NUM
iajs-3302	43	58	healthy	healthy	ADJ
iajs-3302	43	59	people	people	NOUN
iajs-3302	43	60	were	be	AUX
iajs-3302	43	61	the	the	DET
iajs-3302	43	62	control	control	NOUN
iajs-3302	43	63	group	group	NOUN
iajs-3302	43	64	.	.	PUNCT
iajs-3302	44	1	groups	group	NOUN
iajs-3302	44	2	of	of	ADP
iajs-3302	44	3	analysis	analysis	NOUN
iajs-3302	44	4	included	include	VERB
iajs-3302	44	5	:	:	PUNCT
iajs-3302	44	6	1	1	X
iajs-3302	44	7	)	)	PUNCT
iajs-3302	44	8	the	the	DET
iajs-3302	44	9	control	control	NOUN
iajs-3302	44	10	group	group	NOUN
iajs-3302	44	11	included	include	VERB
iajs-3302	44	12	15	15	NUM
iajs-3302	44	13	males	male	NOUN
iajs-3302	44	14	and	and	CCONJ
iajs-3302	44	15	15	15	NUM
iajs-3302	44	16	females	female	NOUN
iajs-3302	44	17	who	who	PRON
iajs-3302	44	18	were	be	AUX
iajs-3302	44	19	healthy	healthy	ADJ
iajs-3302	44	20	-	-	PUNCT
iajs-3302	44	21	looking	look	VERB
iajs-3302	44	22	subjects	subject	NOUN
iajs-3302	44	23	without	without	ADP
iajs-3302	44	24	any	any	DET
iajs-3302	44	25	diseases	disease	NOUN
iajs-3302	44	26	.	.	PUNCT
iajs-3302	45	1	2	2	X
iajs-3302	45	2	)	)	PUNCT
iajs-3302	45	3	diabetic	diabetic	ADJ
iajs-3302	45	4	patients	patient	NOUN
iajs-3302	45	5	:	:	PUNCT
iajs-3302	45	6	included	include	VERB
iajs-3302	45	7	90	90	NUM
iajs-3302	45	8	patients	patient	NOUN
iajs-3302	45	9	who	who	PRON
iajs-3302	45	10	were	be	AUX
iajs-3302	45	11	divided	divide	VERB
iajs-3302	45	12	into	into	ADP
iajs-3302	45	13	three	three	NUM
iajs-3302	45	14	groups	group	NOUN
iajs-3302	45	15	according	accord	VERB
iajs-3302	45	16	to	to	ADP
iajs-3302	45	17	the	the	DET
iajs-3302	45	18	albumin	albumin	NOUN
iajs-3302	45	19	-	-	PUNCT
iajs-3302	45	20	to	to	ADP
iajs-3302	45	21	-	-	PUNCT
iajs-3302	45	22	creatinine	creatinine	NOUN
iajs-3302	45	23	ratio	ratio	NOUN
iajs-3302	45	24	(	(	PUNCT
iajs-3302	45	25	acr	acr	PROPN
iajs-3302	45	26	)	)	PUNCT
iajs-3302	45	27	criterion	criterion	NOUN
iajs-3302	45	28	:	:	PUNCT
iajs-3302	45	29	ihjpas	ihjpas	PROPN
iajs-3302	45	30	.	.	PUNCT
iajs-3302	46	1	37	37	NUM
iajs-3302	46	2	(	(	PUNCT
iajs-3302	46	3	2	2	NUM
iajs-3302	46	4	)	)	PUNCT
iajs-3302	46	5	2024	2024	NUM
iajs-3302	46	6	262	262	NUM
iajs-3302	46	7	normoalbuminuria	normoalbuminuria	NOUN
iajs-3302	46	8	group	group	NOUN
iajs-3302	46	9	included	include	VERB
iajs-3302	46	10	15	15	NUM
iajs-3302	46	11	male	male	ADJ
iajs-3302	46	12	and	and	CCONJ
iajs-3302	46	13	15	15	NUM
iajs-3302	46	14	female	female	ADJ
iajs-3302	46	15	patients	patient	NOUN
iajs-3302	46	16	with	with	ADP
iajs-3302	46	17	an	an	DET
iajs-3302	46	18	acr	acr	PROPN
iajs-3302	46	19	<	<	X
iajs-3302	46	20	30	30	NUM
iajs-3302	46	21	mg	mg	NUM
iajs-3302	46	22	/	/	SYM
iajs-3302	46	23	g.	g.	PROPN
iajs-3302	46	24	microalbuminuria	microalbuminuria	PROPN
iajs-3302	46	25	group	group	PROPN
iajs-3302	46	26	included	include	VERB
iajs-3302	46	27	15	15	NUM
iajs-3302	46	28	male	male	ADJ
iajs-3302	46	29	and	and	CCONJ
iajs-3302	46	30	15	15	NUM
iajs-3302	46	31	female	female	ADJ
iajs-3302	46	32	patients	patient	NOUN
iajs-3302	46	33	with	with	ADP
iajs-3302	46	34	the	the	DET
iajs-3302	46	35	range	range	NOUN
iajs-3302	46	36	of	of	ADP
iajs-3302	46	37	acr	acr	PROPN
iajs-3302	46	38	30	30	NUM
iajs-3302	46	39	-	-	SYM
iajs-3302	46	40	300	300	NUM
iajs-3302	46	41	mg	mg	PROPN
iajs-3302	46	42	/	/	SYM
iajs-3302	46	43	g	g	PROPN
iajs-3302	46	44	macroalbuminuria	macroalbuminuria	PROPN
iajs-3302	46	45	group	group	NOUN
iajs-3302	46	46	included	include	VERB
iajs-3302	46	47	15	15	NUM
iajs-3302	46	48	male	male	ADJ
iajs-3302	46	49	and	and	CCONJ
iajs-3302	46	50	15	15	NUM
iajs-3302	46	51	female	female	ADJ
iajs-3302	46	52	patients	patient	NOUN
iajs-3302	46	53	with	with	ADP
iajs-3302	46	54	an	an	DET
iajs-3302	46	55	acr	acr	PROPN
iajs-3302	46	56	>	>	ADP
iajs-3302	46	57	300	300	NUM
iajs-3302	46	58	mg	mg	PROPN
iajs-3302	46	59	/	/	SYM
iajs-3302	46	60	g.	g.	NOUN
iajs-3302	46	61	2.2	2.2	NUM
iajs-3302	46	62	biochemical	biochemical	ADJ
iajs-3302	46	63	analysis	analysis	NOUN
iajs-3302	46	64	seven	seven	NUM
iajs-3302	46	65	ml	ml	NOUN
iajs-3302	46	66	of	of	ADP
iajs-3302	46	67	blood	blood	NOUN
iajs-3302	46	68	from	from	ADP
iajs-3302	46	69	the	the	DET
iajs-3302	46	70	antecubital	antecubital	ADJ
iajs-3302	46	71	vein	vein	NOUN
iajs-3302	46	72	was	be	AUX
iajs-3302	46	73	withdrawn	withdraw	VERB
iajs-3302	46	74	and	and	CCONJ
iajs-3302	46	75	divided	divide	VERB
iajs-3302	46	76	into	into	ADP
iajs-3302	46	77	two	two	NUM
iajs-3302	46	78	parts	part	NOUN
iajs-3302	46	79	.	.	PUNCT
iajs-3302	47	1	part	part	NOUN
iajs-3302	47	2	1	1	NUM
iajs-3302	47	3	:	:	SYM
iajs-3302	47	4	5	5	NUM
iajs-3302	47	5	ml	ml	NOUN
iajs-3302	47	6	were	be	AUX
iajs-3302	47	7	placed	place	VERB
iajs-3302	47	8	in	in	ADP
iajs-3302	47	9	gel	gel	NOUN
iajs-3302	47	10	tubes	tube	NOUN
iajs-3302	47	11	and	and	CCONJ
iajs-3302	47	12	solidified	solidify	VERB
iajs-3302	47	13	at	at	ADP
iajs-3302	47	14	room	room	NOUN
iajs-3302	47	15	temperature	temperature	NOUN
iajs-3302	47	16	for	for	ADP
iajs-3302	47	17	30	30	NUM
iajs-3302	47	18	minutes	minute	NOUN
iajs-3302	47	19	.	.	PUNCT
iajs-3302	48	1	after	after	ADP
iajs-3302	48	2	centrifuging	centrifuge	VERB
iajs-3302	48	3	for	for	ADP
iajs-3302	48	4	10	10	NUM
iajs-3302	48	5	minutes	minute	NOUN
iajs-3302	48	6	,	,	PUNCT
iajs-3302	48	7	separated	separate	VERB
iajs-3302	48	8	the	the	DET
iajs-3302	48	9	serum	serum	NOUN
iajs-3302	48	10	and	and	CCONJ
iajs-3302	48	11	stored	store	VERB
iajs-3302	48	12	it	it	PRON
iajs-3302	48	13	in	in	ADP
iajs-3302	48	14	eppendorf	eppendorf	PROPN
iajs-3302	48	15	tubes	tubes	PROPN
iajs-3302	48	16	.	.	PUNCT
iajs-3302	49	1	the	the	DET
iajs-3302	49	2	first	first	ADJ
iajs-3302	49	3	part	part	NOUN
iajs-3302	49	4	was	be	AUX
iajs-3302	49	5	utilized	utilize	VERB
iajs-3302	49	6	to	to	PART
iajs-3302	49	7	rapidly	rapidly	ADV
iajs-3302	49	8	identify	identify	VERB
iajs-3302	49	9	(	(	PUNCT
iajs-3302	49	10	fasting	fast	VERB
iajs-3302	49	11	blood	blood	NOUN
iajs-3302	49	12	sugar	sugar	NOUN
iajs-3302	49	13	,	,	PUNCT
iajs-3302	49	14	urea	urea	NOUN
iajs-3302	49	15	,	,	PUNCT
iajs-3302	49	16	and	and	CCONJ
iajs-3302	49	17	creatinine	creatinine	NOUN
iajs-3302	49	18	in	in	ADP
iajs-3302	49	19	serum	serum	NOUN
iajs-3302	49	20	)	)	PUNCT
iajs-3302	49	21	using	use	VERB
iajs-3302	49	22	an	an	DET
iajs-3302	49	23	autospectrophotometer	autospectrophotometer	NOUN
iajs-3302	49	24	,	,	PUNCT
iajs-3302	49	25	which	which	PRON
iajs-3302	49	26	is	be	AUX
iajs-3302	49	27	a	a	DET
iajs-3302	49	28	clinical	clinical	ADJ
iajs-3302	49	29	chemistry	chemistry	NOUN
iajs-3302	49	30	analyzer	analyzer	NOUN
iajs-3302	49	31	that	that	PRON
iajs-3302	49	32	performs	perform	VERB
iajs-3302	49	33	diagnostic	diagnostic	ADJ
iajs-3302	49	34	tests	test	NOUN
iajs-3302	49	35	.	.	PUNCT
iajs-3302	50	1	also	also	ADV
iajs-3302	50	2	,	,	PUNCT
iajs-3302	50	3	it	it	PRON
iajs-3302	50	4	was	be	AUX
iajs-3302	50	5	utilized	utilize	VERB
iajs-3302	50	6	after	after	ADP
iajs-3302	50	7	being	be	AUX
iajs-3302	50	8	maintained	maintain	VERB
iajs-3302	50	9	at	at	ADP
iajs-3302	50	10	-20	-20	PROPN
iajs-3302	50	11	°	°	ADP
iajs-3302	50	12	c	c	NOUN
iajs-3302	50	13	to	to	PART
iajs-3302	50	14	assess	assess	VERB
iajs-3302	50	15	ctgf	ctgf	NOUN
iajs-3302	50	16	and	and	CCONJ
iajs-3302	50	17	tgf	tgf	PROPN
iajs-3302	50	18	-	-	PUNCT
iajs-3302	50	19	b1	b1	NOUN
iajs-3302	50	20	,	,	PUNCT
iajs-3302	50	21	which	which	PRON
iajs-3302	50	22	were	be	AUX
iajs-3302	50	23	evaluated	evaluate	VERB
iajs-3302	50	24	using	use	VERB
iajs-3302	50	25	a	a	DET
iajs-3302	50	26	biosource	biosource	NOUN
iajs-3302	50	27	enzyme	enzyme	NOUN
iajs-3302	50	28	-	-	PUNCT
iajs-3302	50	29	linked	link	VERB
iajs-3302	50	30	immunosorbent	immunosorbent	NOUN
iajs-3302	50	31	test	test	NOUN
iajs-3302	50	32	(	(	PUNCT
iajs-3302	50	33	elisa	elisa	NOUN
iajs-3302	50	34	)	)	PUNCT
iajs-3302	50	35	kit	kit	PROPN
iajs-3302	50	36	,	,	PUNCT
iajs-3302	50	37	usa	usa	PROPN
iajs-3302	50	38	.	.	PROPN
iajs-3302	50	39	part	part	NOUN
iajs-3302	50	40	2	2	NUM
iajs-3302	50	41	:	:	SYM
iajs-3302	50	42	2	2	NUM
iajs-3302	50	43	ml	ml	NOUN
iajs-3302	50	44	of	of	ADP
iajs-3302	50	45	the	the	DET
iajs-3302	50	46	blood	blood	NOUN
iajs-3302	50	47	was	be	AUX
iajs-3302	50	48	kept	keep	VERB
iajs-3302	50	49	in	in	ADP
iajs-3302	50	50	a	a	DET
iajs-3302	50	51	test	test	NOUN
iajs-3302	50	52	tube	tube	NOUN
iajs-3302	50	53	containing	contain	VERB
iajs-3302	50	54	an	an	DET
iajs-3302	50	55	anticoagulant	anticoagulant	NOUN
iajs-3302	50	56	for	for	ADP
iajs-3302	50	57	hemoglobin	hemoglobin	NOUN
iajs-3302	50	58	a1c	a1c	PROPN
iajs-3302	50	59	(	(	PUNCT
iajs-3302	50	60	hba1c	hba1c	NOUN
iajs-3302	50	61	)	)	PUNCT
iajs-3302	50	62	measurement	measurement	NOUN
iajs-3302	50	63	by	by	ADP
iajs-3302	50	64	an	an	DET
iajs-3302	50	65	i	i	NOUN
iajs-3302	50	66	-	-	PUNCT
iajs-3302	50	67	chroma	chroma	NOUN
iajs-3302	50	68	device	device	NOUN
iajs-3302	50	69	.	.	PUNCT
iajs-3302	51	1	2.3	2.3	NUM
iajs-3302	51	2	statistical	statistical	ADJ
iajs-3302	51	3	analysis	analysis	NOUN
iajs-3302	51	4	the	the	DET
iajs-3302	51	5	spss	spss	PROPN
iajs-3302	51	6	software	software	NOUN
iajs-3302	51	7	version	version	NOUN
iajs-3302	51	8	26	26	NUM
iajs-3302	51	9	was	be	AUX
iajs-3302	51	10	used	use	VERB
iajs-3302	51	11	to	to	PART
iajs-3302	51	12	analyze	analyze	VERB
iajs-3302	51	13	the	the	DET
iajs-3302	51	14	data	datum	NOUN
iajs-3302	51	15	statistically	statistically	ADV
iajs-3302	51	16	.	.	PUNCT
iajs-3302	52	1	the	the	DET
iajs-3302	52	2	variables	variable	NOUN
iajs-3302	52	3	'	'	PART
iajs-3302	52	4	means	mean	NOUN
iajs-3302	52	5	and	and	CCONJ
iajs-3302	52	6	standard	standard	ADJ
iajs-3302	52	7	deviations	deviation	NOUN
iajs-3302	52	8	were	be	AUX
iajs-3302	52	9	reported	report	VERB
iajs-3302	52	10	.	.	PUNCT
iajs-3302	53	1	to	to	PART
iajs-3302	53	2	find	find	VERB
iajs-3302	53	3	out	out	ADP
iajs-3302	53	4	whether	whether	SCONJ
iajs-3302	53	5	there	there	PRON
iajs-3302	53	6	are	be	VERB
iajs-3302	53	7	statistically	statistically	ADV
iajs-3302	53	8	significant	significant	ADJ
iajs-3302	53	9	variations	variation	NOUN
iajs-3302	53	10	in	in	ADP
iajs-3302	53	11	the	the	DET
iajs-3302	53	12	means	mean	NOUN
iajs-3302	53	13	of	of	ADP
iajs-3302	53	14	the	the	DET
iajs-3302	53	15	four	four	NUM
iajs-3302	53	16	independent	independent	ADJ
iajs-3302	53	17	studied	study	VERB
iajs-3302	53	18	groups	group	NOUN
iajs-3302	53	19	,	,	PUNCT
iajs-3302	53	20	one	one	NUM
iajs-3302	53	21	-	-	PUNCT
iajs-3302	53	22	way	way	NOUN
iajs-3302	53	23	analysis	analysis	NOUN
iajs-3302	53	24	of	of	ADP
iajs-3302	53	25	variance	variance	NOUN
iajs-3302	53	26	(	(	PUNCT
iajs-3302	53	27	anova	anova	PROPN
iajs-3302	53	28	)	)	PUNCT
iajs-3302	53	29	is	be	AUX
iajs-3302	53	30	utilized	utilize	VERB
iajs-3302	53	31	(	(	PUNCT
iajs-3302	53	32	control	control	NOUN
iajs-3302	53	33	,	,	PUNCT
iajs-3302	53	34	dm	dm	PROPN
iajs-3302	53	35	with	with	ADP
iajs-3302	53	36	normoalbuminuria	normoalbuminuria	PROPN
iajs-3302	53	37	,	,	PUNCT
iajs-3302	53	38	dm	dm	PROPN
iajs-3302	53	39	with	with	ADP
iajs-3302	53	40	microalbuminuria	microalbuminuria	NOUN
iajs-3302	53	41	,	,	PUNCT
iajs-3302	53	42	and	and	CCONJ
iajs-3302	53	43	dm	dm	X
iajs-3302	53	44	with	with	ADP
iajs-3302	53	45	macroalbuminuria	macroalbuminuria	PROPN
iajs-3302	53	46	)	)	PUNCT
iajs-3302	54	1	[	[	X
iajs-3302	54	2	9	9	NUM
iajs-3302	54	3	]	]	PUNCT
iajs-3302	54	4	.	.	PUNCT
iajs-3302	55	1	3	3	X
iajs-3302	55	2	.	.	X
iajs-3302	55	3	results	result	NOUN
iajs-3302	55	4	as	as	SCONJ
iajs-3302	55	5	shown	show	VERB
iajs-3302	55	6	in	in	ADP
iajs-3302	55	7	table	table	NOUN
iajs-3302	55	8	1	1	NUM
iajs-3302	55	9	,	,	PUNCT
iajs-3302	55	10	the	the	DET
iajs-3302	55	11	mean	mean	ADJ
iajs-3302	55	12	±	±	NUM
iajs-3302	55	13	standard	standard	ADJ
iajs-3302	55	14	deviation	deviation	NOUN
iajs-3302	55	15	values	value	VERB
iajs-3302	55	16	parameters	parameter	NOUN
iajs-3302	55	17	for	for	ADP
iajs-3302	55	18	the	the	DET
iajs-3302	55	19	studied	study	VERB
iajs-3302	55	20	groups	group	NOUN
iajs-3302	55	21	showed	show	VERB
iajs-3302	55	22	highly	highly	ADV
iajs-3302	55	23	significant	significant	ADJ
iajs-3302	55	24	(	(	PUNCT
iajs-3302	55	25	p	p	X
iajs-3302	55	26	<	<	X
iajs-3302	55	27	0.05	0.05	NUM
iajs-3302	55	28	)	)	PUNCT
iajs-3302	55	29	differences	difference	NOUN
iajs-3302	55	30	in	in	ADP
iajs-3302	55	31	blood	blood	NOUN
iajs-3302	55	32	sugar	sugar	NOUN
iajs-3302	55	33	,	,	PUNCT
iajs-3302	55	34	hba1c	hba1c	PROPN
iajs-3302	55	35	,	,	PUNCT
iajs-3302	55	36	creatinine	creatinine	NOUN
iajs-3302	55	37	,	,	PUNCT
iajs-3302	55	38	blood	blood	NOUN
iajs-3302	55	39	urea	urea	NOUN
iajs-3302	55	40	,	,	PUNCT
iajs-3302	55	41	egfr	egfr	ADJ
iajs-3302	55	42	levels	level	NOUN
iajs-3302	55	43	,	,	PUNCT
iajs-3302	55	44	and	and	CCONJ
iajs-3302	55	45	albumin	albumin	ADJ
iajs-3302	55	46	creatinine	creatinine	NOUN
iajs-3302	55	47	to	to	PART
iajs-3302	55	48	ratio	ratio	VERB
iajs-3302	55	49	in	in	ADP
iajs-3302	55	50	urine	urine	NOUN
iajs-3302	55	51	.	.	PUNCT
iajs-3302	56	1	table	table	NOUN
iajs-3302	56	2	1	1	NUM
iajs-3302	56	3	shows	show	VERB
iajs-3302	56	4	the	the	DET
iajs-3302	56	5	mean	mean	ADJ
iajs-3302	56	6	±	±	NOUN
iajs-3302	56	7	sd	sd	NOUN
iajs-3302	56	8	for	for	ADP
iajs-3302	56	9	fbs	fbs	PROPN
iajs-3302	56	10	and	and	CCONJ
iajs-3302	56	11	hba1c	hba1c	PROPN
iajs-3302	56	12	in	in	ADP
iajs-3302	56	13	the	the	DET
iajs-3302	56	14	three	three	NUM
iajs-3302	56	15	patient	patient	ADJ
iajs-3302	56	16	groups	group	NOUN
iajs-3302	56	17	and	and	CCONJ
iajs-3302	56	18	the	the	DET
iajs-3302	56	19	control	control	NOUN
iajs-3302	56	20	group	group	NOUN
iajs-3302	56	21	.	.	PUNCT
iajs-3302	57	1	the	the	DET
iajs-3302	57	2	results	result	NOUN
iajs-3302	57	3	revealed	reveal	VERB
iajs-3302	57	4	a	a	DET
iajs-3302	57	5	significant	significant	ADJ
iajs-3302	57	6	difference	difference	NOUN
iajs-3302	57	7	(	(	PUNCT
iajs-3302	57	8	p	p	NOUN
iajs-3302	57	9	=	=	NOUN
iajs-3302	57	10	0.0001	0.0001	NUM
iajs-3302	57	11	)	)	PUNCT
iajs-3302	57	12	between	between	ADP
iajs-3302	57	13	the	the	DET
iajs-3302	57	14	control	control	NOUN
iajs-3302	57	15	group	group	NOUN
iajs-3302	57	16	and	and	CCONJ
iajs-3302	57	17	the	the	DET
iajs-3302	57	18	patients	patient	NOUN
iajs-3302	57	19	in	in	ADP
iajs-3302	57	20	the	the	DET
iajs-3302	57	21	current	current	ADJ
iajs-3302	57	22	study	study	NOUN
iajs-3302	57	23	for	for	ADP
iajs-3302	57	24	both	both	DET
iajs-3302	57	25	females	female	NOUN
iajs-3302	57	26	and	and	CCONJ
iajs-3302	57	27	males	male	NOUN
iajs-3302	57	28	.	.	PUNCT
iajs-3302	58	1	this	this	PRON
iajs-3302	58	2	means	mean	VERB
iajs-3302	58	3	that	that	SCONJ
iajs-3302	58	4	sex	sex	NOUN
iajs-3302	58	5	does	do	AUX
iajs-3302	58	6	not	not	PART
iajs-3302	58	7	affect	affect	VERB
iajs-3302	58	8	the	the	DET
iajs-3302	58	9	results	result	NOUN
iajs-3302	58	10	obtained	obtain	VERB
iajs-3302	58	11	for	for	ADP
iajs-3302	58	12	the	the	DET
iajs-3302	58	13	fbs	fbs	PROPN
iajs-3302	58	14	and	and	CCONJ
iajs-3302	58	15	hba1c	hba1c	PROPN
iajs-3302	58	16	groups	group	NOUN
iajs-3302	58	17	.	.	PUNCT
iajs-3302	59	1	the	the	DET
iajs-3302	59	2	results	result	NOUN
iajs-3302	59	3	of	of	ADP
iajs-3302	59	4	creatinine	creatinine	NOUN
iajs-3302	59	5	and	and	CCONJ
iajs-3302	59	6	urea	urea	NOUN
iajs-3302	59	7	for	for	ADP
iajs-3302	59	8	both	both	DET
iajs-3302	59	9	females	female	NOUN
iajs-3302	59	10	and	and	CCONJ
iajs-3302	59	11	males	male	NOUN
iajs-3302	59	12	in	in	ADP
iajs-3302	59	13	patients	patient	NOUN
iajs-3302	59	14	and	and	CCONJ
iajs-3302	59	15	control	control	NOUN
iajs-3302	59	16	groups	group	NOUN
iajs-3302	59	17	are	be	AUX
iajs-3302	59	18	recorded	record	VERB
iajs-3302	59	19	in	in	ADP
iajs-3302	59	20	table	table	NOUN
iajs-3302	59	21	1	1	NUM
iajs-3302	59	22	,	,	PUNCT
iajs-3302	59	23	and	and	CCONJ
iajs-3302	59	24	there	there	PRON
iajs-3302	59	25	were	be	VERB
iajs-3302	59	26	significant	significant	ADJ
iajs-3302	59	27	differences	difference	NOUN
iajs-3302	59	28	.	.	PUNCT
iajs-3302	60	1	then	then	ADV
iajs-3302	60	2	,	,	PUNCT
iajs-3302	60	3	a	a	DET
iajs-3302	60	4	comparison	comparison	NOUN
iajs-3302	60	5	was	be	AUX
iajs-3302	60	6	made	make	VERB
iajs-3302	60	7	that	that	PRON
iajs-3302	60	8	included	include	VERB
iajs-3302	60	9	the	the	DET
iajs-3302	60	10	patients	patient	NOUN
iajs-3302	60	11	’	'	PUNCT
iajs-3302	60	12	totals	total	NOUN
iajs-3302	60	13	,	,	PUNCT
iajs-3302	60	14	each	each	DET
iajs-3302	60	15	group	group	NOUN
iajs-3302	60	16	separately	separately	ADV
iajs-3302	60	17	,	,	PUNCT
iajs-3302	60	18	the	the	DET
iajs-3302	60	19	control	control	NOUN
iajs-3302	60	20	,	,	PUNCT
iajs-3302	60	21	and	and	CCONJ
iajs-3302	60	22	the	the	DET
iajs-3302	60	23	results	result	NOUN
iajs-3302	60	24	.	.	PUNCT
iajs-3302	61	1	the	the	DET
iajs-3302	61	2	results	result	NOUN
iajs-3302	61	3	of	of	ADP
iajs-3302	61	4	creatinine	creatinine	NOUN
iajs-3302	61	5	in	in	ADP
iajs-3302	61	6	both	both	DET
iajs-3302	61	7	sex	sex	NOUN
iajs-3302	61	8	showed	show	VERB
iajs-3302	61	9	a	a	DET
iajs-3302	61	10	significant	significant	ADJ
iajs-3302	61	11	difference	difference	NOUN
iajs-3302	61	12	(	(	PUNCT
iajs-3302	61	13	p	p	NOUN
iajs-3302	61	14	=	=	NOUN
iajs-3302	61	15	0.0001	0.0001	NUM
iajs-3302	61	16	)	)	PUNCT
iajs-3302	61	17	between	between	ADP
iajs-3302	61	18	macro	macro	ADJ
iajs-3302	61	19	groups	group	NOUN
iajs-3302	61	20	(	(	PUNCT
iajs-3302	61	21	3.50±2.85	3.50±2.85	NUM
iajs-3302	61	22	af	af	NOUN
iajs-3302	61	23	,	,	PUNCT
iajs-3302	61	24	3.36	3.36	NUM
iajs-3302	61	25	±	±	NUM
iajs-3302	61	26	2.99	2.99	NUM
iajs-3302	61	27	am	am	NOUN
iajs-3302	61	28	)	)	PUNCT
iajs-3302	61	29	and	and	CCONJ
iajs-3302	61	30	other	other	ADJ
iajs-3302	61	31	studied	study	VERB
iajs-3302	61	32	groups	group	NOUN
iajs-3302	61	33	that	that	PRON
iajs-3302	61	34	include	include	VERB
iajs-3302	61	35	micro-	micro-	NOUN
iajs-3302	61	36	,	,	PUNCT
iajs-3302	61	37	normoalbuminuria	normoalbuminuria	PROPN
iajs-3302	61	38	,	,	PUNCT
iajs-3302	61	39	and	and	CCONJ
iajs-3302	61	40	control	control	NOUN
iajs-3302	61	41	groups	group	NOUN
iajs-3302	61	42	for	for	ADP
iajs-3302	61	43	both	both	DET
iajs-3302	61	44	sex	sex	NOUN
iajs-3302	61	45	(	(	PUNCT
iajs-3302	61	46	1.50	1.50	NUM
iajs-3302	61	47	±	±	NUM
iajs-3302	61	48	0.67	0.67	NUM
iajs-3302	61	49	b	b	PROPN
iajs-3302	61	50	,	,	PUNCT
iajs-3302	61	51	0.91	0.91	NUM
iajs-3302	61	52	±0.20	±0.20	PROPN
iajs-3302	61	53	b	b	PROPN
iajs-3302	61	54	,	,	PUNCT
iajs-3302	61	55	0.70	0.70	NUM
iajs-3302	61	56	±	±	NOUN
iajs-3302	61	57	0.12	0.12	NUM
iajs-3302	61	58	b	b	NOUN
iajs-3302	61	59	)	)	PUNCT
iajs-3302	61	60	for	for	ADP
iajs-3302	61	61	female	female	ADJ
iajs-3302	61	62	groups	group	NOUN
iajs-3302	61	63	and	and	CCONJ
iajs-3302	61	64	(	(	PUNCT
iajs-3302	61	65	1.30	1.30	NUM
iajs-3302	61	66	±	±	NUM
iajs-3302	61	67	0.74	0.74	NUM
iajs-3302	61	68	b	b	NOUN
iajs-3302	61	69	,	,	PUNCT
iajs-3302	61	70	0.95	0.95	NUM
iajs-3302	61	71	±	±	NUM
iajs-3302	61	72	0.27	0.27	NUM
iajs-3302	61	73	b	b	NOUN
iajs-3302	61	74	,	,	PUNCT
iajs-3302	61	75	0.80	0.80	NUM
iajs-3302	61	76	±	±	NUM
iajs-3302	61	77	0.06	0.06	NUM
iajs-3302	61	78	b	b	PROPN
iajs-3302	61	79	)	)	PUNCT
iajs-3302	61	80	for	for	ADP
iajs-3302	61	81	male	male	ADJ
iajs-3302	61	82	groups	group	NOUN
iajs-3302	61	83	,	,	PUNCT
iajs-3302	61	84	respectively	respectively	ADV
iajs-3302	61	85	.	.	PUNCT
iajs-3302	62	1	in	in	ADP
iajs-3302	62	2	contrast	contrast	NOUN
iajs-3302	62	3	,	,	PUNCT
iajs-3302	62	4	results	result	NOUN
iajs-3302	62	5	of	of	ADP
iajs-3302	62	6	urea	urea	NOUN
iajs-3302	62	7	in	in	ADP
iajs-3302	62	8	females	female	NOUN
iajs-3302	62	9	revealed	reveal	VERB
iajs-3302	62	10	significant	significant	ADJ
iajs-3302	62	11	differences	difference	NOUN
iajs-3302	62	12	(	(	PUNCT
iajs-3302	62	13	p=0.0001	p=0.0001	NOUN
iajs-3302	62	14	)	)	PUNCT
iajs-3302	62	15	among	among	ADP
iajs-3302	62	16	macro(88.83	macro(88.83	ADJ
iajs-3302	62	17	±	±	NUM
iajs-3302	62	18	40.61	40.61	NUM
iajs-3302	62	19	a	a	PRON
iajs-3302	62	20	)	)	PUNCT
iajs-3302	62	21	,	,	PUNCT
iajs-3302	62	22	micro	micro	X
iajs-3302	62	23	(	(	PUNCT
iajs-3302	62	24	61.01±22.12	61.01±22.12	NUM
iajs-3302	62	25	b	b	NOUN
iajs-3302	62	26	)	)	PUNCT
iajs-3302	62	27	,	,	PUNCT
iajs-3302	62	28	and	and	CCONJ
iajs-3302	62	29	normoalbuminuria	normoalbuminuria	PROPN
iajs-3302	62	30	(	(	PUNCT
iajs-3302	62	31	35.93±7.83	35.93±7.83	PROPN
iajs-3302	62	32	c	c	NOUN
iajs-3302	62	33	)	)	PUNCT
iajs-3302	62	34	compared	compare	VERB
iajs-3302	62	35	with	with	ADP
iajs-3302	62	36	control	control	NOUN
iajs-3302	62	37	(	(	PUNCT
iajs-3302	62	38	27.50±4.77	27.50±4.77	NUM
iajs-3302	62	39	c	c	NOUN
iajs-3302	62	40	)	)	PUNCT
iajs-3302	62	41	groups	group	NOUN
iajs-3302	62	42	.	.	PUNCT
iajs-3302	63	1	at	at	ADP
iajs-3302	63	2	the	the	DET
iajs-3302	63	3	same	same	ADJ
iajs-3302	63	4	time	time	NOUN
iajs-3302	63	5	,	,	PUNCT
iajs-3302	63	6	findings	finding	NOUN
iajs-3302	63	7	of	of	ADP
iajs-3302	63	8	urea	urea	NOUN
iajs-3302	63	9	for	for	ADP
iajs-3302	63	10	males	male	NOUN
iajs-3302	63	11	indicated	indicate	VERB
iajs-3302	63	12	significant	significant	ADJ
iajs-3302	63	13	differences	difference	NOUN
iajs-3302	63	14	(	(	PUNCT
iajs-3302	63	15	p=	p=	NOUN
iajs-3302	63	16	0.0001	0.0001	NUM
iajs-3302	63	17	)	)	PUNCT
iajs-3302	63	18	between	between	ADP
iajs-3302	63	19	both	both	PRON
iajs-3302	63	20	macro(81.82±39.67	macro(81.82±39.67	PROPN
iajs-3302	63	21	a	a	NOUN
iajs-3302	63	22	)	)	PUNCT
iajs-3302	63	23	and	and	CCONJ
iajs-3302	63	24	micro(59.24	micro(59.24	X
iajs-3302	63	25	±	±	NUM
iajs-3302	63	26	25.92	25.92	NUM
iajs-3302	63	27	a	a	DET
iajs-3302	63	28	)	)	PUNCT
iajs-3302	63	29	groups	group	NOUN
iajs-3302	63	30	compared	compare	VERB
iajs-3302	63	31	to	to	ADP
iajs-3302	63	32	both	both	DET
iajs-3302	63	33	normoalbuminuria	normoalbuminuria	PROPN
iajs-3302	63	34	(	(	PUNCT
iajs-3302	63	35	32.93±10.27	32.93±10.27	NUM
iajs-3302	63	36	b	b	NOUN
iajs-3302	63	37	)	)	PUNCT
iajs-3302	63	38	and	and	CCONJ
iajs-3302	63	39	control	control	NOUN
iajs-3302	63	40	(	(	PUNCT
iajs-3302	63	41	34.15	34.15	NUM
iajs-3302	63	42	±	±	NUM
iajs-3302	63	43	2.79	2.79	NUM
iajs-3302	63	44	b	b	NOUN
iajs-3302	63	45	)	)	PUNCT
iajs-3302	63	46	groups	group	NOUN
iajs-3302	63	47	,	,	PUNCT
iajs-3302	63	48	as	as	SCONJ
iajs-3302	63	49	reported	report	VERB
iajs-3302	63	50	in	in	ADP
iajs-3302	63	51	table	table	NOUN
iajs-3302	63	52	1	1	NUM
iajs-3302	63	53	.	.	PUNCT
iajs-3302	63	54	ihjpas	ihjpas	PROPN
iajs-3302	63	55	.	.	PUNCT
iajs-3302	64	1	37	37	NUM
iajs-3302	64	2	(	(	PUNCT
iajs-3302	64	3	2	2	NUM
iajs-3302	64	4	)	)	PUNCT
iajs-3302	64	5	2024	2024	NUM
iajs-3302	64	6	263	263	NUM
iajs-3302	64	7	table	table	NOUN
iajs-3302	64	8	1	1	NUM
iajs-3302	64	9	.	.	PUNCT
iajs-3302	64	10	glycemic	glycemic	ADJ
iajs-3302	64	11	profile	profile	NOUN
iajs-3302	64	12	and	and	CCONJ
iajs-3302	64	13	renal	renal	ADJ
iajs-3302	64	14	function	function	NOUN
iajs-3302	64	15	test	test	NOUN
iajs-3302	64	16	in	in	ADP
iajs-3302	64	17	the	the	DET
iajs-3302	64	18	studied	study	VERB
iajs-3302	64	19	groups	group	NOUN
iajs-3302	64	20	.	.	PUNCT
iajs-3302	65	1	the	the	DET
iajs-3302	65	2	values	value	NOUN
iajs-3302	65	3	of	of	ADP
iajs-3302	65	4	egfr	egfr	NOUN
iajs-3302	65	5	and	and	CCONJ
iajs-3302	65	6	acr	acr	PROPN
iajs-3302	65	7	of	of	ADP
iajs-3302	65	8	the	the	DET
iajs-3302	65	9	studied	study	VERB
iajs-3302	65	10	groups	group	NOUN
iajs-3302	65	11	for	for	ADP
iajs-3302	65	12	both	both	DET
iajs-3302	65	13	sex	sex	NOUN
iajs-3302	65	14	are	be	AUX
iajs-3302	65	15	recorded	record	VERB
iajs-3302	65	16	in	in	ADP
iajs-3302	65	17	table	table	NOUN
iajs-3302	65	18	1	1	NUM
iajs-3302	65	19	.	.	PUNCT
iajs-3302	66	1	the	the	DET
iajs-3302	66	2	results	result	NOUN
iajs-3302	66	3	of	of	ADP
iajs-3302	66	4	egfr	egfr	NOUN
iajs-3302	66	5	in	in	ADP
iajs-3302	66	6	females	female	NOUN
iajs-3302	66	7	revealed	reveal	VERB
iajs-3302	66	8	a	a	DET
iajs-3302	66	9	significant	significant	ADJ
iajs-3302	66	10	(	(	PUNCT
iajs-3302	66	11	p=	p=	NOUN
iajs-3302	66	12	0.0001	0.0001	NUM
iajs-3302	66	13	)	)	PUNCT
iajs-3302	66	14	decrease	decrease	NOUN
iajs-3302	66	15	in	in	ADP
iajs-3302	66	16	all	all	DET
iajs-3302	66	17	patient	patient	ADJ
iajs-3302	66	18	groups	group	NOUN
iajs-3302	66	19	(	(	PUNCT
iajs-3302	66	20	normoalbuminuria	normoalbuminuria	PROPN
iajs-3302	66	21	,	,	PUNCT
iajs-3302	66	22	micro-	micro-	NOUN
iajs-3302	66	23	,	,	PUNCT
iajs-3302	66	24	and	and	CCONJ
iajs-3302	66	25	macro(15.86	macro(15.86	NOUN
iajs-3302	66	26	±	±	NUM
iajs-3302	66	27	5.37	5.37	NUM
iajs-3302	66	28	a	a	PRON
iajs-3302	66	29	)	)	PUNCT
iajs-3302	66	30	,	,	PUNCT
iajs-3302	66	31	(	(	PUNCT
iajs-3302	66	32	91.53	91.53	NUM
iajs-3302	66	33	±	±	NUM
iajs-3302	66	34	59.70	59.70	NUM
iajs-3302	66	35	b	b	NOUN
iajs-3302	66	36	)	)	PUNCT
iajs-3302	66	37	,	,	PUNCT
iajs-3302	66	38	and	and	CCONJ
iajs-3302	66	39	(	(	PUNCT
iajs-3302	66	40	629.04	629.04	NUM
iajs-3302	66	41	±	±	NUM
iajs-3302	66	42	248.6	248.6	NUM
iajs-3302	66	43	c	c	NOUN
iajs-3302	66	44	)	)	PUNCT
iajs-3302	66	45	,	,	PUNCT
iajs-3302	66	46	respectively	respectively	ADV
iajs-3302	66	47	,	,	PUNCT
iajs-3302	66	48	compared	compare	VERB
iajs-3302	66	49	with	with	ADP
iajs-3302	66	50	the	the	DET
iajs-3302	66	51	control	control	NOUN
iajs-3302	66	52	group	group	NOUN
iajs-3302	66	53	(	(	PUNCT
iajs-3302	66	54	105.81	105.81	NUM
iajs-3302	66	55	±	±	NUM
iajs-3302	66	56	13.30	13.30	NUM
iajs-3302	66	57	a	a	PRON
iajs-3302	66	58	)	)	PUNCT
iajs-3302	66	59	.	.	PUNCT
iajs-3302	67	1	similar	similar	ADJ
iajs-3302	67	2	results	result	NOUN
iajs-3302	67	3	were	be	AUX
iajs-3302	67	4	found	find	VERB
iajs-3302	67	5	in	in	ADP
iajs-3302	67	6	males	male	NOUN
iajs-3302	67	7	,	,	PUNCT
iajs-3302	67	8	where	where	SCONJ
iajs-3302	67	9	their	their	PRON
iajs-3302	67	10	egfr	egfr	ADJ
iajs-3302	67	11	values	value	NOUN
iajs-3302	67	12	were	be	AUX
iajs-3302	67	13	found	find	VERB
iajs-3302	67	14	to	to	PART
iajs-3302	67	15	decrease	decrease	VERB
iajs-3302	67	16	significantly	significantly	ADV
iajs-3302	67	17	(	(	PUNCT
iajs-3302	67	18	p=	p=	NOUN
iajs-3302	67	19	0.0001	0.0001	NUM
iajs-3302	67	20	)	)	PUNCT
iajs-3302	67	21	.	.	PUNCT
iajs-3302	68	1	patient	patient	ADJ
iajs-3302	68	2	groups	group	NOUN
iajs-3302	68	3	include	include	VERB
iajs-3302	68	4	normoalbuminuria	normoalbuminuria	PROPN
iajs-3302	68	5	,	,	PUNCT
iajs-3302	68	6	microalbuminuria	microalbuminuria	NOUN
iajs-3302	68	7	,	,	PUNCT
iajs-3302	68	8	and	and	CCONJ
iajs-3302	68	9	macroalbuminuria	macroalbuminuria	PROPN
iajs-3302	68	10	(	(	PUNCT
iajs-3302	68	11	98.40±21.10	98.40±21.10	NUM
iajs-3302	68	12	b	b	NOUN
iajs-3302	68	13	)	)	PUNCT
iajs-3302	68	14	,	,	PUNCT
iajs-3302	68	15	(	(	PUNCT
iajs-3302	68	16	81.93±34.72	81.93±34.72	NOUN
iajs-3302	68	17	bc	bc	PROPN
iajs-3302	68	18	)	)	PUNCT
iajs-3302	68	19	,	,	PUNCT
iajs-3302	68	20	and	and	CCONJ
iajs-3302	68	21	(	(	PUNCT
iajs-3302	68	22	44.17	44.17	NUM
iajs-3302	68	23	±	±	NUM
iajs-3302	68	24	27.29	27.29	NUM
iajs-3302	68	25	c	c	NOUN
iajs-3302	68	26	)	)	PUNCT
iajs-3302	68	27	compared	compare	VERB
iajs-3302	68	28	with	with	ADP
iajs-3302	68	29	the	the	DET
iajs-3302	68	30	control	control	NOUN
iajs-3302	68	31	group	group	NOUN
iajs-3302	68	32	(	(	PUNCT
iajs-3302	68	33	113.30	113.30	NUM
iajs-3302	68	34	±	±	NUM
iajs-3302	68	35	6.21	6.21	NUM
iajs-3302	68	36	a	a	PRON
iajs-3302	68	37	)	)	PUNCT
iajs-3302	68	38	.	.	PUNCT
iajs-3302	69	1	that	that	PRON
iajs-3302	69	2	means	mean	VERB
iajs-3302	69	3	sex	sex	NOUN
iajs-3302	69	4	has	have	VERB
iajs-3302	69	5	no	no	DET
iajs-3302	69	6	effect	effect	NOUN
iajs-3302	69	7	on	on	ADP
iajs-3302	69	8	egfr	egfr	ADJ
iajs-3302	69	9	.	.	PUNCT
iajs-3302	70	1	table	table	NOUN
iajs-3302	70	2	2	2	NUM
iajs-3302	70	3	displays	display	VERB
iajs-3302	70	4	the	the	DET
iajs-3302	70	5	serum	serum	NOUN
iajs-3302	70	6	biomarkers	biomarker	NOUN
iajs-3302	70	7	for	for	ADP
iajs-3302	70	8	all	all	DET
iajs-3302	70	9	male	male	ADJ
iajs-3302	70	10	and	and	CCONJ
iajs-3302	70	11	female	female	ADJ
iajs-3302	70	12	participants	participant	NOUN
iajs-3302	70	13	.	.	PUNCT
iajs-3302	71	1	the	the	DET
iajs-3302	71	2	result	result	NOUN
iajs-3302	71	3	showed	show	VERB
iajs-3302	71	4	that	that	SCONJ
iajs-3302	71	5	there	there	PRON
iajs-3302	71	6	was	be	VERB
iajs-3302	71	7	a	a	DET
iajs-3302	71	8	significant	significant	ADJ
iajs-3302	71	9	increase	increase	NOUN
iajs-3302	71	10	in	in	ADP
iajs-3302	71	11	the	the	DET
iajs-3302	71	12	serum	serum	NOUN
iajs-3302	71	13	levels	level	NOUN
iajs-3302	71	14	of	of	ADP
iajs-3302	71	15	tgf	tgf	PROPN
iajs-3302	71	16	-	-	PUNCT
iajs-3302	71	17	β1	β1	PROPN
iajs-3302	71	18	and	and	CCONJ
iajs-3302	71	19	ctgf	ctgf	VERB
iajs-3302	71	20	in	in	ADP
iajs-3302	71	21	the	the	DET
iajs-3302	71	22	female	female	ADJ
iajs-3302	71	23	patient	patient	NOUN
iajs-3302	71	24	groups	group	NOUN
iajs-3302	71	25	compared	compare	VERB
iajs-3302	71	26	with	with	ADP
iajs-3302	71	27	the	the	DET
iajs-3302	71	28	control	control	NOUN
iajs-3302	71	29	group	group	NOUN
iajs-3302	71	30	(	(	PUNCT
iajs-3302	71	31	p=	p=	NOUN
iajs-3302	71	32	0.0001	0.0001	NUM
iajs-3302	71	33	)	)	PUNCT
iajs-3302	71	34	.	.	PUNCT
iajs-3302	72	1	when	when	SCONJ
iajs-3302	72	2	conducting	conduct	VERB
iajs-3302	72	3	a	a	DET
iajs-3302	72	4	careful	careful	ADJ
iajs-3302	72	5	comparison	comparison	NOUN
iajs-3302	72	6	between	between	ADP
iajs-3302	72	7	the	the	DET
iajs-3302	72	8	patient	patient	ADJ
iajs-3302	72	9	groups	group	NOUN
iajs-3302	72	10	,	,	PUNCT
iajs-3302	72	11	a	a	DET
iajs-3302	72	12	significant	significant	ADJ
iajs-3302	72	13	increase	increase	NOUN
iajs-3302	72	14	was	be	AUX
iajs-3302	72	15	observed	observe	VERB
iajs-3302	72	16	between	between	ADP
iajs-3302	72	17	the	the	DET
iajs-3302	72	18	two	two	NUM
iajs-3302	72	19	groups	group	NOUN
iajs-3302	72	20	(	(	PUNCT
iajs-3302	72	21	microand	microand	NOUN
iajs-3302	72	22	macroalbuminuria	macroalbuminuria	PROPN
iajs-3302	72	23	)	)	PUNCT
iajs-3302	72	24	and	and	CCONJ
iajs-3302	72	25	the	the	DET
iajs-3302	72	26	control	control	NOUN
iajs-3302	72	27	group	group	NOUN
iajs-3302	72	28	in	in	ADP
iajs-3302	72	29	the	the	DET
iajs-3302	72	30	level	level	NOUN
iajs-3302	72	31	of	of	ADP
iajs-3302	72	32	tgf	tgf	PROPN
iajs-3302	72	33	-	-	PUNCT
iajs-3302	72	34	β1	β1	PROPN
iajs-3302	72	35	.	.	PUNCT
iajs-3302	73	1	the	the	DET
iajs-3302	73	2	results	result	NOUN
iajs-3302	73	3	presented	present	VERB
iajs-3302	73	4	in	in	ADP
iajs-3302	73	5	the	the	DET
iajs-3302	73	6	description	description	NOUN
iajs-3302	73	7	of	of	ADP
iajs-3302	73	8	figure	figure	NOUN
iajs-3302	73	9	1	1	NUM
iajs-3302	73	10	indicate	indicate	VERB
iajs-3302	73	11	that	that	SCONJ
iajs-3302	73	12	there	there	PRON
iajs-3302	73	13	was	be	VERB
iajs-3302	73	14	a	a	DET
iajs-3302	73	15	significant	significant	ADJ
iajs-3302	73	16	increase	increase	NOUN
iajs-3302	73	17	in	in	ADP
iajs-3302	73	18	tgf	tgf	PROPN
iajs-3302	73	19	-	-	PUNCT
iajs-3302	73	20	β1	β1	PROPN
iajs-3302	73	21	in	in	ADP
iajs-3302	73	22	albumin	albumin	NOUN
iajs-3302	73	23	for	for	ADP
iajs-3302	73	24	males	male	NOUN
iajs-3302	73	25	compared	compare	VERB
iajs-3302	73	26	to	to	ADP
iajs-3302	73	27	the	the	DET
iajs-3302	73	28	control	control	NOUN
iajs-3302	73	29	group	group	NOUN
iajs-3302	73	30	(	(	PUNCT
iajs-3302	73	31	p=	p=	NOUN
iajs-3302	73	32	0.003	0.003	NUM
iajs-3302	73	33	)	)	PUNCT
iajs-3302	73	34	.	.	PUNCT
iajs-3302	74	1	also	also	ADV
iajs-3302	74	2	,	,	PUNCT
iajs-3302	74	3	when	when	SCONJ
iajs-3302	74	4	comparing	compare	VERB
iajs-3302	74	5	the	the	DET
iajs-3302	74	6	groups	group	NOUN
iajs-3302	74	7	of	of	ADP
iajs-3302	74	8	patients	patient	NOUN
iajs-3302	74	9	,	,	PUNCT
iajs-3302	74	10	there	there	PRON
iajs-3302	74	11	were	be	VERB
iajs-3302	74	12	no	no	DET
iajs-3302	74	13	significant	significant	ADJ
iajs-3302	74	14	differences	difference	NOUN
iajs-3302	74	15	between	between	ADP
iajs-3302	74	16	normal	normal	ADJ
iajs-3302	74	17	albuminuria	albuminuria	NOUN
iajs-3302	74	18	and	and	CCONJ
iajs-3302	74	19	microalbuminuria	microalbuminuria	PROPN
iajs-3302	74	20	in	in	ADP
iajs-3302	74	21	the	the	DET
iajs-3302	74	22	control	control	NOUN
iajs-3302	74	23	group	group	NOUN
iajs-3302	74	24	.	.	PUNCT
iajs-3302	75	1	when	when	SCONJ
iajs-3302	75	2	comparing	compare	VERB
iajs-3302	75	3	ctgf	ctgf	NOUN
iajs-3302	75	4	levels	level	NOUN
iajs-3302	75	5	in	in	ADP
iajs-3302	75	6	the	the	DET
iajs-3302	75	7	women	woman	NOUN
iajs-3302	75	8	's	's	PART
iajs-3302	75	9	group	group	NOUN
iajs-3302	75	10	,	,	PUNCT
iajs-3302	75	11	each	each	DET
iajs-3302	75	12	group	group	NOUN
iajs-3302	75	13	separately	separately	ADV
iajs-3302	75	14	,	,	PUNCT
iajs-3302	75	15	with	with	ADP
iajs-3302	75	16	the	the	DET
iajs-3302	75	17	control	control	NOUN
iajs-3302	75	18	group	group	NOUN
iajs-3302	75	19	,	,	PUNCT
iajs-3302	75	20	it	it	PRON
iajs-3302	75	21	is	be	AUX
iajs-3302	75	22	indicated	indicate	VERB
iajs-3302	75	23	that	that	SCONJ
iajs-3302	75	24	there	there	PRON
iajs-3302	75	25	were	be	VERB
iajs-3302	75	26	significant	significant	ADJ
iajs-3302	75	27	differences	difference	NOUN
iajs-3302	75	28	between	between	ADP
iajs-3302	75	29	the	the	DET
iajs-3302	75	30	two	two	NUM
iajs-3302	75	31	groups	group	NOUN
iajs-3302	75	32	(	(	PUNCT
iajs-3302	75	33	microalbumin	microalbumin	NOUN
iajs-3302	75	34	and	and	CCONJ
iajs-3302	75	35	macroalbuminuria	macroalbuminuria	PROPN
iajs-3302	75	36	)	)	PUNCT
iajs-3302	75	37	.	.	PUNCT
iajs-3302	76	1	for	for	ADP
iajs-3302	76	2	men	man	NOUN
iajs-3302	76	3	,	,	PUNCT
iajs-3302	76	4	all	all	DET
iajs-3302	76	5	patient	patient	ADJ
iajs-3302	76	6	groups	group	NOUN
iajs-3302	76	7	showed	show	VERB
iajs-3302	76	8	statistically	statistically	ADV
iajs-3302	76	9	significant	significant	ADJ
iajs-3302	76	10	differences	difference	NOUN
iajs-3302	76	11	from	from	ADP
iajs-3302	76	12	the	the	DET
iajs-3302	76	13	healthy	healthy	ADJ
iajs-3302	76	14	group	group	NOUN
iajs-3302	76	15	.	.	PUNCT
iajs-3302	77	1	groups	group	NOUN
iajs-3302	77	2	parameters	parameter	VERB
iajs-3302	77	3	mean±	mean±	PROPN
iajs-3302	77	4	sd	sd	ADP
iajs-3302	77	5	p	p	NOUN
iajs-3302	77	6	-	-	PUNCT
iajs-3302	77	7	value	value	NOUN
iajs-3302	77	8	control	control	NOUN
iajs-3302	77	9	(	(	PUNCT
iajs-3302	77	10	n=	n=	ADJ
iajs-3302	77	11	30	30	NUM
iajs-3302	77	12	)	)	PUNCT
iajs-3302	77	13	normo	normo	NOUN
iajs-3302	77	14	albuminuria	albuminuria	PROPN
iajs-3302	77	15	(	(	PUNCT
iajs-3302	77	16	n=	n=	ADJ
iajs-3302	77	17	30	30	NUM
iajs-3302	77	18	)	)	PUNCT
iajs-3302	77	19	micro	micro	ADJ
iajs-3302	77	20	albuminuria	albuminuria	NOUN
iajs-3302	77	21	(	(	PUNCT
iajs-3302	77	22	n=	n=	ADJ
iajs-3302	77	23	30	30	NUM
iajs-3302	77	24	)	)	PUNCT
iajs-3302	77	25	macro	macro	ADJ
iajs-3302	77	26	albuminuria	albuminuria	NOUN
iajs-3302	77	27	(	(	PUNCT
iajs-3302	77	28	n=	n=	ADJ
iajs-3302	77	29	30	30	NUM
iajs-3302	77	30	)	)	PUNCT
iajs-3302	77	31	fbs	fbs	PROPN
iajs-3302	77	32	(	(	PUNCT
iajs-3302	77	33	mg	mg	PROPN
iajs-3302	77	34	/	/	SYM
iajs-3302	77	35	dl	dl	NOUN
iajs-3302	77	36	)	)	PUNCT
iajs-3302	77	37	female	female	ADJ
iajs-3302	77	38	male	male	NOUN
iajs-3302	77	39	87.75	87.75	NUM
iajs-3302	77	40	±	±	NUM
iajs-3302	77	41	5.15	5.15	NUM
iajs-3302	77	42	b	b	SYM
iajs-3302	77	43	190.23	190.23	NUM
iajs-3302	77	44	±	±	NUM
iajs-3302	77	45	34.20	34.20	NUM
iajs-3302	77	46	a	a	DET
iajs-3302	77	47	199.66	199.66	NUM
iajs-3302	77	48	±	±	NUM
iajs-3302	77	49	34.38	34.38	NUM
iajs-3302	77	50	a	a	DET
iajs-3302	77	51	203.06	203.06	NUM
iajs-3302	77	52	±	±	NUM
iajs-3302	77	53	50.05	50.05	NUM
iajs-3302	77	54	a	a	DET
iajs-3302	77	55	0.0001	0.0001	NUM
iajs-3302	77	56	*	*	PUNCT
iajs-3302	77	57	*	*	PROPN
iajs-3302	77	58	87.0	87.0	NUM
iajs-3302	77	59	±	±	NUM
iajs-3302	77	60	6.60	6.60	NUM
iajs-3302	77	61	b	b	NOUN
iajs-3302	77	62	215.0±47.74	215.0±47.74	NUM
iajs-3302	77	63	a	a	DET
iajs-3302	77	64	222.66	222.66	NUM
iajs-3302	77	65	±	±	NOUN
iajs-3302	77	66	46.83	46.83	NUM
iajs-3302	77	67	a	a	DET
iajs-3302	77	68	232.0	232.0	NUM
iajs-3302	77	69	±	±	NUM
iajs-3302	77	70	84.21	84.21	NUM
iajs-3302	77	71	a	a	DET
iajs-3302	77	72	hba1c	hba1c	PROPN
iajs-3302	77	73	(	(	PUNCT
iajs-3302	77	74	%	%	INTJ
iajs-3302	77	75	)	)	PUNCT
iajs-3302	77	76	female	female	ADJ
iajs-3302	77	77	male	male	NOUN
iajs-3302	77	78	5.13	5.13	NUM
iajs-3302	77	79	±0.32	±0.32	PART
iajs-3302	77	80	b	b	PROPN
iajs-3302	77	81	9.08	9.08	NUM
iajs-3302	77	82	±	±	NUM
iajs-3302	77	83	1.76	1.76	NUM
iajs-3302	77	84	a	a	DET
iajs-3302	77	85	9.40	9.40	NUM
iajs-3302	77	86	±	±	NUM
iajs-3302	77	87	1.18	1.18	NUM
iajs-3302	77	88	a	a	DET
iajs-3302	77	89	10.79	10.79	NUM
iajs-3302	77	90	±	±	NUM
iajs-3302	77	91	3.94	3.94	NUM
iajs-3302	77	92	a	a	DET
iajs-3302	77	93	0.0001	0.0001	NUM
iajs-3302	77	94	*	*	NOUN
iajs-3302	77	95	*	*	PROPN
iajs-3302	77	96	5.23	5.23	NUM
iajs-3302	77	97	±	±	NUM
iajs-3302	77	98	0.33	0.33	NUM
iajs-3302	77	99	b	b	SYM
iajs-3302	77	100	10.28	10.28	NUM
iajs-3302	77	101	±	±	NUM
iajs-3302	77	102	1.97	1.97	NUM
iajs-3302	77	103	a	a	DET
iajs-3302	77	104	10.76	10.76	NUM
iajs-3302	77	105	±	±	NUM
iajs-3302	77	106	2.35	2.35	NUM
iajs-3302	77	107	a	a	DET
iajs-3302	77	108	10.12	10.12	NUM
iajs-3302	77	109	±	±	NUM
iajs-3302	77	110	1.63	1.63	NUM
iajs-3302	77	111	a	a	DET
iajs-3302	77	112	creatinine	creatinine	NOUN
iajs-3302	77	113	(	(	PUNCT
iajs-3302	77	114	mg	mg	PROPN
iajs-3302	77	115	/	/	SYM
iajs-3302	77	116	dl	dl	NOUN
iajs-3302	77	117	)	)	PUNCT
iajs-3302	77	118	female	female	ADJ
iajs-3302	77	119	male	male	NOUN
iajs-3302	77	120	0.70	0.70	NUM
iajs-3302	77	121	±	±	NOUN
iajs-3302	77	122	0.12	0.12	NUM
iajs-3302	77	123	b	b	NOUN
iajs-3302	77	124	0.91	0.91	NUM
iajs-3302	77	125	±0.20	±0.20	PROPN
iajs-3302	77	126	b	b	PROPN
iajs-3302	77	127	1.50	1.50	NUM
iajs-3302	77	128	±	±	NUM
iajs-3302	77	129	0.67	0.67	NUM
iajs-3302	77	130	b	b	NUM
iajs-3302	77	131	3.50	3.50	NUM
iajs-3302	77	132	±	±	NUM
iajs-3302	77	133	2.85	2.85	NUM
iajs-3302	77	134	a	a	DET
iajs-3302	77	135	0.0001	0.0001	NUM
iajs-3302	77	136	*	*	NOUN
iajs-3302	77	137	*	*	PROPN
iajs-3302	77	138	0.80	0.80	NUM
iajs-3302	77	139	±0.06	±0.06	PROPN
iajs-3302	77	140	b	b	PROPN
iajs-3302	77	141	0.95	0.95	NUM
iajs-3302	77	142	±	±	NUM
iajs-3302	77	143	0.27	0.27	NUM
iajs-3302	77	144	b	b	NUM
iajs-3302	77	145	1.30	1.30	NUM
iajs-3302	77	146	±	±	NUM
iajs-3302	77	147	0.74	0.74	NUM
iajs-3302	77	148	b	b	NUM
iajs-3302	77	149	3.36	3.36	NUM
iajs-3302	77	150	±	±	NUM
iajs-3302	77	151	2.99	2.99	NUM
iajs-3302	77	152	a	a	DET
iajs-3302	77	153	urea	urea	NOUN
iajs-3302	77	154	(	(	PUNCT
iajs-3302	77	155	mg	mg	PROPN
iajs-3302	77	156	/	/	SYM
iajs-3302	77	157	dl	dl	NOUN
iajs-3302	77	158	)	)	PUNCT
iajs-3302	77	159	female	female	ADJ
iajs-3302	77	160	male	male	NOUN
iajs-3302	77	161	27.50	27.50	NUM
iajs-3302	77	162	±	±	NUM
iajs-3302	77	163	4.77	4.77	NUM
iajs-3302	77	164	c	c	PROPN
iajs-3302	77	165	35.93	35.93	NUM
iajs-3302	77	166	±	±	NUM
iajs-3302	77	167	7.83	7.83	NUM
iajs-3302	77	168	c	c	NOUN
iajs-3302	77	169	61.01	61.01	NUM
iajs-3302	77	170	±	±	NUM
iajs-3302	77	171	22.12	22.12	NUM
iajs-3302	77	172	b	b	PROPN
iajs-3302	77	173	88.83	88.83	NUM
iajs-3302	77	174	±	±	NUM
iajs-3302	77	175	40.61	40.61	NUM
iajs-3302	77	176	a	a	DET
iajs-3302	77	177	0.0001	0.0001	NUM
iajs-3302	77	178	*	*	PUNCT
iajs-3302	77	179	*	*	PROPN
iajs-3302	77	180	34.15	34.15	NUM
iajs-3302	77	181	±	±	NUM
iajs-3302	77	182	2.79	2.79	NUM
iajs-3302	77	183	b	b	NOUN
iajs-3302	77	184	32.93	32.93	NUM
iajs-3302	77	185	±	±	NUM
iajs-3302	77	186	10.27	10.27	NUM
iajs-3302	77	187	b	b	PROPN
iajs-3302	77	188	59.24	59.24	NUM
iajs-3302	77	189	±	±	NUM
iajs-3302	77	190	25.92	25.92	NUM
iajs-3302	77	191	a	a	DET
iajs-3302	77	192	81.82	81.82	NUM
iajs-3302	77	193	±	±	NOUN
iajs-3302	77	194	39.67	39.67	NUM
iajs-3302	77	195	a	a	DET
iajs-3302	77	196	egfr	egfr	NOUN
iajs-3302	77	197	(	(	PUNCT
iajs-3302	77	198	ml	ml	NOUN
iajs-3302	77	199	/	/	SYM
iajs-3302	77	200	min/1.73	min/1.73	NOUN
iajs-3302	77	201	m	m	NOUN
iajs-3302	77	202	)	)	PUNCT
iajs-3302	77	203	female	female	ADJ
iajs-3302	77	204	male	male	NOUN
iajs-3302	77	205	105.81	105.81	NUM
iajs-3302	77	206	±	±	NOUN
iajs-3302	77	207	13.30	13.30	NUM
iajs-3302	77	208	a	a	DET
iajs-3302	77	209	80.26	80.26	NUM
iajs-3302	77	210	±	±	NUM
iajs-3302	77	211	22.31	22.31	NUM
iajs-3302	77	212	b	b	PROPN
iajs-3302	77	213	50.73	50.73	NUM
iajs-3302	77	214	±	±	NUM
iajs-3302	77	215	30.22	30.22	NUM
iajs-3302	77	216	c	c	PROPN
iajs-3302	77	217	29.46	29.46	NUM
iajs-3302	77	218	±	±	NUM
iajs-3302	77	219	21.10	21.10	NUM
iajs-3302	77	220	d	d	NOUN
iajs-3302	77	221	0.0001	0.0001	NUM
iajs-3302	77	222	*	*	PUNCT
iajs-3302	77	223	*	*	PROPN
iajs-3302	78	1	113.30	113.30	NUM
iajs-3302	78	2	±	±	NUM
iajs-3302	78	3	6.21	6.21	NUM
iajs-3302	78	4	a	a	DET
iajs-3302	78	5	98.40	98.40	NUM
iajs-3302	78	6	±	±	NUM
iajs-3302	78	7	21.10	21.10	NUM
iajs-3302	78	8	b	b	NOUN
iajs-3302	78	9	81.93	81.93	NUM
iajs-3302	78	10	±	±	NUM
iajs-3302	78	11	34.72	34.72	NUM
iajs-3302	78	12	bc	bc	PROPN
iajs-3302	78	13	44.17	44.17	NUM
iajs-3302	78	14	±	±	NUM
iajs-3302	78	15	27.29	27.29	NUM
iajs-3302	78	16	c	c	NOUN
iajs-3302	78	17	acr	acr	PROPN
iajs-3302	78	18	(	(	PUNCT
iajs-3302	78	19	mg	mg	PROPN
iajs-3302	78	20	/	/	SYM
iajs-3302	78	21	g	g	NOUN
iajs-3302	78	22	)	)	PUNCT
iajs-3302	78	23	female	female	ADJ
iajs-3302	78	24	male	male	NOUN
iajs-3302	78	25	15.86	15.86	NUM
iajs-3302	78	26	±5.37	±5.37	NOUN
iajs-3302	78	27	c	c	PROPN
iajs-3302	78	28	91.53	91.53	NUM
iajs-3302	78	29	±	±	NUM
iajs-3302	78	30	59.70	59.70	NUM
iajs-3302	78	31	b	b	PROPN
iajs-3302	78	32	629.04	629.04	NUM
iajs-3302	78	33	±	±	NUM
iajs-3302	78	34	248.6	248.6	NUM
iajs-3302	78	35	a	a	DET
iajs-3302	78	36	0.0001	0.0001	NUM
iajs-3302	78	37	*	*	PUNCT
iajs-3302	78	38	*	*	X
iajs-3302	78	39	16.06	16.06	NUM
iajs-3302	78	40	±	±	NUM
iajs-3302	78	41	5.75	5.75	NUM
iajs-3302	78	42	c	c	NOUN
iajs-3302	78	43	130.80	130.80	NUM
iajs-3302	78	44	±	±	NUM
iajs-3302	78	45	56.37	56.37	NUM
iajs-3302	78	46	b	b	SYM
iajs-3302	78	47	504.64±212.92	504.64±212.92	PROPN
iajs-3302	78	48	a	a	DET
iajs-3302	78	49	significant	significant	ADJ
iajs-3302	78	50	difference	difference	NOUN
iajs-3302	78	51	between	between	ADP
iajs-3302	78	52	means	mean	NOUN
iajs-3302	78	53	using	use	VERB
iajs-3302	78	54	the	the	DET
iajs-3302	78	55	anova	anova	PROPN
iajs-3302	78	56	test	test	NOUN
iajs-3302	78	57	at	at	ADP
iajs-3302	78	58	the	the	DET
iajs-3302	78	59	0.01	0.01	NUM
iajs-3302	78	60	level	level	NOUN
iajs-3302	78	61	.	.	PUNCT
iajs-3302	79	1	significant	significant	ADJ
iajs-3302	79	2	variants	variant	NOUN
iajs-3302	79	3	are	be	AUX
iajs-3302	79	4	denoted	denote	VERB
iajs-3302	79	5	by	by	ADP
iajs-3302	79	6	different	different	ADJ
iajs-3302	79	7	small	small	ADJ
iajs-3302	79	8	letters	letter	NOUN
iajs-3302	79	9	;	;	PUNCT
iajs-3302	79	10	non	non	ADJ
iajs-3302	79	11	-	-	ADJ
iajs-3302	79	12	significant	significant	ADJ
iajs-3302	79	13	variations	variation	NOUN
iajs-3302	79	14	are	be	AUX
iajs-3302	79	15	denoted	denote	VERB
iajs-3302	79	16	by	by	ADP
iajs-3302	79	17	identical	identical	ADJ
iajs-3302	79	18	small	small	ADJ
iajs-3302	79	19	letters	letter	NOUN
iajs-3302	79	20	.	.	PUNCT
iajs-3302	80	1	ihjpas	ihjpas	PROPN
iajs-3302	80	2	.	.	PUNCT
iajs-3302	81	1	37	37	NUM
iajs-3302	81	2	(	(	PUNCT
iajs-3302	81	3	2	2	NUM
iajs-3302	81	4	)	)	PUNCT
iajs-3302	81	5	2024	2024	NUM
iajs-3302	81	6	264	264	NUM
iajs-3302	81	7	table	table	NOUN
iajs-3302	81	8	2	2	NUM
iajs-3302	81	9	.	.	PUNCT
iajs-3302	82	1	the	the	DET
iajs-3302	82	2	tgf	tgf	PROPN
iajs-3302	82	3	-	-	PUNCT
iajs-3302	82	4	β1	β1	PROPN
iajs-3302	82	5	and	and	CCONJ
iajs-3302	82	6	ctgf	ctgf	NOUN
iajs-3302	82	7	levels	level	NOUN
iajs-3302	82	8	in	in	ADP
iajs-3302	82	9	the	the	DET
iajs-3302	82	10	studied	study	VERB
iajs-3302	82	11	groups	group	NOUN
iajs-3302	82	12	.	.	PUNCT
iajs-3302	83	1	groups	group	NOUN
iajs-3302	83	2	parameters	parameter	NOUN
iajs-3302	83	3	mean±sd	mean±sd	ADP
iajs-3302	83	4	p	p	ADJ
iajs-3302	83	5	-	-	PUNCT
iajs-3302	83	6	value	value	NOUN
iajs-3302	83	7	control	control	NOUN
iajs-3302	83	8	(	(	PUNCT
iajs-3302	83	9	n=	n=	ADJ
iajs-3302	83	10	30	30	NUM
iajs-3302	83	11	)	)	PUNCT
iajs-3302	83	12	normo	normo	NOUN
iajs-3302	83	13	albuminuria	albuminuria	PROPN
iajs-3302	83	14	(	(	PUNCT
iajs-3302	83	15	n=	n=	ADJ
iajs-3302	83	16	30	30	NUM
iajs-3302	83	17	)	)	PUNCT
iajs-3302	83	18	micro	micro	ADJ
iajs-3302	83	19	albuminuria	albuminuria	NOUN
iajs-3302	83	20	(	(	PUNCT
iajs-3302	83	21	n=	n=	ADJ
iajs-3302	83	22	30	30	NUM
iajs-3302	83	23	)	)	PUNCT
iajs-3302	83	24	macro	macro	ADJ
iajs-3302	83	25	albuminuria	albuminuria	NOUN
iajs-3302	83	26	(	(	PUNCT
iajs-3302	83	27	n=	n=	ADJ
iajs-3302	83	28	30	30	NUM
iajs-3302	83	29	)	)	PUNCT
iajs-3302	83	30	tgf	tgf	PROPN
iajs-3302	83	31	-	-	PUNCT
iajs-3302	83	32	b1	b1	NOUN
iajs-3302	83	33	(	(	PUNCT
iajs-3302	83	34	mg	mg	PROPN
iajs-3302	83	35	/	/	SYM
iajs-3302	83	36	dl	dl	NOUN
iajs-3302	83	37	)	)	PUNCT
iajs-3302	83	38	female	female	NOUN
iajs-3302	83	39	263.25	263.25	NUM
iajs-3302	83	40	±	±	NOUN
iajs-3302	83	41	86.22	86.22	NUM
iajs-3302	83	42	a	a	DET
iajs-3302	83	43	515.48	515.48	NUM
iajs-3302	83	44	±	±	NUM
iajs-3302	83	45	154.28	154.28	NUM
iajs-3302	83	46	ab	ab	PROPN
iajs-3302	83	47	953.43	953.43	NUM
iajs-3302	83	48	±	±	NUM
iajs-3302	83	49	410.44	410.44	NUM
iajs-3302	83	50	b	b	PROPN
iajs-3302	83	51	680.46	680.46	NUM
iajs-3302	83	52	±	±	NUM
iajs-3302	83	53	321.25	321.25	NUM
iajs-3302	83	54	c	c	NOUN
iajs-3302	83	55	0.0001	0.0001	NUM
iajs-3302	83	56	*	*	PUNCT
iajs-3302	83	57	*	*	NOUN
iajs-3302	83	58	male	male	NOUN
iajs-3302	83	59	257.37±	257.37±	NUM
iajs-3302	83	60	100.76	100.76	NUM
iajs-3302	83	61	a	a	DET
iajs-3302	83	62	673.88	673.88	NUM
iajs-3302	83	63	±	±	NUM
iajs-3302	83	64	296.05	296.05	NUM
iajs-3302	83	65	ab	ab	PROPN
iajs-3302	83	66	712.47	712.47	NUM
iajs-3302	83	67	±	±	NUM
iajs-3302	83	68	370.23	370.23	NUM
iajs-3302	83	69	ab	ab	PROPN
iajs-3302	83	70	1167.6	1167.6	NUM
iajs-3302	83	71	±	±	NUM
iajs-3302	83	72	1094.2	1094.2	NUM
iajs-3302	83	73	b	b	NOUN
iajs-3302	83	74	0.003	0.003	NUM
iajs-3302	83	75	*	*	PUNCT
iajs-3302	83	76	*	*	PUNCT
iajs-3302	83	77	ctgf	ctgf	PROPN
iajs-3302	83	78	(	(	PUNCT
iajs-3302	83	79	pg	pg	NOUN
iajs-3302	83	80	/	/	SYM
iajs-3302	83	81	ml	ml	NOUN
iajs-3302	83	82	)	)	PUNCT
iajs-3302	83	83	female	female	ADJ
iajs-3302	83	84	14.45	14.45	NUM
iajs-3302	83	85	±	±	NUM
iajs-3302	83	86	9.64	9.64	NUM
iajs-3302	83	87	a	a	DET
iajs-3302	83	88	46.06	46.06	NUM
iajs-3302	83	89	±	±	NUM
iajs-3302	83	90	41.90	41.90	NUM
iajs-3302	83	91	ab	ab	PROPN
iajs-3302	83	92	77.04	77.04	NUM
iajs-3302	83	93	±	±	NOUN
iajs-3302	83	94	50.12	50.12	NUM
iajs-3302	83	95	bc	bc	PROPN
iajs-3302	83	96	92.76	92.76	NUM
iajs-3302	83	97	±	±	NUM
iajs-3302	84	1	46.92	46.92	NUM
iajs-3302	84	2	c	c	NOUN
iajs-3302	84	3	0.0001	0.0001	NUM
iajs-3302	84	4	*	*	PUNCT
iajs-3302	84	5	*	*	PUNCT
iajs-3302	84	6	male	male	ADJ
iajs-3302	84	7	24.57	24.57	NUM
iajs-3302	84	8	±	±	NOUN
iajs-3302	84	9	15.45	15.45	NUM
iajs-3302	84	10	a	a	DET
iajs-3302	84	11	77.03	77.03	NUM
iajs-3302	84	12	±	±	NOUN
iajs-3302	84	13	46.97	46.97	NUM
iajs-3302	84	14	b	b	SYM
iajs-3302	84	15	77.73	77.73	NUM
iajs-3302	84	16	±	±	NUM
iajs-3302	84	17	40.44	40.44	NUM
iajs-3302	84	18	b	b	PROPN
iajs-3302	84	19	83.55	83.55	NUM
iajs-3302	84	20	±	±	NUM
iajs-3302	84	21	53.94	53.94	NUM
iajs-3302	84	22	b	b	NOUN
iajs-3302	84	23	0.002	0.002	NUM
iajs-3302	84	24	*	*	PUNCT
iajs-3302	84	25	*	*	PUNCT
iajs-3302	84	26	significant	significant	ADJ
iajs-3302	84	27	difference	difference	NOUN
iajs-3302	84	28	between	between	ADP
iajs-3302	84	29	means	mean	NOUN
iajs-3302	84	30	using	use	VERB
iajs-3302	84	31	the	the	DET
iajs-3302	84	32	anova	anova	PROPN
iajs-3302	84	33	test	test	NOUN
iajs-3302	84	34	at	at	ADP
iajs-3302	84	35	the	the	DET
iajs-3302	84	36	0.01	0.01	NUM
iajs-3302	84	37	level	level	NOUN
iajs-3302	84	38	.	.	PUNCT
iajs-3302	85	1	significant	significant	ADJ
iajs-3302	85	2	variants	variant	NOUN
iajs-3302	85	3	are	be	AUX
iajs-3302	85	4	denoted	denote	VERB
iajs-3302	85	5	by	by	ADP
iajs-3302	85	6	different	different	ADJ
iajs-3302	85	7	small	small	ADJ
iajs-3302	85	8	letters	letter	NOUN
iajs-3302	85	9	;	;	PUNCT
iajs-3302	85	10	non	non	ADJ
iajs-3302	85	11	-	-	ADJ
iajs-3302	85	12	significant	significant	ADJ
iajs-3302	85	13	variations	variation	NOUN
iajs-3302	85	14	are	be	AUX
iajs-3302	85	15	denoted	denote	VERB
iajs-3302	85	16	by	by	ADP
iajs-3302	85	17	identical	identical	ADJ
iajs-3302	85	18	small	small	ADJ
iajs-3302	85	19	letters	letter	NOUN
iajs-3302	85	20	.	.	PUNCT
iajs-3302	86	1	similarly	similarly	ADV
iajs-3302	86	2	,	,	PUNCT
iajs-3302	86	3	acr	acr	PROPN
iajs-3302	86	4	values	value	NOUN
iajs-3302	86	5	for	for	ADP
iajs-3302	86	6	females	female	NOUN
iajs-3302	86	7	revealed	reveal	VERB
iajs-3302	86	8	a	a	DET
iajs-3302	86	9	significant	significant	ADJ
iajs-3302	86	10	increase	increase	NOUN
iajs-3302	86	11	in	in	ADP
iajs-3302	86	12	patient	patient	ADJ
iajs-3302	86	13	groups	group	NOUN
iajs-3302	86	14	(	(	PUNCT
iajs-3302	86	15	normoalbuminuria	normoalbuminuria	PROPN
iajs-3302	86	16	,	,	PUNCT
iajs-3302	86	17	micro-	micro-	NOUN
iajs-3302	86	18	,	,	PUNCT
iajs-3302	86	19	and	and	CCONJ
iajs-3302	86	20	macro-	macro-	X
iajs-3302	86	21	)	)	PUNCT
iajs-3302	86	22	.	.	PUNCT
iajs-3302	87	1	the	the	DET
iajs-3302	87	2	same	same	ADJ
iajs-3302	87	3	results	result	NOUN
iajs-3302	87	4	were	be	AUX
iajs-3302	87	5	obtained	obtain	VERB
iajs-3302	87	6	for	for	ADP
iajs-3302	87	7	males	male	NOUN
iajs-3302	87	8	;	;	PUNCT
iajs-3302	87	9	thus	thus	ADV
iajs-3302	87	10	,	,	PUNCT
iajs-3302	87	11	sex	sex	NOUN
iajs-3302	87	12	has	have	VERB
iajs-3302	87	13	no	no	DET
iajs-3302	87	14	effect	effect	NOUN
iajs-3302	87	15	on	on	ADP
iajs-3302	87	16	acr	acr	PROPN
iajs-3302	87	17	in	in	ADP
iajs-3302	87	18	the	the	DET
iajs-3302	87	19	case	case	NOUN
iajs-3302	87	20	of	of	ADP
iajs-3302	87	21	patient	patient	ADJ
iajs-3302	87	22	groups	group	NOUN
iajs-3302	87	23	,	,	PUNCT
iajs-3302	87	24	as	as	SCONJ
iajs-3302	87	25	shown	show	VERB
iajs-3302	87	26	in	in	ADP
iajs-3302	87	27	figures	figure	NOUN
iajs-3302	87	28	1	1	NUM
iajs-3302	87	29	and	and	CCONJ
iajs-3302	87	30	2	2	NUM
iajs-3302	87	31	.	.	X
iajs-3302	87	32	figure	figure	NOUN
iajs-3302	87	33	1	1	NUM
iajs-3302	87	34	.	.	PUNCT
iajs-3302	87	35	box	box	NOUN
iajs-3302	87	36	plot	plot	NOUN
iajs-3302	87	37	showing	show	VERB
iajs-3302	87	38	the	the	DET
iajs-3302	87	39	effects	effect	NOUN
iajs-3302	87	40	of	of	ADP
iajs-3302	87	41	sex	sex	NOUN
iajs-3302	87	42	on	on	ADP
iajs-3302	87	43	ctgf	ctgf	NOUN
iajs-3302	87	44	and	and	CCONJ
iajs-3302	87	45	tgf	tgf	PROPN
iajs-3302	87	46	-	-	PUNCT
iajs-3302	87	47	b1	b1	NOUN
iajs-3302	87	48	levels	level	NOUN
iajs-3302	87	49	between	between	ADP
iajs-3302	87	50	patients	patient	NOUN
iajs-3302	87	51	(	(	PUNCT
iajs-3302	87	52	normo-	normo-	X
iajs-3302	87	53	,	,	PUNCT
iajs-3302	87	54	micro-	micro-	NOUN
iajs-3302	87	55	,	,	PUNCT
iajs-3302	87	56	macroalbuminuria	macroalbuminuria	PROPN
iajs-3302	87	57	)	)	PUNCT
iajs-3302	87	58	and	and	CCONJ
iajs-3302	87	59	control	control	NOUN
iajs-3302	87	60	groups	group	NOUN
iajs-3302	87	61	.	.	PUNCT
iajs-3302	88	1	figure	figure	NOUN
iajs-3302	88	2	2	2	NUM
iajs-3302	88	3	.	.	PUNCT
iajs-3302	88	4	box	box	NOUN
iajs-3302	88	5	plot	plot	NOUN
iajs-3302	88	6	showing	show	VERB
iajs-3302	88	7	the	the	DET
iajs-3302	88	8	effects	effect	NOUN
iajs-3302	88	9	of	of	ADP
iajs-3302	88	10	sex	sex	NOUN
iajs-3302	88	11	on	on	ADP
iajs-3302	88	12	the	the	DET
iajs-3302	88	13	ctgf	ctgf	NOUN
iajs-3302	88	14	,	,	PUNCT
iajs-3302	88	15	tgfβ1	tgfβ1	NOUN
iajs-3302	88	16	levels	level	NOUN
iajs-3302	88	17	between	between	ADP
iajs-3302	88	18	patients	patient	NOUN
iajs-3302	88	19	(	(	PUNCT
iajs-3302	88	20	normo-	normo-	X
iajs-3302	88	21	,	,	PUNCT
iajs-3302	88	22	micro-	micro-	NOUN
iajs-3302	88	23	,	,	PUNCT
iajs-3302	88	24	macroalbuminuria	macroalbuminuria	PROPN
iajs-3302	88	25	)	)	PUNCT
iajs-3302	88	26	and	and	CCONJ
iajs-3302	88	27	control	control	NOUN
iajs-3302	88	28	groups	group	NOUN
iajs-3302	88	29	.	.	PUNCT
iajs-3302	89	1	0	0	NUM
iajs-3302	90	1	200	200	NUM
iajs-3302	90	2	400	400	NUM
iajs-3302	90	3	600	600	NUM
iajs-3302	90	4	800	800	NUM
iajs-3302	90	5	1000	1000	NUM
iajs-3302	90	6	1200	1200	NUM
iajs-3302	90	7	1400	1400	NUM
iajs-3302	90	8	ctgf	ctgf	NOUN
iajs-3302	90	9	(	(	PUNCT
iajs-3302	90	10	pg	pg	NOUN
iajs-3302	90	11	/	/	SYM
iajs-3302	90	12	ml	ml	NOUN
iajs-3302	90	13	)	)	PUNCT
iajs-3302	90	14	female	female	ADJ
iajs-3302	90	15	ctgf	ctgf	NOUN
iajs-3302	90	16	(	(	PUNCT
iajs-3302	90	17	pg	pg	NOUN
iajs-3302	90	18	/	/	SYM
iajs-3302	90	19	ml	ml	NOUN
iajs-3302	90	20	)	)	PUNCT
iajs-3302	90	21	male	male	PROPN
iajs-3302	90	22	tgf	tgf	PROPN
iajs-3302	90	23	-	-	PUNCT
iajs-3302	90	24	b1	b1	NOUN
iajs-3302	90	25	(	(	PUNCT
iajs-3302	90	26	mg	mg	PROPN
iajs-3302	90	27	/	/	SYM
iajs-3302	90	28	dl	dl	NOUN
iajs-3302	90	29	)	)	PUNCT
iajs-3302	90	30	female	female	ADJ
iajs-3302	90	31	tgf	tgf	PROPN
iajs-3302	90	32	-	-	PUNCT
iajs-3302	90	33	b1	b1	NOUN
iajs-3302	90	34	(	(	PUNCT
iajs-3302	90	35	mg	mg	PROPN
iajs-3302	90	36	/	/	SYM
iajs-3302	90	37	dl	dl	NOUN
iajs-3302	90	38	)	)	PUNCT
iajs-3302	90	39	male	male	ADJ
iajs-3302	90	40	macromicronormo	macromicronormo	NOUN
iajs-3302	90	41	control	control	NOUN
iajs-3302	90	42	0	0	NUM
iajs-3302	90	43	100	100	NUM
iajs-3302	90	44	200	200	NUM
iajs-3302	90	45	300	300	NUM
iajs-3302	90	46	400	400	NUM
iajs-3302	90	47	500	500	NUM
iajs-3302	90	48	600	600	NUM
iajs-3302	90	49	700	700	NUM
iajs-3302	90	50	fbs	fb	NOUN
iajs-3302	90	51	(	(	PUNCT
iajs-3302	90	52	mg	mg	PROPN
iajs-3302	90	53	/	/	SYM
iajs-3302	90	54	dl	dl	NOUN
iajs-3302	90	55	)	)	PUNCT
iajs-3302	90	56	female	female	ADJ
iajs-3302	90	57	fbs	fbs	NOUN
iajs-3302	90	58	(	(	PUNCT
iajs-3302	90	59	mg	mg	PROPN
iajs-3302	90	60	/	/	SYM
iajs-3302	90	61	dl	dl	NOUN
iajs-3302	90	62	)	)	PUNCT
iajs-3302	90	63	male	male	NOUN
iajs-3302	90	64	hba1c	hba1c	PROPN
iajs-3302	90	65	female	female	ADJ
iajs-3302	90	66	hba1c	hba1c	PROPN
iajs-3302	90	67	male	male	ADJ
iajs-3302	90	68	creatinine	creatinine	NOUN
iajs-3302	90	69	(	(	PUNCT
iajs-3302	90	70	mg	mg	PROPN
iajs-3302	90	71	/	/	SYM
iajs-3302	90	72	dl	dl	ADJ
iajs-3302	90	73	)	)	PUNCT
iajs-3302	90	74	female	female	ADJ
iajs-3302	90	75	creatinine	creatinine	NOUN
iajs-3302	90	76	(	(	PUNCT
iajs-3302	90	77	mg	mg	PROPN
iajs-3302	90	78	/	/	SYM
iajs-3302	90	79	dl	dl	NOUN
iajs-3302	90	80	)	)	PUNCT
iajs-3302	90	81	male	male	ADJ
iajs-3302	90	82	urea	urea	NOUN
iajs-3302	90	83	(	(	PUNCT
iajs-3302	90	84	mg	mg	PROPN
iajs-3302	90	85	/	/	SYM
iajs-3302	90	86	dl	dl	NOUN
iajs-3302	90	87	)	)	PUNCT
iajs-3302	90	88	female	female	ADJ
iajs-3302	90	89	urea	urea	NOUN
iajs-3302	90	90	(	(	PUNCT
iajs-3302	90	91	mg	mg	PROPN
iajs-3302	90	92	/	/	SYM
iajs-3302	90	93	dl	dl	NOUN
iajs-3302	90	94	)	)	PUNCT
iajs-3302	90	95	male	male	NOUN
iajs-3302	90	96	egfr(ml	egfr(ml	NOUN
iajs-3302	90	97	/	/	SYM
iajs-3302	90	98	min/1.73	min/1.73	NOUN
iajs-3302	90	99	m	m	VERB
iajs-3302	90	100	)	)	PUNCT
iajs-3302	90	101	egfr(ml	egfr(ml	NOUN
iajs-3302	90	102	/	/	SYM
iajs-3302	90	103	min/1.73	min/1.73	NOUN
iajs-3302	90	104	m	m	NOUN
iajs-3302	90	105	)	)	PUNCT
iajs-3302	90	106	male	male	NOUN
iajs-3302	90	107	acr(mg	acr(mg	ADJ
iajs-3302	90	108	/	/	SYM
iajs-3302	90	109	g	g	NOUN
iajs-3302	90	110	)	)	PUNCT
iajs-3302	90	111	female	female	ADJ
iajs-3302	90	112	acr(mg	acr(mg	NOUN
iajs-3302	90	113	/	/	SYM
iajs-3302	90	114	g	g	NOUN
iajs-3302	90	115	)	)	PUNCT
iajs-3302	90	116	male	male	ADJ
iajs-3302	90	117	general	general	ADJ
iajs-3302	90	118	parameters	parameter	NOUN
iajs-3302	90	119	macro	macro	PROPN
iajs-3302	90	120	micro	micro	PROPN
iajs-3302	90	121	normo	normo	PROPN
iajs-3302	90	122	control	control	PROPN
iajs-3302	90	123	ihjpas	ihjpas	PROPN
iajs-3302	90	124	.	.	PUNCT
iajs-3302	91	1	37	37	NUM
iajs-3302	91	2	(	(	PUNCT
iajs-3302	91	3	2	2	NUM
iajs-3302	91	4	)	)	PUNCT
iajs-3302	91	5	2024	2024	NUM
iajs-3302	91	6	265	265	NUM
iajs-3302	91	7	4	4	NUM
iajs-3302	91	8	.	.	PUNCT
iajs-3302	91	9	discussion	discussion	NOUN
iajs-3302	91	10	numerous	numerous	ADJ
iajs-3302	91	11	investigations	investigation	NOUN
iajs-3302	91	12	have	have	AUX
iajs-3302	91	13	been	be	AUX
iajs-3302	91	14	carried	carry	VERB
iajs-3302	91	15	out	out	ADP
iajs-3302	91	16	to	to	PART
iajs-3302	91	17	determine	determine	VERB
iajs-3302	91	18	the	the	DET
iajs-3302	91	19	causes	cause	NOUN
iajs-3302	91	20	of	of	ADP
iajs-3302	91	21	glomerulus	glomerulus	NOUN
iajs-3302	91	22	damage	damage	NOUN
iajs-3302	91	23	and	and	CCONJ
iajs-3302	91	24	fibrosis	fibrosis	NOUN
iajs-3302	91	25	,	,	PUNCT
iajs-3302	91	26	as	as	ADV
iajs-3302	91	27	well	well	ADV
iajs-3302	91	28	as	as	ADP
iajs-3302	91	29	how	how	SCONJ
iajs-3302	91	30	to	to	PART
iajs-3302	91	31	detect	detect	VERB
iajs-3302	91	32	these	these	DET
iajs-3302	91	33	conditions	condition	NOUN
iajs-3302	91	34	early	early	ADV
iajs-3302	91	35	[	[	X
iajs-3302	91	36	10	10	NUM
iajs-3302	91	37	]	]	PUNCT
iajs-3302	91	38	.	.	PUNCT
iajs-3302	92	1	the	the	DET
iajs-3302	92	2	current	current	ADJ
iajs-3302	92	3	investigation	investigation	NOUN
iajs-3302	92	4	was	be	AUX
iajs-3302	92	5	undertaken	undertake	VERB
iajs-3302	92	6	for	for	ADP
iajs-3302	92	7	diabetic	diabetic	ADJ
iajs-3302	92	8	patients	patient	NOUN
iajs-3302	92	9	with	with	ADP
iajs-3302	92	10	or	or	CCONJ
iajs-3302	92	11	without	without	ADP
iajs-3302	92	12	nephropathy	nephropathy	NOUN
iajs-3302	92	13	(	(	PUNCT
iajs-3302	92	14	micro	micro	NOUN
iajs-3302	92	15	or	or	CCONJ
iajs-3302	92	16	macroalbuminuria	macroalbuminuria	PROPN
iajs-3302	92	17	)	)	PUNCT
iajs-3302	92	18	,	,	PUNCT
iajs-3302	92	19	which	which	PRON
iajs-3302	92	20	was	be	AUX
iajs-3302	92	21	characterized	characterize	VERB
iajs-3302	92	22	by	by	ADP
iajs-3302	92	23	hyperglycemia	hyperglycemia	NOUN
iajs-3302	92	24	(	(	PUNCT
iajs-3302	92	25	fbs	fbs	PROPN
iajs-3302	92	26	)	)	PUNCT
iajs-3302	92	27	,	,	PUNCT
iajs-3302	92	28	proteinuria	proteinuria	NOUN
iajs-3302	92	29	(	(	PUNCT
iajs-3302	92	30	acr	acr	PROPN
iajs-3302	92	31	)	)	PUNCT
iajs-3302	92	32	,	,	PUNCT
iajs-3302	92	33	and	and	CCONJ
iajs-3302	92	34	egfr	egfr	ADJ
iajs-3302	92	35	values	value	NOUN
iajs-3302	92	36	as	as	ADP
iajs-3302	92	37	dependent	dependent	ADJ
iajs-3302	92	38	criteria	criterion	NOUN
iajs-3302	92	39	for	for	ADP
iajs-3302	92	40	the	the	DET
iajs-3302	92	41	classification	classification	NOUN
iajs-3302	92	42	of	of	ADP
iajs-3302	92	43	patient	patient	ADJ
iajs-3302	92	44	groups	group	NOUN
iajs-3302	92	45	,	,	PUNCT
iajs-3302	92	46	in	in	ADP
iajs-3302	92	47	addition	addition	NOUN
iajs-3302	92	48	to	to	ADP
iajs-3302	92	49	other	other	ADJ
iajs-3302	92	50	indicators	indicator	NOUN
iajs-3302	92	51	such	such	ADJ
iajs-3302	92	52	as	as	ADP
iajs-3302	92	53	urea	urea	NOUN
iajs-3302	92	54	and	and	CCONJ
iajs-3302	92	55	creatinine	creatinine	NOUN
iajs-3302	92	56	that	that	PRON
iajs-3302	92	57	support	support	VERB
iajs-3302	92	58	the	the	DET
iajs-3302	92	59	criterion	criterion	NOUN
iajs-3302	92	60	of	of	ADP
iajs-3302	92	61	dkd	dkd	PROPN
iajs-3302	92	62	.	.	PUNCT
iajs-3302	92	63	hyperglycemia	hyperglycemia	NOUN
iajs-3302	92	64	,	,	PUNCT
iajs-3302	92	65	fibrosis	fibrosis	NOUN
iajs-3302	92	66	,	,	PUNCT
iajs-3302	92	67	and	and	CCONJ
iajs-3302	92	68	inflammation	inflammation	NOUN
iajs-3302	92	69	are	be	AUX
iajs-3302	92	70	linked	link	VERB
iajs-3302	92	71	to	to	PART
iajs-3302	92	72	risk	risk	VERB
iajs-3302	92	73	factors	factor	NOUN
iajs-3302	92	74	for	for	ADP
iajs-3302	92	75	dkd	dkd	ADJ
iajs-3302	92	76	stimulation	stimulation	NOUN
iajs-3302	92	77	and	and	CCONJ
iajs-3302	92	78	development	development	NOUN
iajs-3302	92	79	.	.	PUNCT
iajs-3302	93	1	chronic	chronic	ADJ
iajs-3302	93	2	kidney	kidney	NOUN
iajs-3302	93	3	disease	disease	NOUN
iajs-3302	93	4	is	be	AUX
iajs-3302	93	5	characterized	characterize	VERB
iajs-3302	93	6	by	by	ADP
iajs-3302	93	7	a	a	DET
iajs-3302	93	8	progressive	progressive	ADJ
iajs-3302	93	9	loss	loss	NOUN
iajs-3302	93	10	or	or	CCONJ
iajs-3302	93	11	impairment	impairment	NOUN
iajs-3302	93	12	of	of	ADP
iajs-3302	93	13	kidney	kidney	NOUN
iajs-3302	93	14	function	function	NOUN
iajs-3302	93	15	as	as	ADP
iajs-3302	93	16	a	a	DET
iajs-3302	93	17	result	result	NOUN
iajs-3302	93	18	of	of	ADP
iajs-3302	93	19	glomerulus	glomerulus	NOUN
iajs-3302	93	20	and	and	CCONJ
iajs-3302	93	21	tubular	tubular	ADJ
iajs-3302	93	22	damage	damage	NOUN
iajs-3302	93	23	[	[	X
iajs-3302	93	24	11	11	NUM
iajs-3302	93	25	]	]	PUNCT
iajs-3302	93	26	.	.	PUNCT
iajs-3302	94	1	the	the	DET
iajs-3302	94	2	current	current	ADJ
iajs-3302	94	3	study	study	NOUN
iajs-3302	94	4	did	do	AUX
iajs-3302	94	5	not	not	PART
iajs-3302	94	6	find	find	VERB
iajs-3302	94	7	any	any	DET
iajs-3302	94	8	effect	effect	NOUN
iajs-3302	94	9	of	of	ADP
iajs-3302	94	10	sex	sex	NOUN
iajs-3302	94	11	on	on	ADP
iajs-3302	94	12	the	the	DET
iajs-3302	94	13	rate	rate	NOUN
iajs-3302	94	14	of	of	ADP
iajs-3302	94	15	hyperglycemia	hyperglycemia	NOUN
iajs-3302	94	16	.	.	PUNCT
iajs-3302	95	1	the	the	DET
iajs-3302	95	2	results	result	NOUN
iajs-3302	95	3	of	of	ADP
iajs-3302	95	4	the	the	DET
iajs-3302	95	5	study	study	NOUN
iajs-3302	95	6	were	be	AUX
iajs-3302	95	7	not	not	PART
iajs-3302	95	8	in	in	ADP
iajs-3302	95	9	agreement	agreement	NOUN
iajs-3302	95	10	with	with	ADP
iajs-3302	95	11	many	many	ADJ
iajs-3302	95	12	other	other	ADJ
iajs-3302	95	13	studies	study	NOUN
iajs-3302	95	14	.	.	PUNCT
iajs-3302	96	1	an	an	DET
iajs-3302	96	2	increase	increase	NOUN
iajs-3302	96	3	in	in	ADP
iajs-3302	96	4	fasting	fast	VERB
iajs-3302	96	5	blood	blood	NOUN
iajs-3302	96	6	sugar	sugar	NOUN
iajs-3302	96	7	was	be	AUX
iajs-3302	96	8	found	find	VERB
iajs-3302	96	9	in	in	ADP
iajs-3302	96	10	patients	patient	NOUN
iajs-3302	96	11	with	with	ADP
iajs-3302	96	12	micro	micro	ADJ
iajs-3302	96	13	or	or	CCONJ
iajs-3302	96	14	total	total	ADJ
iajs-3302	96	15	albumin	albumin	ADJ
iajs-3302	96	16	urine	urine	NOUN
iajs-3302	96	17	compared	compare	VERB
iajs-3302	96	18	to	to	ADP
iajs-3302	96	19	normal	normal	ADJ
iajs-3302	96	20	albuminuria	albuminuria	NOUN
iajs-3302	96	21	in	in	ADP
iajs-3302	96	22	both	both	DET
iajs-3302	96	23	men	man	NOUN
iajs-3302	96	24	and	and	CCONJ
iajs-3302	96	25	women	woman	NOUN
iajs-3302	96	26	.	.	PUNCT
iajs-3302	97	1	the	the	DET
iajs-3302	97	2	current	current	ADJ
iajs-3302	97	3	study	study	NOUN
iajs-3302	97	4	's	's	PART
iajs-3302	97	5	findings	finding	NOUN
iajs-3302	97	6	demonstrated	demonstrate	VERB
iajs-3302	97	7	that	that	SCONJ
iajs-3302	97	8	sex	sex	NOUN
iajs-3302	97	9	has	have	VERB
iajs-3302	97	10	no	no	DET
iajs-3302	97	11	impact	impact	NOUN
iajs-3302	97	12	on	on	ADP
iajs-3302	97	13	groups	group	NOUN
iajs-3302	97	14	of	of	ADP
iajs-3302	97	15	men	man	NOUN
iajs-3302	97	16	and	and	CCONJ
iajs-3302	97	17	women	woman	NOUN
iajs-3302	97	18	's	's	PART
iajs-3302	97	19	[	[	X
iajs-3302	97	20	12	12	NUM
iajs-3302	97	21	]	]	PUNCT
iajs-3302	97	22	urea	urea	NOUN
iajs-3302	97	23	and	and	CCONJ
iajs-3302	97	24	creatinine	creatinine	NOUN
iajs-3302	97	25	levels	level	NOUN
iajs-3302	97	26	.	.	PUNCT
iajs-3302	98	1	the	the	DET
iajs-3302	98	2	present	present	ADJ
iajs-3302	98	3	findings	finding	NOUN
iajs-3302	98	4	imply	imply	VERB
iajs-3302	98	5	that	that	SCONJ
iajs-3302	98	6	female	female	ADJ
iajs-3302	98	7	kidneys	kidney	NOUN
iajs-3302	98	8	appear	appear	VERB
iajs-3302	98	9	to	to	PART
iajs-3302	98	10	be	be	AUX
iajs-3302	98	11	better	well	ADV
iajs-3302	98	12	protected	protect	VERB
iajs-3302	98	13	than	than	ADP
iajs-3302	98	14	male	male	ADJ
iajs-3302	98	15	kidneys	kidney	NOUN
iajs-3302	98	16	[	[	X
iajs-3302	98	17	13	13	NUM
iajs-3302	98	18	]	]	PUNCT
iajs-3302	98	19	.	.	PUNCT
iajs-3302	99	1	the	the	DET
iajs-3302	99	2	protection	protection	NOUN
iajs-3302	99	3	of	of	ADP
iajs-3302	99	4	the	the	DET
iajs-3302	99	5	kidneys	kidney	NOUN
iajs-3302	99	6	may	may	AUX
iajs-3302	99	7	be	be	AUX
iajs-3302	99	8	brought	bring	VERB
iajs-3302	99	9	about	about	ADP
iajs-3302	99	10	by	by	ADP
iajs-3302	99	11	an	an	DET
iajs-3302	99	12	increase	increase	NOUN
iajs-3302	99	13	in	in	ADP
iajs-3302	99	14	female	female	ADJ
iajs-3302	99	15	no	no	PRON
iajs-3302	99	16	(	(	PUNCT
iajs-3302	99	17	nitric	nitric	ADJ
iajs-3302	99	18	oxide	oxide	NOUN
iajs-3302	99	19	)	)	PUNCT
iajs-3302	99	20	levels	level	NOUN
iajs-3302	99	21	.	.	PUNCT
iajs-3302	100	1	the	the	DET
iajs-3302	100	2	no	no	NOUN
iajs-3302	100	3	is	be	AUX
iajs-3302	100	4	essential	essential	ADJ
iajs-3302	100	5	for	for	ADP
iajs-3302	100	6	tubular	tubular	ADJ
iajs-3302	100	7	transport	transport	NOUN
iajs-3302	100	8	,	,	PUNCT
iajs-3302	100	9	autoregulation	autoregulation	NOUN
iajs-3302	100	10	,	,	PUNCT
iajs-3302	100	11	and	and	CCONJ
iajs-3302	100	12	modulation	modulation	NOUN
iajs-3302	100	13	in	in	ADP
iajs-3302	100	14	the	the	DET
iajs-3302	100	15	kidney	kidney	NOUN
iajs-3302	100	16	,	,	PUNCT
iajs-3302	100	17	no	no	DET
iajs-3302	100	18	production	production	NOUN
iajs-3302	100	19	has	have	AUX
iajs-3302	100	20	been	be	AUX
iajs-3302	100	21	reported	report	VERB
iajs-3302	100	22	to	to	PART
iajs-3302	100	23	decrease	decrease	VERB
iajs-3302	100	24	as	as	ADP
iajs-3302	100	25	ckd	ckd	PROPN
iajs-3302	100	26	advances	advance	NOUN
iajs-3302	100	27	.	.	PUNCT
iajs-3302	101	1	as	as	ADP
iajs-3302	101	2	men	man	NOUN
iajs-3302	101	3	age	age	NOUN
iajs-3302	101	4	,	,	PUNCT
iajs-3302	101	5	their	their	PRON
iajs-3302	101	6	renal	renal	ADJ
iajs-3302	101	7	blood	blood	NOUN
iajs-3302	101	8	vessels	vessel	NOUN
iajs-3302	101	9	become	become	VERB
iajs-3302	101	10	more	more	ADV
iajs-3302	101	11	dependent	dependent	ADJ
iajs-3302	101	12	on	on	ADP
iajs-3302	101	13	nitric	nitric	ADJ
iajs-3302	101	14	oxide	oxide	NOUN
iajs-3302	101	15	.	.	PUNCT
iajs-3302	102	1	by	by	ADP
iajs-3302	102	2	controlling	control	VERB
iajs-3302	102	3	the	the	DET
iajs-3302	102	4	expression	expression	NOUN
iajs-3302	102	5	and	and	CCONJ
iajs-3302	102	6	activity	activity	NOUN
iajs-3302	102	7	of	of	ADP
iajs-3302	102	8	no	no	DET
iajs-3302	102	9	synthase	synthase	NOUN
iajs-3302	102	10	,	,	PUNCT
iajs-3302	102	11	testosterone	testosterone	NOUN
iajs-3302	102	12	deficiency	deficiency	NOUN
iajs-3302	102	13	may	may	AUX
iajs-3302	102	14	exacerbate	exacerbate	VERB
iajs-3302	102	15	endothelial	endothelial	ADJ
iajs-3302	102	16	dysfunction	dysfunction	NOUN
iajs-3302	102	17	by	by	ADP
iajs-3302	102	18	reducing	reduce	VERB
iajs-3302	102	19	no	no	DET
iajs-3302	102	20	levels	level	NOUN
iajs-3302	102	21	[	[	X
iajs-3302	102	22	14	14	NUM
iajs-3302	102	23	]	]	PUNCT
iajs-3302	102	24	.	.	PUNCT
iajs-3302	103	1	albumin	albumin	NOUN
iajs-3302	103	2	to	to	ADP
iajs-3302	103	3	creatinine	creatinine	NOUN
iajs-3302	103	4	ratio	ratio	NOUN
iajs-3302	103	5	evaluation	evaluation	NOUN
iajs-3302	103	6	in	in	ADP
iajs-3302	103	7	urine	urine	NOUN
iajs-3302	103	8	was	be	AUX
iajs-3302	103	9	recommended	recommend	VERB
iajs-3302	103	10	for	for	ADP
iajs-3302	103	11	the	the	DET
iajs-3302	103	12	estimation	estimation	NOUN
iajs-3302	103	13	of	of	ADP
iajs-3302	103	14	albuminuria	albuminuria	NOUN
iajs-3302	103	15	in	in	ADP
iajs-3302	103	16	the	the	DET
iajs-3302	103	17	diagnosis	diagnosis	NOUN
iajs-3302	103	18	of	of	ADP
iajs-3302	103	19	diabetic	diabetic	ADJ
iajs-3302	103	20	nephropathy	nephropathy	NOUN
iajs-3302	103	21	in	in	ADP
iajs-3302	103	22	patients	patient	NOUN
iajs-3302	103	23	with	with	ADP
iajs-3302	103	24	t2	t2	PROPN
iajs-3302	103	25	dm	dm	NOUN
iajs-3302	103	26	.	.	PUNCT
iajs-3302	104	1	due	due	ADP
iajs-3302	104	2	to	to	ADP
iajs-3302	104	3	the	the	DET
iajs-3302	104	4	high	high	ADJ
iajs-3302	104	5	incidence	incidence	NOUN
iajs-3302	104	6	of	of	ADP
iajs-3302	104	7	microalbuminuria	microalbuminuria	PROPN
iajs-3302	104	8	in	in	ADP
iajs-3302	104	9	diabetic	diabetic	ADJ
iajs-3302	104	10	patients	patient	NOUN
iajs-3302	104	11	,	,	PUNCT
iajs-3302	104	12	the	the	DET
iajs-3302	104	13	development	development	NOUN
iajs-3302	104	14	of	of	ADP
iajs-3302	104	15	glomerular	glomerular	ADJ
iajs-3302	104	16	and	and	CCONJ
iajs-3302	104	17	tubular	tubular	ADJ
iajs-3302	104	18	fibrosis	fibrosis	NOUN
iajs-3302	104	19	is	be	AUX
iajs-3302	104	20	attributed	attribute	VERB
iajs-3302	104	21	to	to	ADP
iajs-3302	104	22	endothelial	endothelial	ADJ
iajs-3302	104	23	damage	damage	NOUN
iajs-3302	104	24	[	[	X
iajs-3302	104	25	15	15	NUM
iajs-3302	104	26	]	]	PUNCT
iajs-3302	104	27	.	.	PUNCT
iajs-3302	105	1	so	so	ADV
iajs-3302	105	2	,	,	PUNCT
iajs-3302	105	3	the	the	DET
iajs-3302	105	4	prevention	prevention	NOUN
iajs-3302	105	5	of	of	ADP
iajs-3302	105	6	kidney	kidney	NOUN
iajs-3302	105	7	disease	disease	NOUN
iajs-3302	105	8	progression	progression	NOUN
iajs-3302	105	9	depends	depend	VERB
iajs-3302	105	10	on	on	ADP
iajs-3302	105	11	early	early	ADJ
iajs-3302	105	12	diagnosis	diagnosis	NOUN
iajs-3302	105	13	;	;	PUNCT
iajs-3302	105	14	hyperglycemia	hyperglycemia	NOUN
iajs-3302	105	15	leads	lead	VERB
iajs-3302	105	16	to	to	ADP
iajs-3302	105	17	severe	severe	ADJ
iajs-3302	105	18	kidney	kidney	NOUN
iajs-3302	105	19	damage	damage	NOUN
iajs-3302	105	20	that	that	PRON
iajs-3302	105	21	causes	cause	VERB
iajs-3302	105	22	a	a	DET
iajs-3302	105	23	decline	decline	NOUN
iajs-3302	105	24	in	in	ADP
iajs-3302	105	25	egfr	egfr	NOUN
iajs-3302	105	26	.	.	PUNCT
iajs-3302	106	1	therefore	therefore	ADV
iajs-3302	106	2	,	,	PUNCT
iajs-3302	106	3	egfr	egfr	NOUN
iajs-3302	106	4	can	can	AUX
iajs-3302	106	5	be	be	AUX
iajs-3302	106	6	helpful	helpful	ADJ
iajs-3302	106	7	as	as	ADP
iajs-3302	106	8	a	a	DET
iajs-3302	106	9	marker	marker	NOUN
iajs-3302	106	10	for	for	ADP
iajs-3302	106	11	early	early	ADJ
iajs-3302	106	12	renal	renal	ADJ
iajs-3302	106	13	impairment	impairment	ADJ
iajs-3302	106	14	diagnosis	diagnosis	NOUN
iajs-3302	106	15	in	in	ADP
iajs-3302	106	16	patients	patient	NOUN
iajs-3302	106	17	with	with	ADP
iajs-3302	106	18	t2	t2	NOUN
iajs-3302	106	19	dm	dm	PROPN
iajs-3302	107	1	[	[	X
iajs-3302	107	2	16	16	NUM
iajs-3302	107	3	]	]	PUNCT
iajs-3302	107	4	.	.	PUNCT
iajs-3302	108	1	both	both	PRON
iajs-3302	108	2	albuminuria	albuminuria	PROPN
iajs-3302	108	3	and	and	CCONJ
iajs-3302	108	4	egfr	egfr	NOUN
iajs-3302	108	5	are	be	AUX
iajs-3302	108	6	significantly	significantly	ADV
iajs-3302	108	7	better	well	ADJ
iajs-3302	108	8	indicators	indicator	NOUN
iajs-3302	108	9	of	of	ADP
iajs-3302	108	10	endstage	endstage	NOUN
iajs-3302	108	11	renal	renal	ADJ
iajs-3302	108	12	disease	disease	NOUN
iajs-3302	108	13	,	,	PUNCT
iajs-3302	108	14	but	but	CCONJ
iajs-3302	108	15	urine	urine	NOUN
iajs-3302	108	16	acr	acr	PROPN
iajs-3302	108	17	was	be	AUX
iajs-3302	108	18	found	find	VERB
iajs-3302	108	19	to	to	PART
iajs-3302	108	20	have	have	VERB
iajs-3302	108	21	a	a	DET
iajs-3302	108	22	more	more	ADV
iajs-3302	108	23	significant	significant	ADJ
iajs-3302	108	24	impact	impact	NOUN
iajs-3302	108	25	on	on	ADP
iajs-3302	108	26	clinical	clinical	ADJ
iajs-3302	108	27	practice	practice	NOUN
iajs-3302	108	28	than	than	ADP
iajs-3302	108	29	egfr	egfr	ADJ
iajs-3302	108	30	.	.	PUNCT
iajs-3302	109	1	as	as	ADP
iajs-3302	109	2	a	a	DET
iajs-3302	109	3	result	result	NOUN
iajs-3302	109	4	,	,	PUNCT
iajs-3302	109	5	the	the	DET
iajs-3302	109	6	presence	presence	NOUN
iajs-3302	109	7	of	of	ADP
iajs-3302	109	8	albuminuria	albuminuria	PROPN
iajs-3302	109	9	indicates	indicate	VERB
iajs-3302	109	10	damage	damage	NOUN
iajs-3302	109	11	to	to	ADP
iajs-3302	109	12	both	both	DET
iajs-3302	109	13	the	the	DET
iajs-3302	109	14	glomeruli	glomeruli	NOUN
iajs-3302	109	15	and	and	CCONJ
iajs-3302	109	16	the	the	DET
iajs-3302	109	17	tubules	tubule	NOUN
iajs-3302	109	18	,	,	PUNCT
iajs-3302	109	19	whereas	whereas	SCONJ
iajs-3302	109	20	an	an	DET
iajs-3302	109	21	egfr	egfr	ADJ
iajs-3302	109	22	disorder	disorder	NOUN
iajs-3302	109	23	only	only	ADV
iajs-3302	109	24	indicates	indicate	VERB
iajs-3302	109	25	glomerular	glomerular	ADJ
iajs-3302	109	26	damage	damage	NOUN
iajs-3302	109	27	.	.	PUNCT
iajs-3302	110	1	according	accord	VERB
iajs-3302	110	2	to	to	ADP
iajs-3302	110	3	the	the	DET
iajs-3302	110	4	findings	finding	NOUN
iajs-3302	110	5	of	of	ADP
iajs-3302	110	6	this	this	DET
iajs-3302	110	7	study	study	NOUN
iajs-3302	110	8	,	,	PUNCT
iajs-3302	110	9	assessment	assessment	NOUN
iajs-3302	110	10	of	of	ADP
iajs-3302	110	11	acr	acr	PROPN
iajs-3302	110	12	and	and	CCONJ
iajs-3302	110	13	gfr	gfr	PROPN
iajs-3302	110	14	could	could	AUX
iajs-3302	110	15	serve	serve	VERB
iajs-3302	110	16	as	as	ADP
iajs-3302	110	17	helpful	helpful	ADJ
iajs-3302	110	18	markers	marker	NOUN
iajs-3302	110	19	in	in	ADP
iajs-3302	110	20	this	this	DET
iajs-3302	110	21	setting	setting	NOUN
iajs-3302	110	22	for	for	ADP
iajs-3302	110	23	the	the	DET
iajs-3302	110	24	early	early	ADJ
iajs-3302	110	25	detection	detection	NOUN
iajs-3302	110	26	of	of	ADP
iajs-3302	110	27	diabetic	diabetic	ADJ
iajs-3302	110	28	nephropathy	nephropathy	NOUN
iajs-3302	110	29	,	,	PUNCT
iajs-3302	110	30	the	the	DET
iajs-3302	110	31	prevention	prevention	NOUN
iajs-3302	110	32	of	of	ADP
iajs-3302	110	33	overt	overt	ADJ
iajs-3302	110	34	nephropathy	nephropathy	NOUN
iajs-3302	110	35	,	,	PUNCT
iajs-3302	110	36	and	and	CCONJ
iajs-3302	110	37	the	the	DET
iajs-3302	110	38	progression	progression	NOUN
iajs-3302	110	39	to	to	PART
iajs-3302	110	40	end	end	VERB
iajs-3302	110	41	-	-	PUNCT
iajs-3302	110	42	stage	stage	NOUN
iajs-3302	110	43	renal	renal	ADJ
iajs-3302	110	44	disease	disease	NOUN
iajs-3302	110	45	.	.	PUNCT
iajs-3302	111	1	sex	sex	NOUN
iajs-3302	111	2	had	have	VERB
iajs-3302	111	3	no	no	DET
iajs-3302	111	4	impact	impact	NOUN
iajs-3302	111	5	on	on	ADP
iajs-3302	111	6	acr	acr	PROPN
iajs-3302	111	7	or	or	CCONJ
iajs-3302	111	8	gfr	gfr	NOUN
iajs-3302	111	9	in	in	ADP
iajs-3302	111	10	the	the	DET
iajs-3302	111	11	current	current	ADJ
iajs-3302	111	12	study	study	NOUN
iajs-3302	111	13	[	[	X
iajs-3302	111	14	17	17	NUM
iajs-3302	111	15	]	]	PUNCT
iajs-3302	111	16	.	.	PUNCT
iajs-3302	112	1	in	in	ADP
iajs-3302	112	2	general	general	ADJ
iajs-3302	112	3	,	,	PUNCT
iajs-3302	112	4	ctgf	ctgf	NOUN
iajs-3302	112	5	expression	expression	NOUN
iajs-3302	112	6	is	be	AUX
iajs-3302	112	7	modest	modest	ADJ
iajs-3302	112	8	in	in	ADP
iajs-3302	112	9	healthy	healthy	ADJ
iajs-3302	112	10	adult	adult	NOUN
iajs-3302	112	11	kidneys	kidney	NOUN
iajs-3302	112	12	but	but	CCONJ
iajs-3302	112	13	dramatically	dramatically	ADV
iajs-3302	112	14	elevated	elevate	VERB
iajs-3302	112	15	in	in	ADP
iajs-3302	112	16	a	a	DET
iajs-3302	112	17	number	number	NOUN
iajs-3302	112	18	of	of	ADP
iajs-3302	112	19	renal	renal	ADJ
iajs-3302	112	20	disorders	disorder	NOUN
iajs-3302	112	21	,	,	PUNCT
iajs-3302	112	22	where	where	SCONJ
iajs-3302	112	23	it	it	PRON
iajs-3302	112	24	plays	play	VERB
iajs-3302	112	25	a	a	DET
iajs-3302	112	26	critical	critical	ADJ
iajs-3302	112	27	role	role	NOUN
iajs-3302	112	28	in	in	ADP
iajs-3302	112	29	the	the	DET
iajs-3302	112	30	progression	progression	NOUN
iajs-3302	112	31	of	of	ADP
iajs-3302	112	32	glomerular	glomerular	ADJ
iajs-3302	112	33	and	and	CCONJ
iajs-3302	112	34	tubule	tubule	VERB
iajs-3302	112	35	interstitial	interstitial	ADJ
iajs-3302	112	36	fibrosis	fibrosis	NOUN
iajs-3302	112	37	[	[	X
iajs-3302	112	38	18	18	NUM
iajs-3302	112	39	]	]	PUNCT
iajs-3302	112	40	.	.	PUNCT
iajs-3302	113	1	involved	involve	VERB
iajs-3302	113	2	in	in	ADP
iajs-3302	113	3	cell	cell	NOUN
iajs-3302	113	4	migration	migration	NOUN
iajs-3302	113	5	,	,	PUNCT
iajs-3302	113	6	proliferation	proliferation	NOUN
iajs-3302	113	7	,	,	PUNCT
iajs-3302	113	8	and	and	CCONJ
iajs-3302	113	9	differentiation	differentiation	NOUN
iajs-3302	113	10	,	,	PUNCT
iajs-3302	113	11	ctgf	ctgf	VERB
iajs-3302	113	12	either	either	CCONJ
iajs-3302	113	13	works	work	VERB
iajs-3302	113	14	directly	directly	ADV
iajs-3302	113	15	to	to	PART
iajs-3302	113	16	advance	advance	VERB
iajs-3302	113	17	fibrosis	fibrosis	NOUN
iajs-3302	113	18	or	or	CCONJ
iajs-3302	113	19	functions	function	NOUN
iajs-3302	113	20	as	as	ADP
iajs-3302	113	21	a	a	DET
iajs-3302	113	22	factor	factor	NOUN
iajs-3302	113	23	downstream	downstream	NOUN
iajs-3302	113	24	of	of	ADP
iajs-3302	113	25	tgf	tgf	PROPN
iajs-3302	113	26	-	-	PUNCT
iajs-3302	113	27	β1	β1	PROPN
iajs-3302	113	28	.	.	PUNCT
iajs-3302	114	1	in	in	ADP
iajs-3302	114	2	addition	addition	NOUN
iajs-3302	114	3	,	,	PUNCT
iajs-3302	114	4	ctgf	ctgf	NOUN
iajs-3302	114	5	controls	control	VERB
iajs-3302	114	6	the	the	DET
iajs-3302	114	7	expression	expression	NOUN
iajs-3302	114	8	and	and	CCONJ
iajs-3302	114	9	activity	activity	NOUN
iajs-3302	114	10	of	of	ADP
iajs-3302	114	11	tgfand	tgfand	NOUN
iajs-3302	114	12	bone	bone	NOUN
iajs-3302	114	13	morphogenetic	morphogenetic	ADJ
iajs-3302	114	14	protein	protein	NOUN
iajs-3302	114	15	(	(	PUNCT
iajs-3302	114	16	bmp	bmp	NOUN
iajs-3302	114	17	)	)	PUNCT
iajs-3302	114	18	,	,	PUNCT
iajs-3302	114	19	thereby	thereby	ADV
iajs-3302	114	20	playing	play	VERB
iajs-3302	114	21	an	an	DET
iajs-3302	114	22	essential	essential	ADJ
iajs-3302	114	23	role	role	NOUN
iajs-3302	114	24	in	in	ADP
iajs-3302	114	25	the	the	DET
iajs-3302	114	26	process	process	NOUN
iajs-3302	114	27	of	of	ADP
iajs-3302	114	28	kidney	kidney	NOUN
iajs-3302	114	29	repair	repair	NOUN
iajs-3302	114	30	[	[	X
iajs-3302	114	31	19	19	NUM
iajs-3302	114	32	]	]	PUNCT
iajs-3302	114	33	.	.	PUNCT
iajs-3302	115	1	elevated	elevated	ADJ
iajs-3302	115	2	plasma	plasma	NOUN
iajs-3302	115	3	ctgf	ctgf	NOUN
iajs-3302	115	4	in	in	ADP
iajs-3302	115	5	individuals	individual	NOUN
iajs-3302	115	6	with	with	ADP
iajs-3302	115	7	ckd	ckd	PROPN
iajs-3302	115	8	is	be	AUX
iajs-3302	115	9	an	an	DET
iajs-3302	115	10	independent	independent	ADJ
iajs-3302	115	11	risk	risk	NOUN
iajs-3302	115	12	factor	factor	NOUN
iajs-3302	115	13	for	for	ADP
iajs-3302	115	14	the	the	DET
iajs-3302	115	15	development	development	NOUN
iajs-3302	115	16	of	of	ADP
iajs-3302	115	17	end	end	NOUN
iajs-3302	115	18	-	-	PUNCT
iajs-3302	115	19	stage	stage	NOUN
iajs-3302	115	20	renal	renal	ADJ
iajs-3302	115	21	disease	disease	NOUN
iajs-3302	115	22	and	and	CCONJ
iajs-3302	115	23	is	be	AUX
iajs-3302	115	24	closely	closely	ADV
iajs-3302	115	25	correlated	correlate	VERB
iajs-3302	115	26	with	with	ADP
iajs-3302	115	27	glomerular	glomerular	ADJ
iajs-3302	115	28	filtration	filtration	NOUN
iajs-3302	115	29	rate	rate	NOUN
iajs-3302	115	30	.	.	PUNCT
iajs-3302	116	1	as	as	ADP
iajs-3302	116	2	a	a	DET
iajs-3302	116	3	result	result	NOUN
iajs-3302	116	4	,	,	PUNCT
iajs-3302	116	5	ctgf	ctgf	PROPN
iajs-3302	116	6	may	may	AUX
iajs-3302	116	7	serve	serve	VERB
iajs-3302	116	8	as	as	ADP
iajs-3302	116	9	a	a	DET
iajs-3302	116	10	biological	biological	ADJ
iajs-3302	116	11	indicator	indicator	NOUN
iajs-3302	116	12	of	of	ADP
iajs-3302	116	13	kidney	kidney	NOUN
iajs-3302	116	14	fibrosis	fibrosis	NOUN
iajs-3302	116	15	.	.	PUNCT
iajs-3302	117	1	the	the	DET
iajs-3302	117	2	current	current	ADJ
iajs-3302	117	3	study	study	NOUN
iajs-3302	117	4	ihjpas	ihjpa	VERB
iajs-3302	117	5	.	.	PUNCT
iajs-3302	118	1	37	37	NUM
iajs-3302	118	2	(	(	PUNCT
iajs-3302	118	3	2	2	NUM
iajs-3302	118	4	)	)	PUNCT
iajs-3302	118	5	2024	2024	NUM
iajs-3302	118	6	266	266	NUM
iajs-3302	118	7	showed	show	VERB
iajs-3302	118	8	an	an	DET
iajs-3302	118	9	increase	increase	NOUN
iajs-3302	118	10	in	in	ADP
iajs-3302	118	11	connective	connective	ADJ
iajs-3302	118	12	tissue	tissue	NOUN
iajs-3302	118	13	growth	growth	NOUN
iajs-3302	118	14	factor	factor	NOUN
iajs-3302	118	15	,	,	PUNCT
iajs-3302	118	16	indicating	indicate	VERB
iajs-3302	118	17	the	the	DET
iajs-3302	118	18	occurrence	occurrence	NOUN
iajs-3302	118	19	of	of	ADP
iajs-3302	118	20	glomerular	glomerular	ADJ
iajs-3302	118	21	and	and	CCONJ
iajs-3302	118	22	tubular	tubular	ADJ
iajs-3302	118	23	damage	damage	NOUN
iajs-3302	118	24	and	and	CCONJ
iajs-3302	118	25	fibrosis	fibrosis	NOUN
iajs-3302	118	26	in	in	ADP
iajs-3302	118	27	diabetic	diabetic	ADJ
iajs-3302	118	28	patients	patient	NOUN
iajs-3302	118	29	[	[	X
iajs-3302	118	30	20	20	NUM
iajs-3302	118	31	]	]	PUNCT
iajs-3302	118	32	.	.	PUNCT
iajs-3302	119	1	this	this	DET
iajs-3302	119	2	result	result	NOUN
iajs-3302	119	3	is	be	AUX
iajs-3302	119	4	in	in	ADP
iajs-3302	119	5	agreement	agreement	NOUN
iajs-3302	119	6	with	with	ADP
iajs-3302	119	7	koszegi	koszegi	PROPN
iajs-3302	119	8	et	et	PROPN
iajs-3302	119	9	al	al	PROPN
iajs-3302	119	10	.	.	PROPN
iajs-3302	119	11	,	,	PUNCT
iajs-3302	119	12	who	who	PRON
iajs-3302	119	13	found	find	VERB
iajs-3302	119	14	dm	dm	PROPN
iajs-3302	119	15	is	be	AUX
iajs-3302	119	16	a	a	DET
iajs-3302	119	17	significant	significant	ADJ
iajs-3302	119	18	health	health	NOUN
iajs-3302	119	19	concern	concern	NOUN
iajs-3302	119	20	,	,	PUNCT
iajs-3302	119	21	impairing	impair	VERB
iajs-3302	119	22	the	the	DET
iajs-3302	119	23	quality	quality	NOUN
iajs-3302	119	24	of	of	ADP
iajs-3302	119	25	life	life	NOUN
iajs-3302	119	26	and	and	CCONJ
iajs-3302	119	27	diminishing	diminish	VERB
iajs-3302	119	28	the	the	DET
iajs-3302	119	29	life	life	NOUN
iajs-3302	119	30	expectancy	expectancy	NOUN
iajs-3302	119	31	of	of	ADP
iajs-3302	119	32	millions	million	NOUN
iajs-3302	119	33	of	of	ADP
iajs-3302	119	34	people	people	NOUN
iajs-3302	119	35	.	.	PUNCT
iajs-3302	120	1	the	the	DET
iajs-3302	120	2	dkd	dkd	PROPN
iajs-3302	120	3	affects	affect	VERB
iajs-3302	120	4	more	more	ADJ
iajs-3302	120	5	than	than	ADP
iajs-3302	120	6	20	20	NUM
iajs-3302	120	7	%	%	NOUN
iajs-3302	120	8	of	of	ADP
iajs-3302	120	9	all	all	DET
iajs-3302	120	10	diabetic	diabetic	ADJ
iajs-3302	120	11	patients	patient	NOUN
iajs-3302	120	12	,	,	PUNCT
iajs-3302	120	13	and	and	CCONJ
iajs-3302	120	14	due	due	ADP
iajs-3302	120	15	to	to	ADP
iajs-3302	120	16	limited	limited	ADJ
iajs-3302	120	17	therapeutic	therapeutic	ADJ
iajs-3302	120	18	options	option	NOUN
iajs-3302	120	19	,	,	PUNCT
iajs-3302	120	20	it	it	PRON
iajs-3302	120	21	remains	remain	VERB
iajs-3302	120	22	the	the	DET
iajs-3302	120	23	leading	lead	VERB
iajs-3302	120	24	cause	cause	NOUN
iajs-3302	120	25	of	of	ADP
iajs-3302	120	26	ckd	ckd	PROPN
iajs-3302	120	27	.	.	PUNCT
iajs-3302	121	1	the	the	DET
iajs-3302	121	2	ckd	ckd	PROPN
iajs-3302	121	3	are	be	AUX
iajs-3302	121	4	defined	define	VERB
iajs-3302	121	5	by	by	ADP
iajs-3302	121	6	the	the	DET
iajs-3302	121	7	buildup	buildup	NOUN
iajs-3302	121	8	of	of	ADP
iajs-3302	121	9	extracellular	extracellular	ADJ
iajs-3302	121	10	matrix	matrix	NOUN
iajs-3302	121	11	(	(	PUNCT
iajs-3302	121	12	ecm	ecm	NOUN
iajs-3302	121	13	)	)	PUNCT
iajs-3302	121	14	components	component	NOUN
iajs-3302	121	15	in	in	ADP
iajs-3302	121	16	the	the	DET
iajs-3302	121	17	glomeruli	glomeruli	NOUN
iajs-3302	121	18	(	(	PUNCT
iajs-3302	121	19	glomerular	glomerular	ADJ
iajs-3302	121	20	fibrosis	fibrosis	NOUN
iajs-3302	121	21	,	,	PUNCT
iajs-3302	121	22	glomerulosclerosis	glomerulosclerosis	NOUN
iajs-3302	121	23	)	)	PUNCT
iajs-3302	121	24	,	,	PUNCT
iajs-3302	121	25	and	and	CCONJ
iajs-3302	121	26	the	the	DET
iajs-3302	121	27	tubular	tubular	ADJ
iajs-3302	121	28	interstitium	interstitium	NOUN
iajs-3302	121	29	,	,	PUNCT
iajs-3302	121	30	and	and	CCONJ
iajs-3302	121	31	tgf	tgf	PROPN
iajs-3302	121	32	-	-	PUNCT
iajs-3302	121	33	β1	β1	PROPN
iajs-3302	121	34	has	have	AUX
iajs-3302	121	35	been	be	AUX
iajs-3302	121	36	identified	identify	VERB
iajs-3302	121	37	as	as	ADP
iajs-3302	121	38	a	a	DET
iajs-3302	121	39	critical	critical	ADJ
iajs-3302	121	40	mediator	mediator	NOUN
iajs-3302	121	41	in	in	ADP
iajs-3302	121	42	the	the	DET
iajs-3302	121	43	genesis	genesis	NOUN
iajs-3302	121	44	of	of	ADP
iajs-3302	121	45	ckd	ckd	PROPN
iajs-3302	121	46	(	(	PUNCT
iajs-3302	121	47	tubulointerstitial	tubulointerstitial	ADJ
iajs-3302	121	48	fibrosis	fibrosis	NOUN
iajs-3302	121	49	)	)	PUNCT
iajs-3302	122	1	[	[	X
iajs-3302	122	2	21	21	NUM
iajs-3302	122	3	]	]	PUNCT
iajs-3302	122	4	.	.	PUNCT
iajs-3302	123	1	one	one	NUM
iajs-3302	123	2	of	of	ADP
iajs-3302	123	3	the	the	DET
iajs-3302	123	4	main	main	ADJ
iajs-3302	123	5	reasons	reason	NOUN
iajs-3302	123	6	for	for	ADP
iajs-3302	123	7	decreased	decrease	VERB
iajs-3302	123	8	glomerular	glomerular	ADJ
iajs-3302	123	9	filtration	filtration	NOUN
iajs-3302	123	10	rate	rate	NOUN
iajs-3302	123	11	in	in	ADP
iajs-3302	123	12	ckd	ckd	PROPN
iajs-3302	123	13	is	be	AUX
iajs-3302	123	14	the	the	DET
iajs-3302	123	15	formation	formation	NOUN
iajs-3302	123	16	of	of	ADP
iajs-3302	123	17	fibrosis	fibrosis	NOUN
iajs-3302	123	18	,	,	PUNCT
iajs-3302	123	19	which	which	PRON
iajs-3302	123	20	is	be	AUX
iajs-3302	123	21	contributed	contribute	VERB
iajs-3302	123	22	to	to	ADP
iajs-3302	123	23	by	by	ADP
iajs-3302	123	24	the	the	DET
iajs-3302	123	25	three	three	NUM
iajs-3302	123	26	main	main	ADJ
iajs-3302	123	27	types	type	NOUN
iajs-3302	123	28	of	of	ADP
iajs-3302	123	29	glomerular	glomerular	ADJ
iajs-3302	123	30	cells	cell	NOUN
iajs-3302	123	31	(	(	PUNCT
iajs-3302	123	32	visceral	visceral	ADJ
iajs-3302	123	33	epithelial	epithelial	ADJ
iajs-3302	123	34	cells	cell	NOUN
iajs-3302	123	35	,	,	PUNCT
iajs-3302	123	36	mesangial	mesangial	ADJ
iajs-3302	123	37	cells	cell	NOUN
iajs-3302	123	38	,	,	PUNCT
iajs-3302	123	39	and	and	CCONJ
iajs-3302	123	40	endothelial	endothelial	ADJ
iajs-3302	123	41	cells	cell	NOUN
iajs-3302	123	42	)	)	PUNCT
iajs-3302	124	1	[	[	X
iajs-3302	124	2	22	22	NUM
iajs-3302	124	3	]	]	PUNCT
iajs-3302	124	4	.	.	PUNCT
iajs-3302	125	1	the	the	DET
iajs-3302	125	2	tgf	tgf	PROPN
iajs-3302	125	3	-	-	PUNCT
iajs-3302	125	4	b1	b1	NOUN
iajs-3302	125	5	causes	cause	VERB
iajs-3302	125	6	mesangial	mesangial	ADJ
iajs-3302	125	7	expansion	expansion	NOUN
iajs-3302	125	8	due	due	ADP
iajs-3302	125	9	to	to	ADP
iajs-3302	125	10	mesangial	mesangial	ADJ
iajs-3302	125	11	cell	cell	NOUN
iajs-3302	125	12	hypertrophy	hypertrophy	NOUN
iajs-3302	125	13	,	,	PUNCT
iajs-3302	125	14	proliferation	proliferation	NOUN
iajs-3302	125	15	(	(	PUNCT
iajs-3302	125	16	and	and	CCONJ
iajs-3302	125	17	eventually	eventually	ADV
iajs-3302	125	18	apoptosis	apoptosis	VERB
iajs-3302	125	19	)	)	PUNCT
iajs-3302	125	20	,	,	PUNCT
iajs-3302	125	21	and	and	CCONJ
iajs-3302	125	22	extracellular	extracellular	ADJ
iajs-3302	125	23	matrix	matrix	NOUN
iajs-3302	125	24	ecm	ecm	NOUN
iajs-3302	125	25	synthesis	synthesis	NOUN
iajs-3302	125	26	.	.	PUNCT
iajs-3302	126	1	it	it	PRON
iajs-3302	126	2	also	also	ADV
iajs-3302	126	3	causes	cause	VERB
iajs-3302	126	4	endothelial	endothelial	NOUN
iajs-3302	126	5	to	to	ADP
iajs-3302	126	6	mesenchymal	mesenchymal	ADJ
iajs-3302	126	7	transition	transition	NOUN
iajs-3302	126	8	,	,	PUNCT
iajs-3302	126	9	which	which	PRON
iajs-3302	126	10	results	result	VERB
iajs-3302	126	11	in	in	ADP
iajs-3302	126	12	glomerular	glomerular	ADJ
iajs-3302	126	13	myofibroblasts	myofibroblast	NOUN
iajs-3302	126	14	,	,	PUNCT
iajs-3302	126	15	a	a	DET
iajs-3302	126	16	significant	significant	ADJ
iajs-3302	126	17	source	source	NOUN
iajs-3302	126	18	of	of	ADP
iajs-3302	126	19	ecm	ecm	NOUN
iajs-3302	126	20	,	,	PUNCT
iajs-3302	126	21	and	and	CCONJ
iajs-3302	126	22	podocytopenia	podocytopenia	NOUN
iajs-3302	126	23	caused	cause	VERB
iajs-3302	126	24	by	by	ADP
iajs-3302	126	25	podocyte	podocyte	NOUN
iajs-3302	126	26	apoptosis	apoptosis	NOUN
iajs-3302	126	27	and	and	CCONJ
iajs-3302	126	28	detachment	detachment	NOUN
iajs-3302	126	29	from	from	ADP
iajs-3302	126	30	the	the	DET
iajs-3302	126	31	glomerular	glomerular	ADJ
iajs-3302	126	32	basement	basement	NOUN
iajs-3302	126	33	membrane	membrane	NOUN
iajs-3302	126	34	[	[	X
iajs-3302	126	35	23	23	NUM
iajs-3302	126	36	]	]	PUNCT
iajs-3302	126	37	.	.	PUNCT
iajs-3302	127	1	the	the	DET
iajs-3302	127	2	tgf	tgf	PROPN
iajs-3302	127	3	-	-	PUNCT
iajs-3302	127	4	β1	β1	PROPN
iajs-3302	127	5	has	have	AUX
iajs-3302	127	6	been	be	AUX
iajs-3302	127	7	shown	show	VERB
iajs-3302	127	8	to	to	PART
iajs-3302	127	9	mediate	mediate	VERB
iajs-3302	127	10	several	several	ADJ
iajs-3302	127	11	key	key	ADJ
iajs-3302	127	12	tubular	tubular	ADJ
iajs-3302	127	13	pathological	pathological	ADJ
iajs-3302	127	14	events	event	NOUN
iajs-3302	127	15	during	during	ADP
iajs-3302	127	16	ckd	ckd	NOUN
iajs-3302	127	17	progression	progression	NOUN
iajs-3302	127	18	,	,	PUNCT
iajs-3302	127	19	namely	namely	ADV
iajs-3302	127	20	fibroblast	fibroblast	ADJ
iajs-3302	127	21	proliferation	proliferation	NOUN
iajs-3302	127	22	,	,	PUNCT
iajs-3302	127	23	epithelial	epithelial	ADJ
iajs-3302	127	24	to	to	ADP
iajs-3302	127	25	mesenchymal	mesenchymal	ADJ
iajs-3302	127	26	transition	transition	NOUN
iajs-3302	127	27	,	,	PUNCT
iajs-3302	127	28	tubular	tubular	ADJ
iajs-3302	127	29	and	and	CCONJ
iajs-3302	127	30	fibroblast	fibroblast	ADJ
iajs-3302	127	31	ecm	ecm	NOUN
iajs-3302	127	32	production	production	NOUN
iajs-3302	127	33	,	,	PUNCT
iajs-3302	127	34	and	and	CCONJ
iajs-3302	127	35	epithelial	epithelial	ADJ
iajs-3302	127	36	cell	cell	NOUN
iajs-3302	127	37	death	death	NOUN
iajs-3302	127	38	,	,	PUNCT
iajs-3302	127	39	leading	lead	VERB
iajs-3302	127	40	to	to	ADP
iajs-3302	127	41	tubular	tubular	ADJ
iajs-3302	127	42	cell	cell	NOUN
iajs-3302	127	43	deletion	deletion	NOUN
iajs-3302	127	44	and	and	CCONJ
iajs-3302	127	45	interstitial	interstitial	ADJ
iajs-3302	127	46	fibrosis	fibrosis	NOUN
iajs-3302	127	47	.	.	PUNCT
iajs-3302	128	1	tgf	tgf	PROPN
iajs-3302	128	2	-	-	PUNCT
iajs-3302	128	3	β1	β1	PROPN
iajs-3302	128	4	has	have	AUX
iajs-3302	128	5	been	be	AUX
iajs-3302	128	6	shown	show	VERB
iajs-3302	128	7	to	to	PART
iajs-3302	128	8	mediate	mediate	VERB
iajs-3302	128	9	several	several	ADJ
iajs-3302	128	10	key	key	ADJ
iajs-3302	128	11	tubular	tubular	ADJ
iajs-3302	128	12	pathological	pathological	ADJ
iajs-3302	128	13	events	event	NOUN
iajs-3302	128	14	during	during	ADP
iajs-3302	128	15	ckd	ckd	NOUN
iajs-3302	128	16	progression	progression	NOUN
iajs-3302	128	17	,	,	PUNCT
iajs-3302	128	18	namely	namely	ADV
iajs-3302	128	19	fibroblast	fibroblast	ADJ
iajs-3302	128	20	proliferation	proliferation	NOUN
iajs-3302	128	21	,	,	PUNCT
iajs-3302	128	22	epithelial	epithelial	ADJ
iajs-3302	128	23	to	to	ADP
iajs-3302	128	24	mesenchymal	mesenchymal	ADJ
iajs-3302	128	25	transition	transition	NOUN
iajs-3302	128	26	,	,	PUNCT
iajs-3302	128	27	tubular	tubular	ADJ
iajs-3302	128	28	and	and	CCONJ
iajs-3302	128	29	fibroblast	fibroblast	ADJ
iajs-3302	128	30	ecm	ecm	NOUN
iajs-3302	128	31	production	production	NOUN
iajs-3302	128	32	,	,	PUNCT
iajs-3302	128	33	and	and	CCONJ
iajs-3302	128	34	epithelial	epithelial	ADJ
iajs-3302	128	35	cell	cell	NOUN
iajs-3302	128	36	death	death	NOUN
iajs-3302	128	37	,	,	PUNCT
iajs-3302	128	38	leading	lead	VERB
iajs-3302	128	39	to	to	ADP
iajs-3302	128	40	tubular	tubular	ADJ
iajs-3302	128	41	cell	cell	NOUN
iajs-3302	128	42	deletion	deletion	NOUN
iajs-3302	128	43	and	and	CCONJ
iajs-3302	128	44	interstitial	interstitial	ADJ
iajs-3302	128	45	fibrosis	fibrosis	NOUN
iajs-3302	128	46	[	[	X
iajs-3302	128	47	24	24	NUM
iajs-3302	128	48	,	,	PUNCT
iajs-3302	128	49	25	25	NUM
iajs-3302	128	50	]	]	PUNCT
iajs-3302	128	51	.	.	PUNCT
iajs-3302	129	1	through	through	ADP
iajs-3302	129	2	the	the	DET
iajs-3302	129	3	results	result	NOUN
iajs-3302	129	4	of	of	ADP
iajs-3302	129	5	our	our	PRON
iajs-3302	129	6	current	current	ADJ
iajs-3302	129	7	study	study	NOUN
iajs-3302	129	8	,	,	PUNCT
iajs-3302	129	9	there	there	PRON
iajs-3302	129	10	was	be	VERB
iajs-3302	129	11	a	a	DET
iajs-3302	129	12	similar	similar	ADJ
iajs-3302	129	13	effect	effect	NOUN
iajs-3302	129	14	on	on	ADP
iajs-3302	129	15	the	the	DET
iajs-3302	129	16	high	high	ADJ
iajs-3302	129	17	level	level	NOUN
iajs-3302	129	18	of	of	ADP
iajs-3302	129	19	tgf	tgf	PROPN
iajs-3302	129	20	-	-	PUNCT
iajs-3302	129	21	β1	β1	PROPN
iajs-3302	129	22	for	for	ADP
iajs-3302	129	23	both	both	CCONJ
iajs-3302	129	24	male	male	ADJ
iajs-3302	129	25	and	and	CCONJ
iajs-3302	129	26	female	female	ADJ
iajs-3302	129	27	groups	group	NOUN
iajs-3302	129	28	,	,	PUNCT
iajs-3302	129	29	and	and	CCONJ
iajs-3302	129	30	our	our	PRON
iajs-3302	129	31	results	result	NOUN
iajs-3302	129	32	agree	agree	VERB
iajs-3302	129	33	with	with	ADP
iajs-3302	129	34	al	al	PROPN
iajs-3302	129	35	-	-	PROPN
iajs-3302	129	36	maiyaly	maiyaly	PROPN
iajs-3302	129	37	,	,	PUNCT
iajs-3302	129	38	who	who	PRON
iajs-3302	129	39	found	find	VERB
iajs-3302	129	40	that	that	PRON
iajs-3302	129	41	highlevel	highlevel	ADJ
iajs-3302	129	42	tgf	tgf	PROPN
iajs-3302	129	43	-	-	PUNCT
iajs-3302	129	44	β1	β1	PROPN
iajs-3302	129	45	plays	play	VERB
iajs-3302	129	46	a	a	DET
iajs-3302	129	47	significant	significant	ADJ
iajs-3302	129	48	role	role	NOUN
iajs-3302	129	49	in	in	ADP
iajs-3302	129	50	the	the	DET
iajs-3302	129	51	extracellular	extracellular	ADJ
iajs-3302	129	52	accumulation	accumulation	NOUN
iajs-3302	129	53	of	of	ADP
iajs-3302	129	54	protein	protein	NOUN
iajs-3302	129	55	kinase	kinase	PROPN
iajs-3302	129	56	pk	pk	PROPN
iajs-3302	129	57	in	in	ADP
iajs-3302	129	58	both	both	DET
iajs-3302	129	59	men	man	NOUN
iajs-3302	129	60	and	and	CCONJ
iajs-3302	129	61	women	woman	NOUN
iajs-3302	130	1	[	[	X
iajs-3302	130	2	26	26	NUM
iajs-3302	130	3	-	-	SYM
iajs-3302	130	4	28	28	NUM
iajs-3302	130	5	]	]	PUNCT
iajs-3302	130	6	.	.	PUNCT
iajs-3302	131	1	activity	activity	NOUN
iajs-3302	131	2	is	be	AUX
iajs-3302	131	3	reported	report	VERB
iajs-3302	131	4	for	for	ADP
iajs-3302	131	5	its	its	PRON
iajs-3302	131	6	ability	ability	NOUN
iajs-3302	131	7	to	to	PART
iajs-3302	131	8	increase	increase	VERB
iajs-3302	131	9	the	the	DET
iajs-3302	131	10	production	production	NOUN
iajs-3302	131	11	of	of	ADP
iajs-3302	131	12	ecm	ecm	PROPN
iajs-3302	131	13	.	.	PUNCT
iajs-3302	132	1	tgf	tgf	PROPN
iajs-3302	132	2	-	-	PUNCT
iajs-3302	132	3	β1pk	β1pk	PUNCT
iajs-3302	132	4	inhibitors	inhibitor	NOUN
iajs-3302	132	5	can	can	AUX
iajs-3302	132	6	prevent	prevent	VERB
iajs-3302	132	7	hyperglycemia	hyperglycemia	NOUN
iajs-3302	132	8	or	or	CCONJ
iajs-3302	132	9	diabetes	diabetes	NOUN
iajs-3302	132	10	-	-	PUNCT
iajs-3302	132	11	induced	induce	VERB
iajs-3302	132	12	increases	increase	NOUN
iajs-3302	132	13	in	in	ADP
iajs-3302	132	14	ecm	ecm	NOUN
iajs-3302	132	15	accumulation	accumulation	NOUN
iajs-3302	132	16	and	and	CCONJ
iajs-3302	132	17	production	production	NOUN
iajs-3302	132	18	of	of	ADP
iajs-3302	132	19	tgf	tgf	PROPN
iajs-3302	132	20	-	-	PUNCT
iajs-3302	132	21	β1	β1	PROPN
iajs-3302	132	22	in	in	ADP
iajs-3302	132	23	mesangial	mesangial	ADJ
iajs-3302	132	24	cells	cell	NOUN
iajs-3302	132	25	or	or	CCONJ
iajs-3302	132	26	renal	renal	ADJ
iajs-3302	132	27	glomeruli	glomeruli	NOUN
iajs-3302	132	28	[	[	X
iajs-3302	132	29	29	29	NUM
iajs-3302	132	30	,	,	PUNCT
iajs-3302	132	31	30	30	NUM
iajs-3302	132	32	]	]	PUNCT
iajs-3302	132	33	.	.	PUNCT
iajs-3302	133	1	5	5	X
iajs-3302	133	2	.	.	X
iajs-3302	133	3	conclusion	conclusion	NOUN
iajs-3302	133	4	according	accord	VERB
iajs-3302	133	5	to	to	ADP
iajs-3302	133	6	the	the	DET
iajs-3302	133	7	results	result	NOUN
iajs-3302	133	8	obtained	obtain	VERB
iajs-3302	133	9	,	,	PUNCT
iajs-3302	133	10	there	there	PRON
iajs-3302	133	11	were	be	VERB
iajs-3302	133	12	no	no	DET
iajs-3302	133	13	differences	difference	NOUN
iajs-3302	133	14	in	in	ADP
iajs-3302	133	15	the	the	DET
iajs-3302	133	16	levels	level	NOUN
iajs-3302	133	17	of	of	ADP
iajs-3302	133	18	ctgf	ctgf	NOUN
iajs-3302	133	19	and	and	CCONJ
iajs-3302	133	20	tfgβ1	tfgβ1	NOUN
iajs-3302	133	21	in	in	ADP
iajs-3302	133	22	male	male	ADJ
iajs-3302	133	23	and	and	CCONJ
iajs-3302	133	24	female	female	ADJ
iajs-3302	133	25	participants	participant	NOUN
iajs-3302	133	26	who	who	PRON
iajs-3302	133	27	were	be	AUX
iajs-3302	133	28	studied	study	VERB
iajs-3302	133	29	separately	separately	ADV
iajs-3302	133	30	in	in	ADP
iajs-3302	133	31	dkd	dkd	PROPN
iajs-3302	133	32	.	.	PUNCT
iajs-3302	134	1	so	so	ADV
iajs-3302	134	2	,	,	PUNCT
iajs-3302	134	3	this	this	DET
iajs-3302	134	4	study	study	NOUN
iajs-3302	134	5	conclude	conclude	VERB
iajs-3302	134	6	that	that	SCONJ
iajs-3302	134	7	sex	sex	NOUN
iajs-3302	134	8	has	have	VERB
iajs-3302	134	9	no	no	DET
iajs-3302	134	10	effect	effect	NOUN
iajs-3302	134	11	.	.	PUNCT
iajs-3302	135	1	acknowledgment	acknowledgment	NOUN
iajs-3302	135	2	the	the	DET
iajs-3302	135	3	authors	author	NOUN
iajs-3302	135	4	thank	thank	VERB
iajs-3302	135	5	and	and	CCONJ
iajs-3302	135	6	appreciate	appreciate	VERB
iajs-3302	135	7	the	the	DET
iajs-3302	135	8	staff	staff	NOUN
iajs-3302	135	9	of	of	ADP
iajs-3302	135	10	the	the	DET
iajs-3302	135	11	medical	medical	ADJ
iajs-3302	135	12	city	city	NOUN
iajs-3302	135	13	and	and	CCONJ
iajs-3302	135	14	al	al	PROPN
iajs-3302	135	15	-	-	PUNCT
iajs-3302	135	16	yarmouk	yarmouk	PROPN
iajs-3302	135	17	hospital	hospital	NOUN
iajs-3302	135	18	in	in	ADP
iajs-3302	135	19	bagdad	bagdad	PROPN
iajs-3302	135	20	for	for	ADP
iajs-3302	135	21	their	their	PRON
iajs-3302	135	22	assistance	assistance	NOUN
iajs-3302	135	23	in	in	ADP
iajs-3302	135	24	collecting	collect	VERB
iajs-3302	135	25	and	and	CCONJ
iajs-3302	135	26	analyzing	analyze	VERB
iajs-3302	135	27	samples	sample	NOUN
iajs-3302	135	28	and	and	CCONJ
iajs-3302	135	29	for	for	ADP
iajs-3302	135	30	their	their	PRON
iajs-3302	135	31	facilities	facility	NOUN
iajs-3302	135	32	that	that	PRON
iajs-3302	135	33	assisted	assist	VERB
iajs-3302	135	34	in	in	ADP
iajs-3302	135	35	the	the	DET
iajs-3302	135	36	achievement	achievement	NOUN
iajs-3302	135	37	of	of	ADP
iajs-3302	135	38	this	this	DET
iajs-3302	135	39	study	study	NOUN
iajs-3302	135	40	.	.	PUNCT
iajs-3302	136	1	conflict	conflict	NOUN
iajs-3302	136	2	of	of	ADP
iajs-3302	136	3	interest	interest	NOUN
iajs-3302	136	4	there	there	PRON
iajs-3302	136	5	are	be	VERB
iajs-3302	136	6	no	no	DET
iajs-3302	136	7	conflicts	conflict	NOUN
iajs-3302	136	8	of	of	ADP
iajs-3302	136	9	interest	interest	NOUN
iajs-3302	136	10	.	.	PUNCT
iajs-3302	137	1	ihjpas	ihjpas	PROPN
iajs-3302	137	2	.	.	PUNCT
iajs-3302	138	1	37	37	NUM
iajs-3302	138	2	(	(	PUNCT
iajs-3302	138	3	2	2	NUM
iajs-3302	138	4	)	)	PUNCT
iajs-3302	138	5	2024	2024	NUM
iajs-3302	138	6	267	267	NUM
iajs-3302	138	7	funding	funding	NOUN
iajs-3302	138	8	there	there	PRON
iajs-3302	138	9	is	be	VERB
iajs-3302	138	10	no	no	DET
iajs-3302	138	11	funding	funding	NOUN
iajs-3302	138	12	for	for	ADP
iajs-3302	138	13	the	the	DET
iajs-3302	138	14	article	article	NOUN
iajs-3302	138	15	ethical	ethical	ADJ
iajs-3302	138	16	clearance	clearance	NOUN
iajs-3302	138	17	the	the	DET
iajs-3302	138	18	scientific	scientific	ADJ
iajs-3302	138	19	committee	committee	NOUN
iajs-3302	138	20	at	at	ADP
iajs-3302	138	21	the	the	DET
iajs-3302	138	22	university	university	PROPN
iajs-3302	138	23	of	of	ADP
iajs-3302	138	24	baghdad	baghdad	PROPN
iajs-3302	138	25	has	have	AUX
iajs-3302	138	26	approved	approve	VERB
iajs-3302	138	27	this	this	DET
iajs-3302	138	28	work	work	NOUN
iajs-3302	138	29	for	for	ADP
iajs-3302	138	30	both	both	CCONJ
iajs-3302	138	31	the	the	DET
iajs-3302	138	32	college	college	NOUN
iajs-3302	138	33	of	of	ADP
iajs-3302	138	34	science	science	NOUN
iajs-3302	138	35	for	for	ADP
iajs-3302	138	36	women	woman	NOUN
iajs-3302	138	37	and	and	CCONJ
iajs-3302	138	38	the	the	DET
iajs-3302	138	39	college	college	NOUN
iajs-3302	138	40	of	of	ADP
iajs-3302	138	41	medicine	medicine	NOUN
iajs-3302	138	42	.	.	PUNCT
iajs-3302	139	1	references	reference	NOUN
iajs-3302	139	2	1	1	NUM
iajs-3302	139	3	.	.	PUNCT
iajs-3302	139	4	koska	koska	PROPN
iajs-3302	139	5	,	,	PUNCT
iajs-3302	139	6	j.	j.	PROPN
iajs-3302	139	7	;	;	PUNCT
iajs-3302	139	8	gerstein	gerstein	PROPN
iajs-3302	139	9	,	,	PUNCT
iajs-3302	139	10	h.c	h.c	PROPN
iajs-3302	139	11	.	.	PUNCT
iajs-3302	139	12	;	;	PUNCT
iajs-3302	139	13	beisswenger	beisswenger	PROPN
iajs-3302	139	14	p.j	p.j	PROPN
iajs-3302	139	15	;	;	PUNCT
iajs-3302	139	16	reaven	reaven	VERB
iajs-3302	139	17	,	,	PUNCT
iajs-3302	139	18	p.d	p.d	PROPN
iajs-3302	139	19	.	.	PROPN
iajs-3302	139	20	advanced	advanced	ADJ
iajs-3302	139	21	glycation	glycation	NOUN
iajs-3302	139	22	end	end	NOUN
iajs-3302	139	23	products	product	NOUN
iajs-3302	139	24	predict	predict	VERB
iajs-3302	139	25	loss	loss	NOUN
iajs-3302	139	26	of	of	ADP
iajs-3302	139	27	renal	renal	ADJ
iajs-3302	139	28	function	function	NOUN
iajs-3302	139	29	and	and	CCONJ
iajs-3302	139	30	high	high	ADJ
iajs-3302	139	31	-	-	PUNCT
iajs-3302	139	32	risk	risk	NOUN
iajs-3302	139	33	chronic	chronic	ADJ
iajs-3302	139	34	kidney	kidney	NOUN
iajs-3302	139	35	disease	disease	NOUN
iajs-3302	139	36	in	in	ADP
iajs-3302	139	37	type	type	NOUN
iajs-3302	139	38	2	2	NUM
iajs-3302	139	39	diabetes	diabetes	NOUN
iajs-3302	139	40	.	.	PUNCT
iajs-3302	140	1	diabetes	diabetes	NOUN
iajs-3302	140	2	care	care	VERB
iajs-3302	140	3	2022	2022	NUM
iajs-3302	140	4	,	,	PUNCT
iajs-3302	140	5	45(3),684	45(3),684	NUM
iajs-3302	140	6	-	-	SYM
iajs-3302	140	7	691	691	NUM
iajs-3302	140	8	.	.	PUNCT
iajs-3302	141	1	https://doi.org/10.2337/dc21-2196	https://doi.org/10.2337/dc21-2196	PROPN
iajs-3302	141	2	.	.	PUNCT
iajs-3302	142	1	2	2	NUM
iajs-3302	142	2	.	.	X
iajs-3302	142	3	shao	shao	PROPN
iajs-3302	142	4	,	,	PUNCT
iajs-3302	142	5	y.	y.	PROPN
iajs-3302	142	6	;	;	PUNCT
iajs-3302	142	7	shi	shi	PROPN
iajs-3302	142	8	,	,	PUNCT
iajs-3302	142	9	x.	x.	NOUN
iajs-3302	142	10	bibliometric	bibliometric	ADJ
iajs-3302	142	11	analysis	analysis	NOUN
iajs-3302	142	12	and	and	CCONJ
iajs-3302	142	13	visualization	visualization	NOUN
iajs-3302	142	14	of	of	ADP
iajs-3302	142	15	research	research	NOUN
iajs-3302	142	16	progress	progress	NOUN
iajs-3302	142	17	in	in	ADP
iajs-3302	142	18	the	the	DET
iajs-3302	142	19	diabetic	diabetic	ADJ
iajs-3302	142	20	nephropathy	nephropathy	ADJ
iajs-3302	142	21	field	field	NOUN
iajs-3302	142	22	from	from	ADP
iajs-3302	142	23	2001	2001	NUM
iajs-3302	142	24	to	to	ADP
iajs-3302	142	25	2021	2021	NUM
iajs-3302	142	26	.	.	PUNCT
iajs-3302	143	1	oxidative	oxidative	ADJ
iajs-3302	143	2	medicine	medicine	NOUN
iajs-3302	143	3	and	and	CCONJ
iajs-3302	143	4	cellular	cellular	ADJ
iajs-3302	143	5	longevity	longevity	NOUN
iajs-3302	143	6	2023	2023	NUM
iajs-3302	143	7	,	,	PUNCT
iajs-3302	143	8	4555609	4555609	NUM
iajs-3302	143	9	,	,	PUNCT
iajs-3302	143	10	1	1	NUM
iajs-3302	143	11	-	-	SYM
iajs-3302	143	12	16	16	NUM
iajs-3302	143	13	.	.	PUNCT
iajs-3302	144	1	https://doi.org/10.1155/2023/4555609	https://doi.org/10.1155/2023/4555609	NOUN
iajs-3302	144	2	.	.	PUNCT
iajs-3302	145	1	3	3	X
iajs-3302	145	2	.	.	X
iajs-3302	145	3	das	das	PROPN
iajs-3302	145	4	,	,	PUNCT
iajs-3302	145	5	s.	s.	PROPN
iajs-3302	145	6	;	;	PUNCT
iajs-3302	145	7	ramanathan	ramanathan	PROPN
iajs-3302	145	8	,	,	PUNCT
iajs-3302	145	9	g.	g.	PROPN
iajs-3302	145	10	intestinal	intestinal	ADJ
iajs-3302	145	11	microbiome	microbiome	NOUN
iajs-3302	145	12	diversity	diversity	NOUN
iajs-3302	145	13	of	of	ADP
iajs-3302	145	14	diabetic	diabetic	ADJ
iajs-3302	145	15	and	and	CCONJ
iajs-3302	145	16	non	non	ADJ
iajs-3302	145	17	-	-	ADJ
iajs-3302	145	18	diabetic	diabetic	ADJ
iajs-3302	145	19	kidney	kidney	NOUN
iajs-3302	145	20	disease	disease	NOUN
iajs-3302	145	21	:	:	PUNCT
iajs-3302	145	22	current	current	ADJ
iajs-3302	145	23	status	status	NOUN
iajs-3302	145	24	and	and	CCONJ
iajs-3302	145	25	future	future	ADJ
iajs-3302	145	26	perspective	perspective	NOUN
iajs-3302	145	27	.	.	PUNCT
iajs-3302	146	1	life	life	NOUN
iajs-3302	146	2	sciences	science	NOUN
iajs-3302	146	3	2023	2023	NUM
iajs-3302	146	4	,	,	PUNCT
iajs-3302	146	5	316,121414	316,121414	NUM
iajs-3302	146	6	.	.	PUNCT
iajs-3302	147	1	https://doi.org/10.1016/j.lfs.2023.121414	https://doi.org/10.1016/j.lfs.2023.121414	PROPN
iajs-3302	147	2	.	.	PUNCT
iajs-3302	148	1	4	4	X
iajs-3302	148	2	.	.	X
iajs-3302	148	3	jiang	jiang	PROPN
iajs-3302	148	4	,	,	PUNCT
iajs-3302	148	5	s.	s.	PROPN
iajs-3302	148	6	;	;	PUNCT
iajs-3302	148	7	fang	fang	X
iajs-3302	148	8	,	,	PUNCT
iajs-3302	148	9	j.	j.	PROPN
iajs-3302	148	10	;	;	PUNCT
iajs-3302	148	11	li	li	PROPN
iajs-3302	148	12	,	,	PUNCT
iajs-3302	148	13	w.	w.	NOUN
iajs-3302	148	14	protein	protein	NOUN
iajs-3302	148	15	restriction	restriction	NOUN
iajs-3302	148	16	for	for	ADP
iajs-3302	148	17	diabetic	diabetic	ADJ
iajs-3302	148	18	kidney	kidney	NOUN
iajs-3302	148	19	disease	disease	NOUN
iajs-3302	148	20	.	.	PUNCT
iajs-3302	149	1	cochrane	cochrane	NOUN
iajs-3302	149	2	database	database	NOUN
iajs-3302	149	3	of	of	ADP
iajs-3302	149	4	systematic	systematic	ADJ
iajs-3302	149	5	reviews	review	NOUN
iajs-3302	149	6	2023	2023	NUM
iajs-3302	149	7	,	,	PUNCT
iajs-3302	149	8	1(1),cd014906	1(1),cd014906	NUM
iajs-3302	149	9	.	.	PUNCT
iajs-3302	149	10	https://doi.org/10.1002/14651858.cd014906.pub2	https://doi.org/10.1002/14651858.cd014906.pub2	NOUN
iajs-3302	149	11	.	.	PROPN
iajs-3302	150	1	5	5	NUM
iajs-3302	150	2	.	.	X
iajs-3302	150	3	kučuk	kučuk	PROPN
iajs-3302	150	4	,	,	PUNCT
iajs-3302	150	5	n.	n.	PROPN
iajs-3302	150	6	;	;	PUNCT
iajs-3302	150	7	primozic	primozic	PROPN
iajs-3302	150	8	,	,	PUNCT
iajs-3302	150	9	m.	m.	NOUN
iajs-3302	150	10	;	;	PUNCT
iajs-3302	150	11	knez	knez	PROPN
iajs-3302	150	12	z	z	X
iajs-3302	150	13	,	,	PUNCT
iajs-3302	150	14	;	;	PUNCT
iajs-3302	150	15	leitgeb	leitgeb	NOUN
iajs-3302	150	16	,	,	PUNCT
iajs-3302	150	17	m	m	PRON
iajs-3302	150	18	..	..	PUNCT
iajs-3302	150	19	sustainable	sustainable	ADJ
iajs-3302	150	20	biodegradable	biodegradable	ADJ
iajs-3302	150	21	biopolymer	biopolymer	NOUN
iajs-3302	150	22	-	-	PUNCT
iajs-3302	150	23	based	base	VERB
iajs-3302	150	24	nanoparticles	nanoparticle	NOUN
iajs-3302	150	25	for	for	ADP
iajs-3302	150	26	healthcare	healthcare	NOUN
iajs-3302	150	27	applications	application	NOUN
iajs-3302	150	28	.	.	PUNCT
iajs-3302	151	1	international	international	ADJ
iajs-3302	151	2	journal	journal	NOUN
iajs-3302	151	3	of	of	ADP
iajs-3302	151	4	molecular	molecular	ADJ
iajs-3302	151	5	sciences	science	NOUN
iajs-3302	151	6	2023	2023	NUM
iajs-3302	151	7	,	,	PUNCT
iajs-3302	151	8	24(4	24(4	NUM
iajs-3302	151	9	)	)	PUNCT
iajs-3302	151	10	,	,	PUNCT
iajs-3302	151	11	3188	3188	NUM
iajs-3302	151	12	.	.	PUNCT
iajs-3302	152	1	https://doi.org/10.3390/ijms2404318	https://doi.org/10.3390/ijms2404318	PROPN
iajs-3302	152	2	.	.	PUNCT
iajs-3302	153	1	6	6	NUM
iajs-3302	153	2	.	.	X
iajs-3302	153	3	suzumoto	suzumoto	PROPN
iajs-3302	153	4	,	,	PUNCT
iajs-3302	153	5	y.	y.	PROPN
iajs-3302	153	6	;	;	PUNCT
iajs-3302	153	7	zucaro	zucaro	X
iajs-3302	153	8	,	,	PUNCT
iajs-3302	153	9	l.	l.	PROPN
iajs-3302	153	10	;	;	PUNCT
iajs-3302	153	11	iervolino	iervolino	PROPN
iajs-3302	153	12	,	,	PUNCT
iajs-3302	153	13	a.	a.	NOUN
iajs-3302	153	14	;	;	PUNCT
iajs-3302	153	15	capasso	capasso	PROPN
iajs-3302	153	16	,	,	PUNCT
iajs-3302	153	17	g.	g.	PROPN
iajs-3302	153	18	kidney	kidney	PROPN
iajs-3302	153	19	and	and	CCONJ
iajs-3302	153	20	blood	blood	NOUN
iajs-3302	153	21	pressure	pressure	NOUN
iajs-3302	153	22	regulation	regulation	NOUN
iajs-3302	153	23	–	–	PUNCT
iajs-3302	153	24	latest	late	ADJ
iajs-3302	153	25	evidence	evidence	NOUN
iajs-3302	153	26	for	for	ADP
iajs-3302	153	27	molecular	molecular	ADJ
iajs-3302	153	28	mechanisms	mechanism	NOUN
iajs-3302	153	29	.	.	PUNCT
iajs-3302	154	1	clinical	clinical	ADJ
iajs-3302	154	2	kidney	kidney	PROPN
iajs-3302	154	3	journal	journal	NOUN
iajs-3302	154	4	2023	2023	NUM
iajs-3302	154	5	,	,	PUNCT
iajs-3302	154	6	16(6),952	16(6),952	NUM
iajs-3302	154	7	-	-	SYM
iajs-3302	154	8	964	964	NUM
iajs-3302	154	9	.	.	PUNCT
iajs-3302	155	1	https://doi.org/10.1093/ckj/sfad015	https://doi.org/10.1093/ckj/sfad015	PROPN
iajs-3302	155	2	.	.	PUNCT
iajs-3302	156	1	7	7	NUM
iajs-3302	156	2	.	.	NUM
iajs-3302	156	3	linh	linh	PROPN
iajs-3302	156	4	,	,	PUNCT
iajs-3302	156	5	h.t	h.t	PROPN
iajs-3302	156	6	.	.	PROPN
iajs-3302	156	7	;	;	PUNCT
iajs-3302	156	8	iwata	iwata	PROPN
iajs-3302	156	9	,	,	PUNCT
iajs-3302	156	10	y.	y.	PROPN
iajs-3302	156	11	;	;	PUNCT
iajs-3302	156	12	senda	senda	PROPN
iajs-3302	156	13	,	,	PUNCT
iajs-3302	156	14	y.	y.	PROPN
iajs-3302	156	15	;	;	PUNCT
iajs-3302	156	16	sakai	sakai	NOUN
iajs-3302	156	17	-	-	PUNCT
iajs-3302	156	18	takemori	takemori	PROPN
iajs-3302	156	19	,	,	PUNCT
iajs-3302	156	20	y.	y.	NOUN
iajs-3302	156	21	;	;	PUNCT
iajs-3302	156	22	nakade	nakade	NOUN
iajs-3302	156	23	,	,	PUNCT
iajs-3302	156	24	y.	y.	PROPN
iajs-3302	156	25	;	;	PUNCT
iajs-3302	156	26	oshima	oshima	PROPN
iajs-3302	156	27	,	,	PUNCT
iajs-3302	156	28	m.	m.	NOUN
iajs-3302	156	29	;	;	PUNCT
iajs-3302	156	30	nakagawa	nakagawa	PROPN
iajs-3302	156	31	-	-	PUNCT
iajs-3302	156	32	yoneda	yoneda	PROPN
iajs-3302	156	33	,	,	PUNCT
iajs-3302	156	34	s.	s.	PROPN
iajs-3302	156	35	;	;	PUNCT
iajs-3302	156	36	ogura	ogura	PROPN
iajs-3302	156	37	,	,	PUNCT
iajs-3302	156	38	h.	h.	PROPN
iajs-3302	156	39	;	;	PUNCT
iajs-3302	156	40	sato	sato	PROPN
iajs-3302	156	41	,	,	PUNCT
iajs-3302	156	42	k.	k.	PROPN
iajs-3302	156	43	;	;	PUNCT
iajs-3302	156	44	minami	minami	PROPN
iajs-3302	156	45	,	,	PUNCT
iajs-3302	156	46	t.	t.	PROPN
iajs-3302	156	47	;	;	PUNCT
iajs-3302	156	48	kitajima	kitajima	PROPN
iajs-3302	156	49	,	,	PUNCT
iajs-3302	156	50	s.	s.	PROPN
iajs-3302	156	51	intestinal	intestinal	PROPN
iajs-3302	156	52	bacterial	bacterial	ADJ
iajs-3302	156	53	translocation	translocation	NOUN
iajs-3302	156	54	contributes	contribute	VERB
iajs-3302	156	55	to	to	ADP
iajs-3302	156	56	diabetic	diabetic	ADJ
iajs-3302	156	57	kidney	kidney	NOUN
iajs-3302	156	58	disease	disease	NOUN
iajs-3302	156	59	.	.	PUNCT
iajs-3302	157	1	journal	journal	NOUN
iajs-3302	157	2	of	of	ADP
iajs-3302	157	3	the	the	DET
iajs-3302	157	4	american	american	ADJ
iajs-3302	157	5	society	society	NOUN
iajs-3302	157	6	of	of	ADP
iajs-3302	157	7	nephrology	nephrology	NOUN
iajs-3302	157	8	2022	2022	NUM
iajs-3302	157	9	,	,	PUNCT
iajs-3302	157	10	33(6),1105	33(6),1105	NUM
iajs-3302	157	11	-	-	SYM
iajs-3302	157	12	1119	1119	NUM
iajs-3302	157	13	.	.	PUNCT
iajs-3302	158	1	https://doi	https://doi	ADJ
iajs-3302	158	2	:	:	PUNCT
iajs-3302	158	3	10.1681	10.1681	NUM
iajs-3302	158	4	/	/	SYM
iajs-3302	158	5	asn.2021060843	asn.2021060843	NOUN
iajs-3302	158	6	.	.	NOUN
iajs-3302	159	1	8	8	X
iajs-3302	159	2	.	.	X
iajs-3302	160	1	fawcett	fawcett	PROPN
iajs-3302	160	2	,	,	PUNCT
iajs-3302	160	3	j.	j.	PROPN
iajs-3302	160	4	;	;	PUNCT
iajs-3302	160	5	scott	scott	PROPN
iajs-3302	160	6	,	,	PUNCT
iajs-3302	160	7	j.a	j.a	PROPN
iajs-3302	160	8	.	.	PROPN
iajs-3302	160	9	rapid	rapid	ADJ
iajs-3302	160	10	and	and	CCONJ
iajs-3302	160	11	precise	precise	ADJ
iajs-3302	160	12	method	method	NOUN
iajs-3302	160	13	for	for	ADP
iajs-3302	160	14	the	the	DET
iajs-3302	160	15	determination	determination	NOUN
iajs-3302	160	16	of	of	ADP
iajs-3302	160	17	urea	urea	NOUN
iajs-3302	160	18	.	.	PUNCT
iajs-3302	161	1	journal	journal	NOUN
iajs-3302	161	2	of	of	ADP
iajs-3302	161	3	clinical	clinical	ADJ
iajs-3302	161	4	pathology	pathology	NOUN
iajs-3302	161	5	1960	1960	NUM
iajs-3302	161	6	,	,	PUNCT
iajs-3302	161	7	13(2),156	13(2),156	NUM
iajs-3302	161	8	-	-	SYM
iajs-3302	161	9	159	159	NUM
iajs-3302	161	10	.	.	PUNCT
iajs-3302	162	1	https://doi.org/10.1136%2fjcp.13.2.156	https://doi.org/10.1136%2fjcp.13.2.156	NOUN
iajs-3302	162	2	.	.	PUNCT
iajs-3302	163	1	9	9	X
iajs-3302	163	2	.	.	X
iajs-3302	163	3	ikejezie	ikejezie	PROPN
iajs-3302	163	4	,	,	PUNCT
iajs-3302	163	5	j.	j.	PROPN
iajs-3302	163	6	;	;	PUNCT
iajs-3302	163	7	langley	langley	PROPN
iajs-3302	163	8	,	,	PUNCT
iajs-3302	163	9	t.	t.	PROPN
iajs-3302	163	10	;	;	PUNCT
iajs-3302	163	11	lewis	lewis	PROPN
iajs-3302	163	12	,	,	PUNCT
iajs-3302	163	13	s.	s.	PROPN
iajs-3302	163	14	;	;	PUNCT
iajs-3302	163	15	bisanzio	bisanzio	PROPN
iajs-3302	163	16	,	,	PUNCT
iajs-3302	163	17	d.	d.	PROPN
iajs-3302	163	18	;	;	PUNCT
iajs-3302	163	19	phalkey	phalkey	PROPN
iajs-3302	163	20	,	,	PUNCT
iajs-3302	163	21	r.	r.	VERB
iajs-3302	163	22	the	the	DET
iajs-3302	163	23	epidemiology	epidemiology	NOUN
iajs-3302	163	24	of	of	ADP
iajs-3302	163	25	diphtheria	diphtheria	NOUN
iajs-3302	163	26	in	in	ADP
iajs-3302	163	27	haiti	haiti	PROPN
iajs-3302	163	28	,	,	PUNCT
iajs-3302	163	29	december	december	PROPN
iajs-3302	163	30	2014	2014	NUM
iajs-3302	163	31	–	–	PUNCT
iajs-3302	163	32	june	june	PROPN
iajs-3302	163	33	2021	2021	NUM
iajs-3302	163	34	:	:	PUNCT
iajs-3302	163	35	a	a	DET
iajs-3302	163	36	spatial	spatial	ADJ
iajs-3302	163	37	modeling	modeling	NOUN
iajs-3302	163	38	analysis	analysis	NOUN
iajs-3302	163	39	.	.	PUNCT
iajs-3302	164	1	plos	plos	PROPN
iajs-3302	164	2	one	one	NUM
iajs-3302	164	3	2022	2022	NUM
iajs-3302	164	4	,	,	PUNCT
iajs-3302	164	5	17(8),e0273398	17(8),e0273398	NUM
iajs-3302	164	6	.	.	PUNCT
iajs-3302	165	1	https://doi.org/10.1371/journal.pone.0273398	https://doi.org/10.1371/journal.pone.0273398	NOUN
iajs-3302	165	2	.	.	PUNCT
iajs-3302	166	1	10	10	NUM
iajs-3302	166	2	.	.	PUNCT
iajs-3302	166	3	pérez	pérez	NOUN
iajs-3302	166	4	-	-	PUNCT
iajs-3302	166	5	morales	morale	NOUN
iajs-3302	166	6	,	,	PUNCT
iajs-3302	166	7	r.e	r.e	PROPN
iajs-3302	166	8	.	.	PROPN
iajs-3302	166	9	;	;	PUNCT
iajs-3302	166	10	del	del	PROPN
iajs-3302	166	11	pino	pino	PROPN
iajs-3302	166	12	,	,	PUNCT
iajs-3302	166	13	m.d	m.d	PROPN
iajs-3302	166	14	.	.	PROPN
iajs-3302	166	15	;	;	PUNCT
iajs-3302	166	16	valdivielso	valdivielso	ADJ
iajs-3302	166	17	,	,	PUNCT
iajs-3302	166	18	j.m	j.m	PROPN
iajs-3302	166	19	.	.	PROPN
iajs-3302	166	20	;	;	PUNCT
iajs-3302	166	21	ortiz	ortiz	PROPN
iajs-3302	166	22	,	,	PUNCT
iajs-3302	166	23	a.	a.	PROPN
iajs-3302	166	24	;	;	PUNCT
iajs-3302	166	25	mora	mora	PROPN
iajs-3302	166	26	-	-	PUNCT
iajs-3302	166	27	fernández	fernández	PROPN
iajs-3302	166	28	,	,	PUNCT
iajs-3302	166	29	c.	c.	PROPN
iajs-3302	166	30	;	;	PUNCT
iajs-3302	166	31	navarrogonzález	navarrogonzález	PROPN
iajs-3302	166	32	,	,	PUNCT
iajs-3302	166	33	j.f	j.f	PROPN
iajs-3302	166	34	.	.	PROPN
iajs-3302	166	35	inflammation	inflammation	NOUN
iajs-3302	166	36	in	in	ADP
iajs-3302	166	37	diabetic	diabetic	ADJ
iajs-3302	166	38	kidney	kidney	NOUN
iajs-3302	166	39	disease	disease	NOUN
iajs-3302	166	40	.	.	PUNCT
iajs-3302	167	1	nephron	nephron	NOUN
iajs-3302	167	2	2019	2019	NUM
iajs-3302	167	3	,	,	PUNCT
iajs-3302	167	4	143(1),12	143(1),12	NUM
iajs-3302	167	5	-	-	SYM
iajs-3302	167	6	16	16	NUM
iajs-3302	167	7	.	.	PUNCT
iajs-3302	168	1	https://doi.org/10.1159/000493278	https://doi.org/10.1159/000493278	ADJ
iajs-3302	168	2	.	.	PUNCT
iajs-3302	169	1	11	11	NUM
iajs-3302	169	2	.	.	PUNCT
iajs-3302	170	1	fernandez	fernandez	NOUN
iajs-3302	170	2	-	-	PUNCT
iajs-3302	170	3	fernandez	fernandez	PROPN
iajs-3302	170	4	,	,	PUNCT
iajs-3302	170	5	b.	b.	PROPN
iajs-3302	170	6	;	;	PUNCT
iajs-3302	170	7	fernandez	fernandez	PROPN
iajs-3302	170	8	-	-	PUNCT
iajs-3302	170	9	prado	prado	PROPN
iajs-3302	170	10	,	,	PUNCT
iajs-3302	170	11	r.	r.	PROPN
iajs-3302	170	12	;	;	PUNCT
iajs-3302	170	13	górriz	górriz	PROPN
iajs-3302	170	14	,	,	PUNCT
iajs-3302	170	15	j.l	j.l	PROPN
iajs-3302	170	16	.	.	PROPN
iajs-3302	170	17	;	;	PUNCT
iajs-3302	170	18	martinez	martinez	PROPN
iajs-3302	170	19	-	-	PUNCT
iajs-3302	170	20	castelao	castelao	PROPN
iajs-3302	170	21	,	,	PUNCT
iajs-3302	170	22	a.	a.	NOUN
iajs-3302	170	23	;	;	PUNCT
iajs-3302	170	24	navarrogonzalez	navarrogonzalez	PROPN
iajs-3302	170	25	,	,	PUNCT
iajs-3302	170	26	j.f	j.f	PROPN
iajs-3302	170	27	.	.	PROPN
iajs-3302	170	28	;	;	PUNCT
iajs-3302	170	29	porrini	porrini	PROPN
iajs-3302	170	30	,	,	PUNCT
iajs-3302	170	31	e.	e.	PROPN
iajs-3302	170	32	;	;	PUNCT
iajs-3302	170	33	soler	soler	PROPN
iajs-3302	170	34	,	,	PUNCT
iajs-3302	170	35	m.j	m.j	PROPN
iajs-3302	170	36	.	.	PROPN
iajs-3302	170	37	;	;	PUNCT
iajs-3302	170	38	ortiz	ortiz	PROPN
iajs-3302	170	39	,	,	PUNCT
iajs-3302	170	40	a.	a.	NOUN
iajs-3302	170	41	canagliflozin	canagliflozin	PROPN
iajs-3302	170	42	and	and	CCONJ
iajs-3302	170	43	renal	renal	ADJ
iajs-3302	170	44	events	event	NOUN
iajs-3302	170	45	in	in	ADP
iajs-3302	170	46	diabetes	diabetes	NOUN
iajs-3302	170	47	with	with	ADP
iajs-3302	170	48	established	establish	VERB
iajs-3302	170	49	nephropathy	nephropathy	ADJ
iajs-3302	170	50	clinical	clinical	ADJ
iajs-3302	170	51	evaluation	evaluation	NOUN
iajs-3302	170	52	and	and	CCONJ
iajs-3302	170	53	study	study	NOUN
iajs-3302	170	54	of	of	ADP
iajs-3302	170	55	diabetic	diabetic	ADJ
iajs-3302	170	56	nephropathy	nephropathy	NOUN
iajs-3302	170	57	with	with	ADP
iajs-3302	170	58	atrasentan	atrasentan	ADJ
iajs-3302	170	59	:	:	PUNCT
iajs-3302	170	60	what	what	PRON
iajs-3302	170	61	was	be	AUX
iajs-3302	170	62	learned	learn	VERB
iajs-3302	170	63	about	about	ADP
iajs-3302	170	64	the	the	DET
iajs-3302	170	65	treatment	treatment	NOUN
iajs-3302	170	66	of	of	ADP
iajs-3302	170	67	diabetic	diabetic	ADJ
iajs-3302	170	68	kidney	kidney	NOUN
iajs-3302	170	69	disease	disease	NOUN
iajs-3302	170	70	with	with	ADP
iajs-3302	170	71	canagliflozin	canagliflozin	NOUN
iajs-3302	170	72	and	and	CCONJ
iajs-3302	170	73	atrasentan	atrasentan	ADJ
iajs-3302	170	74	?	?	PUNCT
iajs-3302	171	1	clinical	clinical	ADJ
iajs-3302	171	2	kidney	kidney	PROPN
iajs-3302	171	3	journal	journal	PROPN
iajs-3302	171	4	2019	2019	NUM
iajs-3302	171	5	,	,	PUNCT
iajs-3302	171	6	12(3),313	12(3),313	NUM
iajs-3302	171	7	-	-	SYM
iajs-3302	171	8	321	321	NUM
iajs-3302	171	9	.	.	PUNCT
iajs-3302	172	1	https://doi.org/10.1093/ckj/sfz070	https://doi.org/10.1093/ckj/sfz070	PROPN
iajs-3302	172	2	.	.	PUNCT
iajs-3302	173	1	12	12	NUM
iajs-3302	173	2	.	.	PUNCT
iajs-3302	174	1	navaneethan	navaneethan	PROPN
iajs-3302	174	2	,	,	PUNCT
iajs-3302	174	3	s.d	s.d	PROPN
iajs-3302	174	4	.	.	PROPN
iajs-3302	174	5	;	;	PUNCT
iajs-3302	174	6	zoungas	zoungas	PROPN
iajs-3302	174	7	,	,	PUNCT
iajs-3302	174	8	s.	s.	PROPN
iajs-3302	174	9	;	;	PUNCT
iajs-3302	174	10	caramori	caramori	X
iajs-3302	174	11	,	,	PUNCT
iajs-3302	174	12	m.l	m.l	PROPN
iajs-3302	174	13	.	.	PROPN
iajs-3302	174	14	;	;	PUNCT
iajs-3302	174	15	chan	chan	PROPN
iajs-3302	174	16	,	,	PUNCT
iajs-3302	174	17	j.c	j.c	PROPN
iajs-3302	174	18	.	.	PROPN
iajs-3302	174	19	;	;	PUNCT
iajs-3302	174	20	heerspink	heerspink	PROPN
iajs-3302	174	21	,	,	PUNCT
iajs-3302	174	22	h.j	h.j	PROPN
iajs-3302	174	23	.	.	PROPN
iajs-3302	174	24	;	;	PUNCT
iajs-3302	174	25	hurst	hurst	PROPN
iajs-3302	174	26	,	,	PUNCT
iajs-3302	174	27	c.	c.	PROPN
iajs-3302	174	28	;	;	PUNCT
iajs-3302	174	29	liew	liew	PROPN
iajs-3302	174	30	,	,	PUNCT
iajs-3302	174	31	a.	a.	PROPN
iajs-3302	174	32	;	;	PUNCT
iajs-3302	174	33	michos	michos	PROPN
iajs-3302	174	34	,	,	PUNCT
iajs-3302	174	35	e.d	e.d	PROPN
iajs-3302	174	36	.	.	PROPN
iajs-3302	174	37	;	;	PUNCT
iajs-3302	174	38	olowu	olowu	PROPN
iajs-3302	174	39	,	,	PUNCT
iajs-3302	174	40	w.a	w.a	PROPN
iajs-3302	174	41	.	.	PROPN
iajs-3302	174	42	;	;	PUNCT
iajs-3302	174	43	sadusky	sadusky	VERB
iajs-3302	174	44	,	,	PUNCT
iajs-3302	174	45	t.	t.	PROPN
iajs-3302	174	46	;	;	PUNCT
iajs-3302	174	47	tandon	tandon	PROPN
iajs-3302	174	48	,	,	PUNCT
iajs-3302	174	49	n.	n.	PROPN
iajs-3302	174	50	diabetes	diabetes	NOUN
iajs-3302	174	51	management	management	NOUN
iajs-3302	174	52	in	in	ADP
iajs-3302	174	53	chronic	chronic	ADJ
iajs-3302	174	54	kidney	kidney	NOUN
iajs-3302	174	55	disease	disease	NOUN
iajs-3302	174	56	:	:	PUNCT
iajs-3302	174	57	synopsis	synopsis	NOUN
iajs-3302	174	58	of	of	ADP
iajs-3302	174	59	the	the	DET
iajs-3302	174	60	2020	2020	NUM
iajs-3302	174	61	kdigo	kdigo	PROPN
iajs-3302	174	62	clinical	clinical	ADJ
iajs-3302	174	63	practice	practice	NOUN
iajs-3302	174	64	guideline	guideline	NOUN
iajs-3302	174	65	.	.	PUNCT
iajs-3302	175	1	annals	annal	NOUN
iajs-3302	175	2	of	of	ADP
iajs-3302	175	3	internal	internal	ADJ
iajs-3302	175	4	medicine	medicine	NOUN
iajs-3302	175	5	2021	2021	NUM
iajs-3302	175	6	,	,	PUNCT
iajs-3302	175	7	174(3),385	174(3),385	NUM
iajs-3302	175	8	-	-	SYM
iajs-3302	175	9	94	94	NUM
iajs-3302	175	10	.	.	PUNCT
iajs-3302	176	1	https://doi.org/10.7326/m20-5938	https://doi.org/10.7326/m20-5938	ADV
iajs-3302	176	2	.	.	PUNCT
iajs-3302	177	1	https://doi.org/10.2337/dc21-2196	https://doi.org/10.2337/dc21-2196	PROPN
iajs-3302	177	2	.	.	PUNCT
iajs-3302	178	1	https://doi.org/10.1155/2023/4555609	https://doi.org/10.1155/2023/4555609	NOUN
iajs-3302	178	2	.	.	PUNCT
iajs-3302	179	1	https://doi.org/10.1016/j.lfs.2023.121414	https://doi.org/10.1016/j.lfs.2023.121414	PROPN
iajs-3302	179	2	.	.	PUNCT
iajs-3302	180	1	https://doi.org/10.1002/14651858.cd014906.pub2	https://doi.org/10.1002/14651858.cd014906.pub2	NOUN
iajs-3302	180	2	.	.	PUNCT
iajs-3302	181	1	https://doi.org/10.3390/ijms2404318	https://doi.org/10.3390/ijms2404318	PROPN
iajs-3302	181	2	.	.	PUNCT
iajs-3302	182	1	https://doi.org/10.1093/ckj/sfad015	https://doi.org/10.1093/ckj/sfad015	PROPN
iajs-3302	182	2	.	.	PUNCT
iajs-3302	182	3	https://doi:%2010.1681	https://doi:%2010.1681	PROPN
iajs-3302	182	4	/	/	SYM
iajs-3302	182	5	asn.2021060843	asn.2021060843	PROPN
iajs-3302	182	6	.	.	PUNCT
iajs-3302	183	1	https://doi.org/10.1136%2fjcp.13.2.156	https://doi.org/10.1136%2fjcp.13.2.156	PROPN
iajs-3302	183	2	.	.	PUNCT
iajs-3302	184	1	https://doi.org/10.1371/journal.pone.0273398	https://doi.org/10.1371/journal.pone.0273398	NOUN
iajs-3302	184	2	.	.	PUNCT
iajs-3302	185	1	https://doi.org/10.1159/000493278	https://doi.org/10.1159/000493278	PROPN
iajs-3302	185	2	.	.	PUNCT
iajs-3302	186	1	https://doi.org/10.1093/ckj/sfz070	https://doi.org/10.1093/ckj/sfz070	PROPN
iajs-3302	186	2	.	.	PUNCT
iajs-3302	187	1	https://doi.org/10.7326/m20-5938	https://doi.org/10.7326/m20-5938	PRON
iajs-3302	187	2	.	.	PUNCT
iajs-3302	187	3	ihjpas	ihjpas	PROPN
iajs-3302	187	4	.	.	PUNCT
iajs-3302	188	1	37	37	NUM
iajs-3302	188	2	(	(	PUNCT
iajs-3302	188	3	2	2	NUM
iajs-3302	188	4	)	)	PUNCT
iajs-3302	188	5	2024	2024	NUM
iajs-3302	188	6	268	268	NUM
iajs-3302	188	7	13	13	NUM
iajs-3302	188	8	.	.	PUNCT
iajs-3302	189	1	zhuge	zhuge	PROPN
iajs-3302	189	2	,	,	PUNCT
iajs-3302	189	3	z.	z.	PROPN
iajs-3302	189	4	;	;	PUNCT
iajs-3302	189	5	haworth	haworth	PROPN
iajs-3302	189	6	,	,	PUNCT
iajs-3302	189	7	s.m	s.m	PROPN
iajs-3302	189	8	.	.	PROPN
iajs-3302	189	9	;	;	PUNCT
iajs-3302	189	10	nihlén	nihlén	PROPN
iajs-3302	189	11	,	,	PUNCT
iajs-3302	189	12	c.	c.	PROPN
iajs-3302	189	13	;	;	PUNCT
iajs-3302	189	14	carvalho	carvalho	PROPN
iajs-3302	189	15	,	,	PUNCT
iajs-3302	189	16	l.r	l.r	PROPN
iajs-3302	189	17	.	.	PROPN
iajs-3302	189	18	;	;	PUNCT
iajs-3302	189	19	heuser	heuser	PROPN
iajs-3302	189	20	,	,	PUNCT
iajs-3302	189	21	s.k	s.k	PROPN
iajs-3302	189	22	.	.	PROPN
iajs-3302	189	23	;	;	PUNCT
iajs-3302	189	24	kleschyov	kleschyov	PROPN
iajs-3302	189	25	,	,	PUNCT
iajs-3302	189	26	a.l	a.l	PROPN
iajs-3302	189	27	.	.	PROPN
iajs-3302	189	28	;	;	PUNCT
iajs-3302	189	29	nasiell	nasiell	PROPN
iajs-3302	189	30	,	,	PUNCT
iajs-3302	189	31	j.	j.	PROPN
iajs-3302	189	32	;	;	PUNCT
iajs-3302	189	33	cortese	cortese	PROPN
iajs-3302	189	34	-	-	PUNCT
iajs-3302	189	35	krott	krott	PROPN
iajs-3302	189	36	,	,	PUNCT
iajs-3302	189	37	m.m	m.m	PROPN
iajs-3302	189	38	.	.	PROPN
iajs-3302	189	39	;	;	PUNCT
iajs-3302	189	40	weitzberg	weitzberg	PROPN
iajs-3302	189	41	,	,	PUNCT
iajs-3302	189	42	e.	e.	PROPN
iajs-3302	189	43	;	;	PUNCT
iajs-3302	189	44	lundberg	lundberg	PROPN
iajs-3302	189	45	,	,	PUNCT
iajs-3302	189	46	j.o	j.o	PROPN
iajs-3302	189	47	.	.	PROPN
iajs-3302	189	48	;	;	PUNCT
iajs-3302	189	49	carlström	carlström	NOUN
iajs-3302	189	50	,	,	PUNCT
iajs-3302	189	51	m.	m.	NOUN
iajs-3302	189	52	red	red	ADJ
iajs-3302	189	53	blood	blood	NOUN
iajs-3302	189	54	cells	cell	NOUN
iajs-3302	189	55	from	from	ADP
iajs-3302	189	56	endothelial	endothelial	ADJ
iajs-3302	189	57	nitric	nitric	ADJ
iajs-3302	189	58	oxide	oxide	NOUN
iajs-3302	189	59	synthase	synthase	NOUN
iajs-3302	189	60	-	-	PUNCT
iajs-3302	189	61	deficient	deficient	ADJ
iajs-3302	189	62	mice	mouse	NOUN
iajs-3302	189	63	induce	induce	VERB
iajs-3302	189	64	vascular	vascular	ADJ
iajs-3302	189	65	dysfunction	dysfunction	NOUN
iajs-3302	189	66	involving	involve	VERB
iajs-3302	189	67	oxidative	oxidative	ADJ
iajs-3302	189	68	stress	stress	NOUN
iajs-3302	189	69	and	and	CCONJ
iajs-3302	189	70	endothelial	endothelial	NOUN
iajs-3302	189	71	arginase	arginase	PROPN
iajs-3302	189	72	i.	i.	PROPN
iajs-3302	189	73	redox	redox	PROPN
iajs-3302	189	74	biology	biology	NOUN
iajs-3302	189	75	2023	2023	NUM
iajs-3302	189	76	,	,	PUNCT
iajs-3302	189	77	60	60	NUM
iajs-3302	189	78	,	,	PUNCT
iajs-3302	189	79	102612	102612	NUM
iajs-3302	189	80	.	.	PUNCT
iajs-3302	190	1	https://doi.org/10.1016/j.redox.2023.102612	https://doi.org/10.1016/j.redox.2023.102612	PROPN
iajs-3302	190	2	.	.	PUNCT
iajs-3302	191	1	14	14	NUM
iajs-3302	191	2	.	.	X
iajs-3302	192	1	turner	turner	PROPN
iajs-3302	192	2	,	,	PUNCT
iajs-3302	192	3	c.g	c.g	PROPN
iajs-3302	192	4	.	.	PROPN
iajs-3302	192	5	;	;	PUNCT
iajs-3302	192	6	stanhewicz	stanhewicz	VERB
iajs-3302	192	7	,	,	PUNCT
iajs-3302	192	8	a.e	a.e	PROPN
iajs-3302	192	9	.	.	PROPN
iajs-3302	192	10	;	;	PUNCT
iajs-3302	192	11	nielsen	nielsen	PROPN
iajs-3302	192	12	,	,	PUNCT
iajs-3302	192	13	k.e	k.e	PROPN
iajs-3302	192	14	.	.	PROPN
iajs-3302	192	15	;	;	PUNCT
iajs-3302	192	16	otis	otis	PROPN
iajs-3302	192	17	,	,	PUNCT
iajs-3302	192	18	j.s	j.s	PROPN
iajs-3302	192	19	.	.	PROPN
iajs-3302	192	20	;	;	PUNCT
iajs-3302	192	21	feresin	feresin	PROPN
iajs-3302	192	22	,	,	PUNCT
iajs-3302	192	23	r.g	r.g	PROPN
iajs-3302	192	24	.	.	PROPN
iajs-3302	192	25	;	;	PUNCT
iajs-3302	192	26	wong	wong	PROPN
iajs-3302	192	27	,	,	PUNCT
iajs-3302	192	28	b.j	b.j	PROPN
iajs-3302	192	29	.	.	PROPN
iajs-3302	192	30	effects	effect	NOUN
iajs-3302	192	31	of	of	ADP
iajs-3302	192	32	biological	biological	ADJ
iajs-3302	192	33	sex	sex	NOUN
iajs-3302	192	34	and	and	CCONJ
iajs-3302	192	35	oral	oral	ADJ
iajs-3302	192	36	contraceptive	contraceptive	ADJ
iajs-3302	192	37	pill	pill	NOUN
iajs-3302	192	38	use	use	NOUN
iajs-3302	192	39	on	on	ADP
iajs-3302	192	40	cutaneous	cutaneous	ADJ
iajs-3302	192	41	microvascular	microvascular	ADJ
iajs-3302	192	42	endothelial	endothelial	ADJ
iajs-3302	192	43	function	function	NOUN
iajs-3302	192	44	and	and	CCONJ
iajs-3302	192	45	nitric	nitric	ADJ
iajs-3302	192	46	oxide	oxide	NOUN
iajs-3302	192	47	-	-	PUNCT
iajs-3302	192	48	dependent	dependent	ADJ
iajs-3302	192	49	vasodilation	vasodilation	NOUN
iajs-3302	192	50	in	in	ADP
iajs-3302	192	51	humans	human	NOUN
iajs-3302	192	52	.	.	PUNCT
iajs-3302	193	1	journal	journal	NOUN
iajs-3302	193	2	of	of	ADP
iajs-3302	193	3	applied	apply	VERB
iajs-3302	193	4	physiology	physiology	NOUN
iajs-3302	193	5	2023	2023	NUM
iajs-3302	193	6	,	,	PUNCT
iajs-3302	193	7	134(4),858	134(4),858	NOUN
iajs-3302	193	8	-	-	PUNCT
iajs-3302	193	9	867	867	NUM
iajs-3302	193	10	.	.	PUNCT
iajs-3302	194	1	https://doi.org/10.1152/japplphysiol.00586.2022	https://doi.org/10.1152/japplphysiol.00586.2022	NOUN
iajs-3302	194	2	.	.	NOUN
iajs-3302	194	3	15	15	NUM
iajs-3302	194	4	.	.	PUNCT
iajs-3302	194	5	wu	wu	PROPN
iajs-3302	194	6	,	,	PUNCT
iajs-3302	194	7	k.c	k.c	PROPN
iajs-3302	194	8	.	.	PROPN
iajs-3302	194	9	;	;	PUNCT
iajs-3302	194	10	cao	cao	PROPN
iajs-3302	194	11	,	,	PUNCT
iajs-3302	194	12	s.;weaver	s.;weaver	PROPN
iajs-3302	194	13	,	,	PUNCT
iajs-3302	194	14	c.m	c.m	PROPN
iajs-3302	194	15	.	.	PROPN
iajs-3302	194	16	;	;	PUNCT
iajs-3302	194	17	king	king	PROPN
iajs-3302	194	18	,	,	PUNCT
iajs-3302	194	19	n.j	n.j	PROPN
iajs-3302	194	20	.	.	PROPN
iajs-3302	194	21	;	;	PUNCT
iajs-3302	194	22	patel	patel	PROPN
iajs-3302	194	23	,	,	PUNCT
iajs-3302	194	24	s.	s.	PROPN
iajs-3302	194	25	;	;	PUNCT
iajs-3302	194	26	kim	kim	PROPN
iajs-3302	194	27	,	,	PUNCT
iajs-3302	194	28	t.y	t.y	PROPN
iajs-3302	194	29	.	.	PROPN
iajs-3302	194	30	;	;	PUNCT
iajs-3302	194	31	black	black	ADJ
iajs-3302	194	32	,	,	PUNCT
iajs-3302	194	33	d	d	NOUN
iajs-3302	194	34	,	,	PUNCT
iajs-3302	194	35	m.	m.	NOUN
iajs-3302	194	36	;	;	PUNCT
iajs-3302	194	37	kingman	kingman	PROPN
iajs-3302	194	38	,	,	PUNCT
iajs-3302	194	39	h.	h.	PROPN
iajs-3302	194	40	;	;	PUNCT
iajs-3302	194	41	shafer	shafer	PROPN
iajs-3302	194	42	,	,	PUNCT
iajs-3302	194	43	m.m	m.m	PROPN
iajs-3302	194	44	.	.	PROPN
iajs-3302	194	45	;	;	PUNCT
iajs-3302	194	46	rogers	rogers	PROPN
iajs-3302	194	47	,	,	PUNCT
iajs-3302	194	48	s.j	s.j	PROPN
iajs-3302	194	49	.	.	PROPN
iajs-3302	194	50	;	;	PUNCT
iajs-3302	194	51	stewart	stewart	PROPN
iajs-3302	194	52	,	,	PUNCT
iajs-3302	194	53	l.	l.	PROPN
iajs-3302	194	54	intestinal	intestinal	ADJ
iajs-3302	194	55	calcium	calcium	NOUN
iajs-3302	194	56	absorption	absorption	NOUN
iajs-3302	194	57	decreases	decrease	VERB
iajs-3302	194	58	after	after	ADP
iajs-3302	194	59	laparoscopic	laparoscopic	NOUN
iajs-3302	194	60	sleeve	sleeve	NOUN
iajs-3302	194	61	gastrectomy	gastrectomy	NOUN
iajs-3302	194	62	despite	despite	SCONJ
iajs-3302	194	63	optimization	optimization	NOUN
iajs-3302	194	64	of	of	ADP
iajs-3302	194	65	vitamin	vitamin	NOUN
iajs-3302	194	66	d	d	NOUN
iajs-3302	194	67	status	status	NOUN
iajs-3302	194	68	.	.	PUNCT
iajs-3302	195	1	the	the	DET
iajs-3302	195	2	journal	journal	NOUN
iajs-3302	195	3	of	of	ADP
iajs-3302	195	4	clinical	clinical	ADJ
iajs-3302	195	5	endocrinology	endocrinology	NOUN
iajs-3302	195	6	&	&	CCONJ
iajs-3302	195	7	metabolism	metabolism	NOUN
iajs-3302	195	8	2023	2023	NUM
iajs-3302	195	9	,	,	PUNCT
iajs-3302	195	10	108(2),351	108(2),351	NOUN
iajs-3302	195	11	-	-	PUNCT
iajs-3302	195	12	360	360	NUM
iajs-3302	195	13	.	.	PUNCT
iajs-3302	196	1	https://doi.org/10.1210/clinem/dgac579	https://doi.org/10.1210/clinem/dgac579	PROPN
iajs-3302	196	2	.	.	PUNCT
iajs-3302	197	1	16	16	NUM
iajs-3302	197	2	.	.	PUNCT
iajs-3302	198	1	akpoveso	akpoveso	PROPN
iajs-3302	198	2	,	,	PUNCT
iajs-3302	198	3	o.o	o.o	PROPN
iajs-3302	198	4	.	.	PROPN
iajs-3302	198	5	;	;	PUNCT
iajs-3302	198	6	ubah	ubah	PROPN
iajs-3302	198	7	,	,	PUNCT
iajs-3302	198	8	e.e	e.e	PROPN
iajs-3302	198	9	.	.	PROPN
iajs-3302	198	10	;	;	PUNCT
iajs-3302	198	11	obasanmi	obasanmi	PROPN
iajs-3302	198	12	,	,	PUNCT
iajs-3302	198	13	g.	g.	PROPN
iajs-3302	198	14	antioxidant	antioxidant	ADJ
iajs-3302	198	15	phytochemicals	phytochemical	NOUN
iajs-3302	198	16	as	as	ADP
iajs-3302	198	17	potential	potential	ADJ
iajs-3302	198	18	therapy	therapy	NOUN
iajs-3302	198	19	for	for	ADP
iajs-3302	198	20	diabetic	diabetic	ADJ
iajs-3302	198	21	complications	complication	NOUN
iajs-3302	198	22	.	.	PUNCT
iajs-3302	199	1	antioxidants	antioxidant	NOUN
iajs-3302	199	2	2023	2023	NUM
iajs-3302	199	3	,	,	PUNCT
iajs-3302	199	4	12(1),123	12(1),123	NUM
iajs-3302	199	5	.	.	PUNCT
iajs-3302	199	6	https://doi.org/10.3390/antiox12010123	https://doi.org/10.3390/antiox12010123	NOUN
iajs-3302	199	7	.	.	PUNCT
iajs-3302	200	1	17	17	NUM
iajs-3302	200	2	.	.	PUNCT
iajs-3302	201	1	chaulin	chaulin	PROPN
iajs-3302	201	2	,	,	PUNCT
iajs-3302	201	3	a.m.	a.m.	NOUN
iajs-3302	201	4	gender	gender	NOUN
iajs-3302	201	5	specificities	specificity	NOUN
iajs-3302	201	6	of	of	ADP
iajs-3302	201	7	cardiac	cardiac	ADJ
iajs-3302	201	8	troponin	troponin	ADJ
iajs-3302	201	9	serum	serum	NOUN
iajs-3302	201	10	levels	level	NOUN
iajs-3302	201	11	:	:	PUNCT
iajs-3302	201	12	from	from	ADP
iajs-3302	201	13	formation	formation	NOUN
iajs-3302	201	14	mechanisms	mechanism	NOUN
iajs-3302	201	15	to	to	ADP
iajs-3302	201	16	the	the	DET
iajs-3302	201	17	diagnostic	diagnostic	ADJ
iajs-3302	201	18	role	role	NOUN
iajs-3302	201	19	in	in	ADP
iajs-3302	201	20	case	case	NOUN
iajs-3302	201	21	of	of	ADP
iajs-3302	201	22	acute	acute	ADJ
iajs-3302	201	23	coronary	coronary	ADJ
iajs-3302	201	24	syndrome	syndrome	NOUN
iajs-3302	201	25	.	.	PUNCT
iajs-3302	202	1	life	life	NOUN
iajs-3302	202	2	2023	2023	NUM
iajs-3302	202	3	,	,	PUNCT
iajs-3302	202	4	13(2),267	13(2),267	NUM
iajs-3302	202	5	.	.	PUNCT
iajs-3302	202	6	https://doi.org/10.3390/life13020267	https://doi.org/10.3390/life13020267	PROPN
iajs-3302	202	7	.	.	PUNCT
iajs-3302	203	1	18	18	NUM
iajs-3302	203	2	.	.	X
iajs-3302	204	1	abd	abd	PROPN
iajs-3302	204	2	-	-	PUNCT
iajs-3302	204	3	elfattah	elfattah	PROPN
iajs-3302	204	4	,	,	PUNCT
iajs-3302	204	5	r.m	r.m	PROPN
iajs-3302	204	6	.	.	PROPN
iajs-3302	204	7	;	;	PUNCT
iajs-3302	204	8	rashed	rashe	VERB
iajs-3302	204	9	,	,	PUNCT
iajs-3302	204	10	l.a	l.a	PROPN
iajs-3302	204	11	;	;	PUNCT
iajs-3302	204	12	hassan	hassan	PROPN
iajs-3302	204	13	,	,	PUNCT
iajs-3302	204	14	f.a	f.a	PROPN
iajs-3302	204	15	.	.	PROPN
iajs-3302	204	16	gene	gene	NOUN
iajs-3302	204	17	expression	expression	NOUN
iajs-3302	204	18	of	of	ADP
iajs-3302	204	19	connective	connective	ADJ
iajs-3302	204	20	tissue	tissue	NOUN
iajs-3302	204	21	growth	growth	NOUN
iajs-3302	204	22	factor	factor	NOUN
iajs-3302	204	23	in	in	ADP
iajs-3302	204	24	relation	relation	NOUN
iajs-3302	204	25	to	to	ADP
iajs-3302	204	26	nephropathy	nephropathy	NOUN
iajs-3302	204	27	in	in	ADP
iajs-3302	204	28	patients	patient	NOUN
iajs-3302	204	29	with	with	ADP
iajs-3302	204	30	type	type	NOUN
iajs-3302	204	31	2	2	NUM
iajs-3302	204	32	diabetes	diabetes	NOUN
iajs-3302	204	33	.	.	PUNCT
iajs-3302	205	1	azhar	azhar	PROPN
iajs-3302	205	2	international	international	PROPN
iajs-3302	205	3	journal	journal	PROPN
iajs-3302	205	4	of	of	ADP
iajs-3302	205	5	pharmaceutical	pharmaceutical	NOUN
iajs-3302	205	6	and	and	CCONJ
iajs-3302	205	7	medical	medical	ADJ
iajs-3302	205	8	sciences	science	NOUN
iajs-3302	205	9	2023	2023	NUM
iajs-3302	205	10	,	,	PUNCT
iajs-3302	205	11	3(1),172	3(1),172	NUM
iajs-3302	205	12	-	-	SYM
iajs-3302	205	13	179	179	NUM
iajs-3302	205	14	.	.	PUNCT
iajs-3302	206	1	https://doi.org/10.21608/aijpms.2022.149722.1152	https://doi.org/10.21608/aijpms.2022.149722.1152	NUM
iajs-3302	206	2	.	.	PUNCT
iajs-3302	207	1	19	19	NUM
iajs-3302	207	2	.	.	X
iajs-3302	207	3	sun	sun	PROPN
iajs-3302	207	4	,	,	PUNCT
iajs-3302	207	5	y.	y.	PROPN
iajs-3302	207	6	;	;	PUNCT
iajs-3302	207	7	jin	jin	PROPN
iajs-3302	207	8	,	,	PUNCT
iajs-3302	207	9	d.	d.	PROPN
iajs-3302	207	10	;	;	PUNCT
iajs-3302	207	11	zhang	zhang	PROPN
iajs-3302	207	12	,	,	PUNCT
iajs-3302	207	13	z.	z.	PROPN
iajs-3302	207	14	;	;	PUNCT
iajs-3302	207	15	zhang	zhang	PROPN
iajs-3302	207	16	,	,	PUNCT
iajs-3302	207	17	y.	y.	PROPN
iajs-3302	207	18	;	;	PUNCT
iajs-3302	207	19	zhang	zhang	PROPN
iajs-3302	207	20	,	,	PUNCT
iajs-3302	207	21	y.	y.	PROPN
iajs-3302	207	22	;	;	PUNCT
iajs-3302	207	23	kang	kang	PROPN
iajs-3302	207	24	,	,	PUNCT
iajs-3302	207	25	x.	x.	PROPN
iajs-3302	207	26	;	;	PUNCT
iajs-3302	207	27	jiang	jiang	PROPN
iajs-3302	207	28	,	,	PUNCT
iajs-3302	207	29	l.	l.	PROPN
iajs-3302	207	30	;	;	PUNCT
iajs-3302	207	31	tong	tong	PROPN
iajs-3302	207	32	,	,	PUNCT
iajs-3302	207	33	x.	x.	PROPN
iajs-3302	207	34	;	;	PUNCT
iajs-3302	207	35	lian	lian	PROPN
iajs-3302	207	36	,	,	PUNCT
iajs-3302	207	37	f	f	PROPN
iajs-3302	207	38	..	..	PUNCT
iajs-3302	207	39	effects	effect	NOUN
iajs-3302	207	40	of	of	ADP
iajs-3302	207	41	antioxidants	antioxidant	NOUN
iajs-3302	207	42	on	on	ADP
iajs-3302	207	43	diabetic	diabetic	ADJ
iajs-3302	207	44	kidney	kidney	NOUN
iajs-3302	207	45	diseases	disease	NOUN
iajs-3302	207	46	:	:	PUNCT
iajs-3302	207	47	mechanistic	mechanistic	ADJ
iajs-3302	207	48	interpretations	interpretation	NOUN
iajs-3302	207	49	and	and	CCONJ
iajs-3302	207	50	clinical	clinical	ADJ
iajs-3302	207	51	assessment	assessment	NOUN
iajs-3302	207	52	.	.	PUNCT
iajs-3302	208	1	chinese	chinese	ADJ
iajs-3302	208	2	medicine	medicine	NOUN
iajs-3302	208	3	2023	2023	NUM
iajs-3302	208	4	,	,	PUNCT
iajs-3302	208	5	18(1),1	18(1),1	NUM
iajs-3302	208	6	-	-	NOUN
iajs-3302	208	7	21.https://doi.org/10.1186	21.https://doi.org/10.1186	ADJ
iajs-3302	208	8	/	/	SYM
iajs-3302	208	9	s13020	s13020	PROPN
iajs-3302	208	10	-	-	PUNCT
iajs-3302	208	11	022	022	NUM
iajs-3302	208	12	-	-	PUNCT
iajs-3302	208	13	00700	00700	NUM
iajs-3302	208	14	-	-	PUNCT
iajs-3302	208	15	w.	w.	NOUN
iajs-3302	208	16	20	20	NUM
iajs-3302	208	17	.	.	PUNCT
iajs-3302	209	1	sutherland	sutherland	PROPN
iajs-3302	209	2	,	,	PUNCT
iajs-3302	209	3	t.e	t.e	PROPN
iajs-3302	209	4	.	.	PROPN
iajs-3302	209	5	;	;	PUNCT
iajs-3302	209	6	dyer	dyer	PROPN
iajs-3302	209	7	,	,	PUNCT
iajs-3302	209	8	d.p	d.p	PROPN
iajs-3302	209	9	.	.	PROPN
iajs-3302	209	10	;	;	PUNCT
iajs-3302	209	11	allen	allen	PROPN
iajs-3302	209	12	,	,	PUNCT
iajs-3302	209	13	j.e	j.e	PROPN
iajs-3302	209	14	.	.	PROPN
iajs-3302	209	15	the	the	DET
iajs-3302	209	16	extracellular	extracellular	ADJ
iajs-3302	209	17	matrix	matrix	NOUN
iajs-3302	209	18	and	and	CCONJ
iajs-3302	209	19	the	the	DET
iajs-3302	209	20	immune	immune	ADJ
iajs-3302	209	21	system	system	NOUN
iajs-3302	209	22	:	:	PUNCT
iajs-3302	209	23	a	a	DET
iajs-3302	209	24	mutually	mutually	ADV
iajs-3302	209	25	dependent	dependent	ADJ
iajs-3302	209	26	relationship	relationship	NOUN
iajs-3302	209	27	.	.	PUNCT
iajs-3302	210	1	science	science	NOUN
iajs-3302	210	2	2023	2023	NUM
iajs-3302	210	3	,	,	PUNCT
iajs-3302	210	4	379(6633),eabp8964	379(6633),eabp8964	NUM
iajs-3302	210	5	.	.	PUNCT
iajs-3302	211	1	https://doi.org/10.1126/science.abp8964	https://doi.org/10.1126/science.abp8964	PROPN
iajs-3302	211	2	.	.	PUNCT
iajs-3302	212	1	21	21	NUM
iajs-3302	212	2	.	.	PUNCT
iajs-3302	213	1	putra	putra	PROPN
iajs-3302	213	2	,	,	PUNCT
iajs-3302	213	3	i.m	i.m	PROPN
iajs-3302	213	4	.	.	PROPN
iajs-3302	213	5	;	;	PUNCT
iajs-3302	213	6	fakhrudin	fakhrudin	NOUN
iajs-3302	213	7	,	,	PUNCT
iajs-3302	213	8	n.	n.	NOUN
iajs-3302	213	9	;	;	PUNCT
iajs-3302	213	10	nurrochmad	nurrochmad	NOUN
iajs-3302	213	11	,	,	PUNCT
iajs-3302	213	12	a.	a.	NOUN
iajs-3302	213	13	;	;	PUNCT
iajs-3302	213	14	wahyuono	wahyuono	PROPN
iajs-3302	213	15	,	,	PUNCT
iajs-3302	213	16	s.a	s.a	PROPN
iajs-3302	213	17	.	.	PROPN
iajs-3302	213	18	review	review	PROPN
iajs-3302	213	19	of	of	ADP
iajs-3302	213	20	medicinal	medicinal	ADJ
iajs-3302	213	21	plants	plant	NOUN
iajs-3302	213	22	with	with	ADP
iajs-3302	213	23	renoprotective	renoprotective	ADJ
iajs-3302	213	24	activity	activity	NOUN
iajs-3302	213	25	in	in	ADP
iajs-3302	213	26	diabetic	diabetic	ADJ
iajs-3302	213	27	nephropathy	nephropathy	ADJ
iajs-3302	213	28	animal	animal	NOUN
iajs-3302	213	29	models	model	NOUN
iajs-3302	213	30	.	.	PUNCT
iajs-3302	214	1	life	life	NOUN
iajs-3302	214	2	2023	2023	NUM
iajs-3302	214	3	,	,	PUNCT
iajs-3302	214	4	13(2),560	13(2),560	NUM
iajs-3302	214	5	.	.	PUNCT
iajs-3302	215	1	https://doi.org/10.3390/life13020560	https://doi.org/10.3390/life13020560	PROPN
iajs-3302	215	2	.	.	PUNCT
iajs-3302	216	1	22	22	NUM
iajs-3302	216	2	.	.	PUNCT
iajs-3302	217	1	salih	salih	PROPN
iajs-3302	217	2	,	,	PUNCT
iajs-3302	217	3	a.a	a.a	PROPN
iajs-3302	217	4	.	.	PROPN
iajs-3302	217	5	;	;	PUNCT
iajs-3302	217	6	saeedi	saeedi	PROPN
iajs-3302	217	7	,	,	PUNCT
iajs-3302	217	8	s.m	s.m	PROPN
iajs-3302	217	9	.	.	PROPN
iajs-3302	217	10	;	;	PUNCT
iajs-3302	217	11	ghali	ghali	PROPN
iajs-3302	217	12	,	,	PUNCT
iajs-3302	217	13	k.h	k.h	PROPN
iajs-3302	217	14	.	.	PROPN
iajs-3302	217	15	impact	impact	NOUN
iajs-3302	217	16	of	of	ADP
iajs-3302	217	17	fibrosis	fibrosis	NOUN
iajs-3302	217	18	related	relate	VERB
iajs-3302	217	19	to	to	ADP
iajs-3302	217	20	tgf	tgf	NOUN
iajs-3302	217	21	-	-	PUNCT
iajs-3302	217	22	b1	b1	PROPN
iajs-3302	217	23	and	and	CCONJ
iajs-3302	217	24	tnfr-1	tnfr-1	NUM
iajs-3302	217	25	growth	growth	NOUN
iajs-3302	217	26	factors	factor	NOUN
iajs-3302	217	27	in	in	ADP
iajs-3302	217	28	renal	renal	ADJ
iajs-3302	217	29	failure	failure	NOUN
iajs-3302	217	30	patients	patient	NOUN
iajs-3302	217	31	.	.	PUNCT
iajs-3302	218	1	journal	journal	PROPN
iajs-3302	218	2	of	of	ADP
iajs-3302	218	3	medical	medical	ADJ
iajs-3302	218	4	research	research	NOUN
iajs-3302	218	5	and	and	CCONJ
iajs-3302	218	6	health	health	NOUN
iajs-3302	218	7	sciences	science	NOUN
iajs-3302	218	8	2022	2022	NUM
iajs-3302	218	9	,	,	PUNCT
iajs-3302	218	10	5(7	5(7	NUM
iajs-3302	218	11	)	)	PUNCT
iajs-3302	218	12	,	,	PUNCT
iajs-3302	218	13	2105	2105	NUM
iajs-3302	218	14	-	-	SYM
iajs-3302	218	15	2111	2111	NUM
iajs-3302	218	16	.	.	PUNCT
iajs-3302	219	1	https://doi.org/10.52845/jmrhs/2022-5-7-6	https://doi.org/10.52845/jmrhs/2022-5-7-6	PROPN
iajs-3302	219	2	.	.	PROPN
iajs-3302	219	3	23	23	NUM
iajs-3302	219	4	.	.	PUNCT
iajs-3302	220	1	wei	wei	PROPN
iajs-3302	220	2	,	,	PUNCT
iajs-3302	220	3	h.	h.	PROPN
iajs-3302	220	4	;	;	PUNCT
iajs-3302	220	5	li	li	PROPN
iajs-3302	220	6	,	,	PUNCT
iajs-3302	220	7	d.	d.	PROPN
iajs-3302	220	8	;	;	PUNCT
iajs-3302	220	9	luo	luo	PROPN
iajs-3302	220	10	,	,	PUNCT
iajs-3302	220	11	y.	y.	PROPN
iajs-3302	220	12	;	;	PUNCT
iajs-3302	220	13	wang	wang	PROPN
iajs-3302	220	14	,	,	PUNCT
iajs-3302	220	15	y.	y.	PROPN
iajs-3302	220	16	;	;	PUNCT
iajs-3302	220	17	lin	lin	PROPN
iajs-3302	220	18	,	,	PUNCT
iajs-3302	220	19	e.	e.	PROPN
iajs-3302	220	20	;	;	PUNCT
iajs-3302	220	21	wei	wei	PROPN
iajs-3302	220	22	,	,	PUNCT
iajs-3302	220	23	x.	x.	NOUN
iajs-3302	220	24	aluminum	aluminum	PROPN
iajs-3302	220	25	exposure	exposure	NOUN
iajs-3302	220	26	induces	induce	VERB
iajs-3302	220	27	nephrotoxicity	nephrotoxicity	NOUN
iajs-3302	220	28	via	via	ADP
iajs-3302	220	29	fibrosis	fibrosis	NOUN
iajs-3302	220	30	and	and	CCONJ
iajs-3302	220	31	apoptosis	apoptosis	NOUN
iajs-3302	220	32	through	through	ADP
iajs-3302	220	33	the	the	DET
iajs-3302	220	34	tgf	tgf	PROPN
iajs-3302	220	35	-	-	PUNCT
iajs-3302	220	36	β1	β1	PROPN
iajs-3302	220	37	/	/	SYM
iajs-3302	220	38	smads	smad	NOUN
iajs-3302	220	39	pathway	pathway	NOUN
iajs-3302	220	40	in	in	ADP
iajs-3302	220	41	vivo	vivo	NOUN
iajs-3302	220	42	and	and	CCONJ
iajs-3302	220	43	in	in	ADP
iajs-3302	220	44	vitro	vitro	X
iajs-3302	220	45	.	.	PUNCT
iajs-3302	221	1	ecotoxicology	ecotoxicology	NOUN
iajs-3302	221	2	and	and	CCONJ
iajs-3302	221	3	environmental	environmental	ADJ
iajs-3302	221	4	safety	safety	NOUN
iajs-3302	221	5	2023	2023	NUM
iajs-3302	221	6	,	,	PUNCT
iajs-3302	221	7	249,114422	249,114422	NUM
iajs-3302	221	8	.	.	PUNCT
iajs-3302	222	1	https://doi.org/10.1016/j.ecoenv.2022.114422	https://doi.org/10.1016/j.ecoenv.2022.114422	ADJ
iajs-3302	222	2	.	.	PUNCT
iajs-3302	223	1	24	24	NUM
iajs-3302	223	2	.	.	PUNCT
iajs-3302	223	3	hirata	hirata	PROPN
iajs-3302	223	4	,	,	PUNCT
iajs-3302	223	5	r.d	r.d	PROPN
iajs-3302	223	6	.	.	PROPN
iajs-3302	223	7	;	;	PUNCT
iajs-3302	223	8	genvigir	genvigir	PROPN
iajs-3302	223	9	,	,	PUNCT
iajs-3302	223	10	f.d	f.d	PROPN
iajs-3302	223	11	.	.	PROPN
iajs-3302	223	12	;	;	PUNCT
iajs-3302	223	13	hirata	hirata	PROPN
iajs-3302	223	14	,	,	PUNCT
iajs-3302	223	15	t.d	t.d	PROPN
iajs-3302	223	16	.	.	PROPN
iajs-3302	223	17	;	;	PUNCT
iajs-3302	223	18	cerda	cerda	PROPN
iajs-3302	223	19	,	,	PUNCT
iajs-3302	223	20	a.	a.	NOUN
iajs-3302	223	21	;	;	PUNCT
iajs-3302	223	22	hirata	hirata	PROPN
iajs-3302	223	23	,	,	PUNCT
iajs-3302	223	24	m.h	m.h	PROPN
iajs-3302	223	25	.	.	PROPN
iajs-3302	223	26	pharmacogenomics	pharmacogenomic	NOUN
iajs-3302	223	27	of	of	ADP
iajs-3302	223	28	mycophenolic	mycophenolic	ADJ
iajs-3302	223	29	acid	acid	NOUN
iajs-3302	223	30	in	in	ADP
iajs-3302	223	31	kidney	kidney	NOUN
iajs-3302	223	32	transplantation	transplantation	NOUN
iajs-3302	223	33	:	:	PUNCT
iajs-3302	223	34	contribution	contribution	NOUN
iajs-3302	223	35	of	of	ADP
iajs-3302	223	36	immune	immune	ADJ
iajs-3302	223	37	response	response	NOUN
iajs-3302	223	38	-	-	PUNCT
iajs-3302	223	39	related	relate	VERB
iajs-3302	223	40	genes	gene	NOUN
iajs-3302	223	41	.	.	PUNCT
iajs-3302	224	1	brazilian	brazilian	ADJ
iajs-3302	224	2	journal	journal	PROPN
iajs-3302	224	3	of	of	ADP
iajs-3302	224	4	pharmaceutical	pharmaceutical	ADJ
iajs-3302	224	5	sciences	science	NOUN
iajs-3302	224	6	2023	2023	NUM
iajs-3302	224	7	,	,	PUNCT
iajs-3302	224	8	58	58	NUM
iajs-3302	224	9	.	.	PUNCT
iajs-3302	225	1	https://doi.org/10.1590/s2175-97902022e201188	https://doi.org/10.1590/s2175-97902022e201188	NOUN
iajs-3302	225	2	.	.	PUNCT
iajs-3302	226	1	25	25	NUM
iajs-3302	226	2	.	.	PUNCT
iajs-3302	227	1	ke	ke	PROPN
iajs-3302	227	2	,	,	PUNCT
iajs-3302	227	3	b.	b.	PROPN
iajs-3302	227	4	;	;	PUNCT
iajs-3302	227	5	shen	shen	PROPN
iajs-3302	227	6	,	,	PUNCT
iajs-3302	227	7	w.	w.	PROPN
iajs-3302	227	8	;	;	PUNCT
iajs-3302	227	9	song	song	PROPN
iajs-3302	227	10	,	,	PUNCT
iajs-3302	227	11	j.	j.	PROPN
iajs-3302	227	12	;	;	PUNCT
iajs-3302	227	13	fang	fang	X
iajs-3302	227	14	,	,	PUNCT
iajs-3302	227	15	x.	x.	PUNCT
iajs-3302	228	1	mg53	mg53	PROPN
iajs-3302	228	2	:	:	PUNCT
iajs-3302	228	3	a	a	DET
iajs-3302	228	4	potential	potential	ADJ
iajs-3302	228	5	therapeutic	therapeutic	ADJ
iajs-3302	228	6	target	target	NOUN
iajs-3302	228	7	for	for	ADP
iajs-3302	228	8	kidney	kidney	NOUN
iajs-3302	228	9	disease	disease	NOUN
iajs-3302	228	10	.	.	PUNCT
iajs-3302	229	1	pharmacology	pharmacology	NOUN
iajs-3302	229	2	research	research	NOUN
iajs-3302	229	3	&	&	CCONJ
iajs-3302	229	4	perspectives	perspective	NOUN
iajs-3302	229	5	2023	2023	NUM
iajs-3302	229	6	,	,	PUNCT
iajs-3302	229	7	11(1),e01049	11(1),e01049	NUM
iajs-3302	229	8	.	.	PUNCT
iajs-3302	230	1	https://doi.org/10.1002/prp2.1049	https://doi.org/10.1002/prp2.1049	NOUN
iajs-3302	230	2	.	.	PUNCT
iajs-3302	231	1	26	26	NUM
iajs-3302	231	2	.	.	PUNCT
iajs-3302	232	1	sinha	sinha	PROPN
iajs-3302	232	2	,	,	PUNCT
iajs-3302	232	3	r.a	r.a	PROPN
iajs-3302	232	4	.	.	PROPN
iajs-3302	232	5	autophagy	autophagy	NOUN
iajs-3302	232	6	:	:	PUNCT
iajs-3302	232	7	a	a	DET
iajs-3302	232	8	cellular	cellular	ADJ
iajs-3302	232	9	guardian	guardian	NOUN
iajs-3302	232	10	against	against	ADP
iajs-3302	232	11	hepatic	hepatic	ADJ
iajs-3302	232	12	lipotoxicity	lipotoxicity	NOUN
iajs-3302	232	13	.	.	PUNCT
iajs-3302	233	1	genes	gene	NOUN
iajs-3302	233	2	2023	2023	NUM
iajs-3302	233	3	,	,	PUNCT
iajs-3302	233	4	14(3),553	14(3),553	NUM
iajs-3302	233	5	.	.	PUNCT
iajs-3302	233	6	https://doi.org/10.3390/genes14030553	https://doi.org/10.3390/genes14030553	PROPN
iajs-3302	233	7	.	.	PUNCT
iajs-3302	234	1	27	27	NUM
iajs-3302	234	2	.	.	PUNCT
iajs-3302	235	1	fife	fife	PROPN
iajs-3302	235	2	,	,	PUNCT
iajs-3302	235	3	b.t	b.t	PROPN
iajs-3302	235	4	.	.	PROPN
iajs-3302	235	5	;	;	PUNCT
iajs-3302	235	6	pauken	pauken	PROPN
iajs-3302	235	7	,	,	PUNCT
iajs-3302	235	8	k.e	k.e	PROPN
iajs-3302	235	9	.	.	PUNCT
iajs-3302	236	1	the	the	DET
iajs-3302	236	2	role	role	NOUN
iajs-3302	236	3	of	of	ADP
iajs-3302	236	4	the	the	DET
iajs-3302	236	5	pd‐1	pd‐1	NOUN
iajs-3302	236	6	pathway	pathway	NOUN
iajs-3302	236	7	in	in	ADP
iajs-3302	236	8	autoimmunity	autoimmunity	NOUN
iajs-3302	236	9	and	and	CCONJ
iajs-3302	236	10	peripheral	peripheral	ADJ
iajs-3302	236	11	tolerance	tolerance	NOUN
iajs-3302	236	12	.	.	PUNCT
iajs-3302	237	1	ann	ann	PROPN
iajs-3302	237	2	n	n	PROPN
iajs-3302	237	3	y	y	PROPN
iajs-3302	237	4	acad	acad	PROPN
iajs-3302	237	5	sci	sci	PROPN
iajs-3302	237	6	2011	2011	NUM
iajs-3302	237	7	,	,	PUNCT
iajs-3302	237	8	1217,45	1217,45	PROPN
iajs-3302	237	9	-	-	SYM
iajs-3302	237	10	59	59	NUM
iajs-3302	237	11	.	.	PUNCT
iajs-3302	238	1	https://doi.org/10.1111/j.1749-6632.2010.05919.x	https://doi.org/10.1111/j.1749-6632.2010.05919.x	PROPN
iajs-3302	238	2	.	.	PUNCT
iajs-3302	239	1	28	28	NUM
iajs-3302	239	2	.	.	PUNCT
iajs-3302	240	1	lee	lee	PROPN
iajs-3302	240	2	,	,	PUNCT
iajs-3302	240	3	y.h	y.h	PROPN
iajs-3302	240	4	.	.	PROPN
iajs-3302	240	5	;	;	PUNCT
iajs-3302	240	6	woo	woo	PROPN
iajs-3302	240	7	,	,	PUNCT
iajs-3302	240	8	j.h	j.h	PROPN
iajs-3302	240	9	.	.	PROPN
iajs-3302	240	10	;	;	PUNCT
iajs-3302	240	11	choi	choi	NOUN
iajs-3302	240	12	,	,	PUNCT
iajs-3302	240	13	s.j	s.j	PROPN
iajs-3302	240	14	.	.	PROPN
iajs-3302	240	15	;	;	PUNCT
iajs-3302	241	1	ji	ji	PROPN
iajs-3302	241	2	,	,	PUNCT
iajs-3302	241	3	j.d	j.d	PROPN
iajs-3302	241	4	.	.	PROPN
iajs-3302	241	5	;	;	PUNCT
iajs-3302	241	6	song	song	NOUN
iajs-3302	241	7	,	,	PUNCT
iajs-3302	241	8	g.g.association	g.g.association	NOUN
iajs-3302	241	9	of	of	ADP
iajs-3302	241	10	programmed	program	VERB
iajs-3302	241	11	cell	cell	NOUN
iajs-3302	241	12	death	death	NOUN
iajs-3302	241	13	1	1	NUM
iajs-3302	241	14	polymorphisms	polymorphism	NOUN
iajs-3302	241	15	and	and	CCONJ
iajs-3302	241	16	systemic	systemic	ADJ
iajs-3302	241	17	lupus	lupus	PROPN
iajs-3302	241	18	erythematosus	erythematosus	NOUN
iajs-3302	241	19	:	:	PUNCT
iajs-3302	241	20	a	a	DET
iajs-3302	241	21	meta	meta	ADJ
iajs-3302	241	22	-	-	PUNCT
iajs-3302	241	23	analysis	analysis	NOUN
iajs-3302	241	24	.	.	PUNCT
iajs-3302	242	1	lupus	lupus	NOUN
iajs-3302	242	2	2009	2009	NUM
iajs-3302	242	3	,	,	PUNCT
iajs-3302	242	4	18(1),9	18(1),9	NUM
iajs-3302	242	5	-	-	SYM
iajs-3302	242	6	15	15	NUM
iajs-3302	242	7	.	.	PUNCT
iajs-3302	243	1	https://doi	https://doi	ADJ
iajs-3302	243	2	:	:	PUNCT
iajs-3302	243	3	10.1177/0961203308093923	10.1177/0961203308093923	NUM
iajs-3302	243	4	.	.	PUNCT
iajs-3302	244	1	https://doi.org/10.1016/j.redox.2023.102612	https://doi.org/10.1016/j.redox.2023.102612	NOUN
iajs-3302	244	2	.	.	PUNCT
iajs-3302	245	1	https://doi.org/10.1152/japplphysiol.00586.2022	https://doi.org/10.1152/japplphysiol.00586.2022	PROPN
iajs-3302	245	2	.	.	PUNCT
iajs-3302	246	1	https://doi.org/10.1210/clinem/dgac579	https://doi.org/10.1210/clinem/dgac579	PROPN
iajs-3302	246	2	.	.	PUNCT
iajs-3302	247	1	https://doi.org/10.3390/antiox12010123	https://doi.org/10.3390/antiox12010123	NOUN
iajs-3302	247	2	.	.	PUNCT
iajs-3302	248	1	https://doi.org/10.3390/life13020267	https://doi.org/10.3390/life13020267	PROPN
iajs-3302	248	2	.	.	PUNCT
iajs-3302	249	1	https://doi.org/10.21608/aijpms.2022.149722.1152	https://doi.org/10.21608/aijpms.2022.149722.1152	X
iajs-3302	249	2	.	.	PUNCT
iajs-3302	250	1	https://doi.org/10.1186/s13020-022-00700-w	https://doi.org/10.1186/s13020-022-00700-w	PROPN
iajs-3302	250	2	.	.	PUNCT
iajs-3302	251	1	https://doi.org/10.1126/science.abp8964	https://doi.org/10.1126/science.abp8964	PROPN
iajs-3302	251	2	.	.	PUNCT
iajs-3302	252	1	https://doi.org/10.3390/life13020560	https://doi.org/10.3390/life13020560	PROPN
iajs-3302	252	2	.	.	PUNCT
iajs-3302	253	1	https://doi.org/10.52845/jmrhs/2022-5-7-6	https://doi.org/10.52845/jmrhs/2022-5-7-6	PROPN
iajs-3302	253	2	.	.	PUNCT
iajs-3302	254	1	https://doi.org/10.1016/j.ecoenv.2022.114422	https://doi.org/10.1016/j.ecoenv.2022.114422	ADJ
iajs-3302	254	2	.	.	PUNCT
iajs-3302	255	1	https://doi.org/10.1590/s2175-97902022e201188	https://doi.org/10.1590/s2175-97902022e201188	NOUN
iajs-3302	255	2	.	.	PUNCT
iajs-3302	256	1	https://doi.org/10.1002/prp2.1049	https://doi.org/10.1002/prp2.1049	NOUN
iajs-3302	256	2	.	.	PUNCT
iajs-3302	257	1	https://doi.org/10.3390/genes14030553	https://doi.org/10.3390/genes14030553	PROPN
iajs-3302	257	2	.	.	PUNCT
iajs-3302	258	1	https://doi.org/10.1111/j.1749-6632.2010.05919.x	https://doi.org/10.1111/j.1749-6632.2010.05919.x	PROPN
iajs-3302	258	2	.	.	PUNCT
iajs-3302	259	1	https://doi:%2010.1177/0961203308093923	https://doi:%2010.1177/0961203308093923	PRON
iajs-3302	259	2	.	.	PUNCT
iajs-3302	260	1	ihjpas	ihjpas	PROPN
iajs-3302	260	2	.	.	PUNCT
iajs-3302	261	1	37	37	NUM
iajs-3302	261	2	(	(	PUNCT
iajs-3302	261	3	2	2	NUM
iajs-3302	261	4	)	)	PUNCT
iajs-3302	261	5	2024	2024	NUM
iajs-3302	261	6	269	269	NUM
iajs-3302	261	7	29	29	NUM
iajs-3302	261	8	.	.	PUNCT
iajs-3302	262	1	curran	curran	PROPN
iajs-3302	262	2	,	,	PUNCT
iajs-3302	262	3	c.s	c.s	PROPN
iajs-3302	262	4	.	.	PROPN
iajs-3302	262	5	;	;	PUNCT
iajs-3302	262	6	gupta	gupta	PROPN
iajs-3302	262	7	,	,	PUNCT
iajs-3302	262	8	s.	s.	PROPN
iajs-3302	262	9	;	;	PUNCT
iajs-3302	262	10	sanz	sanz	PROPN
iajs-3302	262	11	,	,	PUNCT
iajs-3302	262	12	i.	i.	PROPN
iajs-3302	262	13	;	;	PUNCT
iajs-3302	262	14	sharon	sharon	PROPN
iajs-3302	262	15	,	,	PUNCT
iajs-3302	262	16	e.	e.	PROPN
iajs-3302	262	17	pd-1	pd-1	ADP
iajs-3302	262	18	immunobiology	immunobiology	NOUN
iajs-3302	262	19	in	in	ADP
iajs-3302	262	20	systemic	systemic	ADJ
iajs-3302	262	21	lupus	lupus	PROPN
iajs-3302	262	22	erythematosus	erythematosus	PROPN
iajs-3302	262	23	.	.	PUNCT
iajs-3302	263	1	j	j	PROPN
iajs-3302	263	2	autoimmun	autoimmun	PROPN
iajs-3302	263	3	2019	2019	NUM
iajs-3302	263	4	,	,	PUNCT
iajs-3302	263	5	97(1	97(1	NOUN
iajs-3302	263	6	-	-	PUNCT
iajs-3302	263	7	9),12	9),12	NUM
iajs-3302	263	8	.	.	PUNCT
iajs-3302	264	1	https://doi.org/10.1016/j.jaut.2018.10.025	https://doi.org/10.1016/j.jaut.2018.10.025	PROPN
iajs-3302	264	2	.	.	PROPN
iajs-3302	264	3	30	30	NUM
iajs-3302	264	4	.	.	PUNCT
iajs-3302	265	1	michot	michot	ADJ
iajs-3302	265	2	,	,	PUNCT
iajs-3302	265	3	j.m	j.m	PROPN
iajs-3302	265	4	.	.	PROPN
iajs-3302	265	5	;	;	PUNCT
iajs-3302	265	6	bigenwald	bigenwald	PROPN
iajs-3302	265	7	,	,	PUNCT
iajs-3302	265	8	c.	c.	PROPN
iajs-3302	265	9	;	;	PUNCT
iajs-3302	265	10	champiat	champiat	PROPN
iajs-3302	265	11	,	,	PUNCT
iajs-3302	265	12	s.	s.	PROPN
iajs-3302	265	13	;	;	PUNCT
iajs-3302	265	14	collins	collins	PROPN
iajs-3302	265	15	,	,	PUNCT
iajs-3302	265	16	m.	m.	NOUN
iajs-3302	265	17	;	;	PUNCT
iajs-3302	265	18	carbonnel	carbonnel	PROPN
iajs-3302	265	19	,	,	PUNCT
iajs-3302	265	20	f.	f.	PROPN
iajs-3302	265	21	;	;	PUNCT
iajs-3302	265	22	postel	postel	PROPN
iajs-3302	265	23	-	-	PUNCT
iajs-3302	265	24	vinay	vinay	PROPN
iajs-3302	265	25	,	,	PUNCT
iajs-3302	265	26	s.	s.	PROPN
iajs-3302	265	27	;	;	PUNCT
iajs-3302	265	28	berdelou	berdelou	PROPN
iajs-3302	265	29	,	,	PUNCT
iajs-3302	265	30	a.	a.	PROPN
iajs-3302	265	31	;	;	PUNCT
iajs-3302	265	32	varga	varga	PROPN
iajs-3302	265	33	,	,	PUNCT
iajs-3302	265	34	a.	a.	PROPN
iajs-3302	265	35	;	;	PUNCT
iajs-3302	265	36	bahleda	bahleda	PROPN
iajs-3302	265	37	,	,	PUNCT
iajs-3302	265	38	r.	r.	PROPN
iajs-3302	265	39	;	;	PUNCT
iajs-3302	265	40	hollebecque	hollebecque	ADJ
iajs-3302	265	41	,	,	PUNCT
iajs-3302	265	42	a.	a.	NOUN
iajs-3302	265	43	;	;	PUNCT
iajs-3302	265	44	massard	massard	NOUN
iajs-3302	265	45	,	,	PUNCT
iajs-3302	265	46	c.	c.	PROPN
iajs-3302	265	47	immune	immune	NOUN
iajs-3302	265	48	-	-	PUNCT
iajs-3302	265	49	related	relate	VERB
iajs-3302	265	50	adverse	adverse	ADJ
iajs-3302	265	51	events	event	NOUN
iajs-3302	265	52	with	with	ADP
iajs-3302	265	53	immune	immune	ADJ
iajs-3302	265	54	checkpoint	checkpoint	NOUN
iajs-3302	265	55	blockade	blockade	NOUN
iajs-3302	265	56	:	:	PUNCT
iajs-3302	265	57	a	a	DET
iajs-3302	265	58	comprehensive	comprehensive	ADJ
iajs-3302	265	59	review	review	NOUN
iajs-3302	265	60	.	.	PUNCT
iajs-3302	266	1	eur	eur	PROPN
iajs-3302	266	2	j	j	PROPN
iajs-3302	266	3	cancer	cancer	PROPN
iajs-3302	266	4	2016	2016	NUM
iajs-3302	266	5	,	,	PUNCT
iajs-3302	266	6	54,139	54,139	NUM
iajs-3302	266	7	-	-	SYM
iajs-3302	266	8	148	148	NUM
iajs-3302	266	9	.	.	PUNCT
iajs-3302	267	1	https://doi.org/10.1016/j.ejca.2015.11.016	https://doi.org/10.1016/j.ejca.2015.11.016	PROPN
iajs-3302	267	2	.	.	PUNCT
iajs-3302	268	1	https://doi.org/10.1016/j.jaut.2018.10.025	https://doi.org/10.1016/j.jaut.2018.10.025	PROPN
iajs-3302	268	2	https://doi.org/10.1016/j.ejca.2015.11.016	https://doi.org/10.1016/j.ejca.2015.11.016	PROPN
iajs-3302	268	3	.	.	PUNCT